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Abstract 
Analysis of the proteins of capripoxvirus (KS-1) revealed a 32kd protein that is one of 
the major structural proteins of the virus and is localised in the virus envelope. 
Monospecific serum prepared against the 32kd envelope protein neutralised the virus 
indicating that this protein contains neutralising epitopes. Lymphocyte proliferation 
studies, using the 32kd protein and peripheral blood mononuclear cells from 
capripoxvirus (KS-i) vaccinated sheep, showed that this protein strongly induced cell- 
mediated immune responses. The 32kd protein is capripoxvirus specific and induced 
antibodies in early stages of capripoxvirus infections. Immunoblot analysis of antibody 
responses against this protein has provided a basis for the differential diagnosis of 
capripoxvirus and orf virus infections. The 32kd protein bound to the surface of cultured 
lamb testis cells. The binding of the 32kd protein was completely inhibited by prior 
incubation of cells with purified capripoxvirus (KS-1) but not by bovine serum albumin. 
Trypsin treatment of capripoxvirus (KS-1) degraded the majority of the 32kd protein 
with a minimal effect on a few other virus proteins. Trypsin removed an external 10kd 
fragment from the 32kd protein, leaving a 22kd fragment associated with the virus. In 
addition, the trypsin treatment reduced the virus infectivity by at least ten fold, 
suggesting that the cell surface binding domain of the 32kd protein is located within the 
external 10kd fragment. The monospecific serum to the 32kd protein had no effect of 
the infectivity titre of the trypsin treated virus further supporting the concept that the 
external 10kd fragment of the 32kd protein is involved in binding of the virus particle 
to the cell surface. A degenerate oligonucleotide probe, based on an internal amino acid 
sequence obtained from V8 protease cleavage products of the 32kd protein, was used to 
identify the gene encoding the 32kd protein. The gene encoding the 32kd protein was 
identified within the 2.8kb HindI1l Q1 fragment of the capripoxvirus (KS-1) genome. 
The nucleotide sequence analysis of the Hindu Q1 fragment revealed five open reading 
frames (Q11L, Q12R, Q13L, Q14R and Q15L), one of these open reading frames, Q13L, 
is capable of encoding a 30.6kd protein and contains the complete internal amino acid 
sequence obtained from the V8 protease cleavage products of the 32kd protein, 
indicating that the Q13L encodes the 32kd envelope protein of capripoxvirus (KS-1). The 
deduced amino acid sequence of the Q13L shows a 34.1% identity and 61.3% similarity 
with that of H3L open reading frame of vaccinia virus. 
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CHAPTER 1 
1. Introduction 
1.1 Classification of poxviruses 
Poxviruses comprise a large and diverse family of viruses which, as a group, are capable 
of infecting a wide variety of hosts ranging from insects to man. The International 
Committee for the Taxonomy of Viruses (ICTV) divided the Poxviridae into two sub- 
families on the basis of host range: the Chordopoxvirinae (poxviruses of vertebrates) and 
Entomopoxvirinae (poxviruses of insects) (Matthews, 1982). These sub-families have 
been further classified into genera on the criteria of cross-protection studies in animals, 
cross-neutralization of infectivity in tissue culture, and cross-hybridization of genomic 
DNA from virions. The latter criterion is now the method of choice for classification of 
poxvirus isolates. Characteristic features of all poxviruses include (i) a structurally 
complex virion containing all the enzymes required for mRNA synthesis, (ii) a linear 
dsDNA molecule with a closed terminal loop at the each end, and (iii) replication within 
the cytoplasm of eukaryotic cells. 
The vertebrate poxviruses have been placed into eight genera: Orthopoxvirus, 
Parapoxvirus, Avipoxvirus, Capripoxvirus, Suipoxvirus, Leporipoxvirus, Yatapoxvirus 
and Molluscipoxvirus (Francki et al., 1991). Many of the vertebrate poxviruses exhibit 
serological cross-reactions (Woodroofe and Fenner, 1962) and are able to rescue other 
heat-inactivated poxviruses by a process called non-genetic reactivation (Woodroofe and 
Fenner, 1960). In general, members of a genus are antigenically related and have a 
similar morphology and host range. 
The capripoxviruses, according to the host to which they infect, have been classified as 
sheeppoxvirus, goatpoxvirus and lumpy skin disease virus (Neethling) of cattle 
(Matthews, 1982). However, the host specificity of the members of the capripoxvirus 
group is not always absolute. A large number of isolates of capripoxvirus from different 
parts of the world were indistinguishable on the basis of clinical disease, serum 
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neutralisation and cross-protection studies (Kitching and Taylor, 1985). The restriction 
endonuclease analysis of the genomes of a large number of field and vaccine isolates of 
capripoxvirus from sheep, goats and cattle demonstrated that the isolates possessed a 
high degree of sequence homology (Black et al., 1986; Gershon and Black, 1987,1988). 
In addition, it has been shown that a new isolate of capripoxvirus could have arisen due 
to genetic recombination between the isolates during the natural virus transmission 
(Gershon et al., 1989). These studies clearly show that despite a host preference all 
capripoxviruses are basically isolates of a single virus. In the present study, therefore, 
all isolates are referred to as capripoxvirus, irrespective of their origin from sheep, goats 
or cattle. However, when referring to the work carried out by other groups the 
nomenclature used by them has been retained. 
1.2 The poxvirus particle 
Poxviruses are the largest of all the animal viruses and can be seen by a light 
microscope, although the details of the virus remain obscure. Advances in the field of 
electron microscopy and the use of controlled degradation of the virus particle with 
detergents, reducing agents, and proteolytic enzymes have led to the visualization of the 
structural components of the virus in a greater detail (Easterbrook, 1966; Sarvo and 
Joklik, 1972). Virions appear to be brick or oval-shaped structures of about 200 to 400 
nm in length. Extracellular virus particles which bud via exocytosis from infected cells 
contain an outer envelope which consists of host lipids and several virus specified 
proteins including a haemagglutinin (Appleyard et al., 1971). The majority of the virus 
particles, however, remain cell associated and can be released from the cells by 
mechanical disruption. The virus particles released by cellular disruption lack the outer 
envelope present on the extracellular virus (Appleyard et al., 1971; Boulter and 
Appleyard, 1973). 
1.3 Structural components of the virus 
Poxviruses have a complex structure in which four components have been identified: (a) 
the biconcave or dumb-bell shaped core, (b) the two lateral bodies of unknown function, 
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(c) the outer membrane coat, and (d) the outer envelope. A diagrammatic structure of 
the poxvirus particle is shown in figure 1.1. Each component of the virus consists of a 
large number of proteins. Holowczak and Joklik (1967a), using SDS-polyacrylamide gel 
electrophoresis (SDS-PAGE), showed that 17 proteins are associated with the virus, 
while other workers identified as many as 30 distinct polypeptides ranging from 8kd to 
200kd (Sarvo and Joklik, 1972). More than 100 polypeptides have been shown to be 
associated with the purified virus by two dimensional gel electrophoresis (Essani and 
Dales, 1979; Oie and Ichihashi, 1981a). 
1.3.1 Polypeptides of the outer envelope of the virus 
Poxvirus particles released from the cells by exocytosis, as mentioned earlier, contain 
an additional envelope. These extracellular virus particles have been shown to be 
antigenically different from intracellular virus particles released by cellular disruption 
(Appleyard et al., 1971). Payne (1978) demonstrated that the outer envelope of 
extracellular virus contained eight polypeptides (210kd, 110kd, 89kd, 42kd, 37kd, 
21.5kd, 21kd, 20kd). Seven of these polypeptides are glycosylated. The 37kd non- 
glycosylated polypeptide is acylated and has been shown to be a major component of 
the extracellular virus envelope (Hiller and Weber, 1985). The gene encoding the 37kd 
polypeptide has been mapped to an open reading frame with a coding capacity for a 
42kd protein (Hirt et al., 1986). After synthesis, the 37kd protein accumulates in the 
Golgi region where the virus particle acquires the outer envelope. It has been suggested 
that this protein is involved in cytoplasmic transport of the virus particle. Recently, 
Blasco and Moss (1991) showed that the 37kd protein is involved in the formation and 
release of extracellular virus from the infected cells. 
The 89kd glycoprotein haemagglutinin is produced in infected cells and becomes 
incorporated into the host cell Golgi bodies and plasma membrane, and thereby into the 
envelope during externalization of extracellular virus (Payne, 1979). The virus 
haemagglutinin is N- and O-linked glycosylated. The gene encoding this protein has 
been mapped to an open reading frame which is capable of coding a 35kd polypeptide 
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Figure 1.1 Diagrammatic structure of a poxvirus particle. Right hand side, section of 
enveloped virus; left hand side, surface structure of nonenveloped virus particle (from 
Fenner et al., 1989) 
Surface 
tubules 
Outer 
membrane 
membrane 
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(Shida, 1986). The high molecular weight of the haemagglutinin polypeptide by 
PAGE- is due to the high level of N- and O-linked glycosylation of the protein 
(Shida and Dales, 1981). A functional haemagglutinin gene is not required for growth 
of the virus in tissue culture (Ichihashi and Dales, 1971). In addition, vaccinia virus 
(IHD-J strain) expresses haemagglutinin on the surface of infected cells but does not 
induce cell-cell fusion (Selo et al., 1990), whereas vaccinia virus mutants which do not 
express haemagglutinin on the surface of cells cause cell-cell fusion. These observations 
indicate that the vaccinia virus haemagglutinin behaves as a fusion inhibition protein. It 
has been suggested that the fusion inhibition activity resides in the extracellular domain 
of the haemagglutinin protein (Selo et al., 1990). 
1.3.2 Polypeptides of the intracellular virus envelope 
Several approaches such as enzymatic digestion, non-ionic detergent extraction, the use 
of surface labelling reagents and reactivity with virus neutralising antibodies (Sarvo and 
Joklik, 1972; Stern and Dales, 1976; Oie and Ichihashi, 1987; Rodriguez et at., 1987; 
Gordon et al., 1988; 1991) have been employed to identify the structural polypeptides 
localised within the envelope of the intracellular virus. Stern and Dales (1976) identified 
numerous tubular structures (surface tubules) on the surface of vaccinia virus. These 
surface tubules, composed of a 58kd protein, elicit neutralising antibodies in rabbits. The 
antibody to 58kd protein suppresses virus infectivity and virus induced cell-cell fusion 
observed at late times of infection. Stern and Dales (1976) also proposed a role for these 
surface tubules in mediating the entry of virus into host cells. 
A 14kd protein is present in the envelope which forms disulphide bond linked trimers 
on the surface of virion as well as on the surface of infected host cells (Rodriguez et al., 
1987). Monoclonal antibodies prepared against the 14kd protein neutralise the virus 
(Rodriguez et al., 1985) and inhibit virus penetration into cells (Rodriguez et al., 1987). 
This protein plays an important role in the fusion event of the virus particle with the 
host cell surface and in cell-cell fusion process (Gong et al., 1990). The 14kd protein 
has also been shown to be involved in the envelopment of intracellular virus within the 
Golgi apparatus for the generation of extracellular virus (Rodriguez and Smith, 1990). 
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In addition, Demkowicz et al. (1992) showed that this protein is involved in generating 
the protective immune response in mice. The gene encoding this protein has been 
mapped to an open reading frame A27L which is capable of coding for a 12.5kd 
polypeptide (Rodriguez and Esteban, 1987). 
Using an antibody as a probe, Gordon et al. (1988) identified a 35kd protein that is an 
integral component of the virus envelope and which is synthesized prior to onset of viral 
DNA replication. The surface location of this protein was confirmed by immune electron 
microscopy and surface labelling reagents (Gordon et at., 1991). Monospecific or 
monoclonal antibodies prepared against the 35kd protein were shown to neutralise the 
virus infectivity, which indicates that this protein has a function in the early stages of 
virus-host cell interactions (Gordon et al., 1991). The H6R open reading frame encoding 
this protein is capable of coding for a 22.3kd polypeptide, which is much lower than the 
apparent molecular weight determined on SDS-polyacrylamide gel. The discrepancy in 
molecular weight is not due to glycosylation or phosphorylation of the polypeptide but 
possibly due to its proline-rich sequence. The amino acid sequence of this protein 
deduced from the DNA sequence shows a 68% similarity and 24% identity with that of 
Respiratory Syncytial virus glycoprotein-G. Although both the 35kd and glycoprotein-G 
are virus envelope components, the significance of their chemical relatedness is not 
clear. 
An open reading frame D8L was identified in vaccinia virus (Western Reserve strain) 
capable of coding a 35.4kd protein (Niles and Seto, 1988). This protein is synthesized 
late in infection and is localised on the envelope of virus. The N-terminus of the protein 
forms an extra-viral domain which is released by digestion with trypsin. Computer 
analysis of the predicted amino acid sequence of this protein displays a high degree of 
homology with the mammalian carbonic anhydrase enzyme. In addition, the C-terminus 
of this protein possesses a stretch of 19 hydrophobic amino acids flanked by hydrophillic 
amino acids, which is a characteristic feature of transmembrane anchor sequences in 
several transmembrane proteins. In order to determine whether the D8L protein is 
required for virus replication, a mutant virus containing a frameshift mutation in the D8L 
gene was constructed (Niles and Seto, 1988). In the mutant virus, the molecular weight 
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of this protein is reduced to 29.5kd due to deletion of 56 amino acids from the carboxyl- 
terminal. The mutant virus shows normal replication in tissue culture indicating that 
normal-length D8L protein is not essential for virus propagation in tissue culture. 
Monospecific serum raised against the 35.4kd protein did not neutralise either the wild- 
type or mutant virus. 
Maa et al. (1990) identified a 32kd envelope protein which binds to the surface of 
cultured cells. The D8L open reading frame was found to encode this protein 
demonstrating that this protein and the protein characterised by Niles and Seto (1988) 
are identical. The C-terminal domain of this protein contains amino acid sequences 
similar to those of the attachment glycoprotein VP7 of rotavirus and to transmembrane 
proteins. The cell surface binding domain of this protein is thought to be present in the 
C-terminal 50 amino acids and that it is important for efficient virus replication in tissue 
culture (Maa et al., 1990). However, mutant virus lacking the cell surface binding 
domain has been shown to replicate with normal kinetics in tissue culture (Niles and 
Seto, 1988). 
1.3.3 Polypeptides of the lateral bodies 
Within the intact virion, the concavities of the core accommodate two lateral bodies. 
These lateral bodies can be seen in electron photomicrographs of thin sections of virus 
particles (Medzon and Baur, 1970). Five proteins (70,69,66,64 and 13.8kd) have been 
shown to be associated with the lateral bodies (Ichihashi et al., 1984). The 13.5kd 
protein, which is a major component of the lateral bodies, shows an affinity for binding 
with viral DNA (Ichihashi et al., 1984). 
1.3.4 Polypeptides of the core 
Cores can be isolated from the purified virus by treatment with 2-mercaptoethanol and 
nonionic detergent (Easterbrook, 1966). The core within the intact virus is a biconcave 
structure, but after release the core assumes a rounded rectangular shape of about the 
same size as a mature virus. 17 polypeptides have been shown to be associated with the 
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viral cores prepared by treating virions with NP-40 and 2-mercaptoethanol followed by 
banding in sucrose density gradients (Sarvo and Joklik, 1972). Ichihashi et al. (1984) 
showed that 61kd, 57kd and 22kd proteins are localised in the core coat and 27kd and 
13kd proteins within the core. Four of these polypeptides namely 61kd, 57kd, 27kd and 
22kd corresponded to the V4a, V4b, V8 and V9a proteins described by Sarvo and 
Joklik (1972). The V4a and V4b, major components of the virus core (Katz and Moss, 
1970; Moss and Rosenblum, 1973), have been genetically mapped (Rosel and Moss, 
1985; van Mier and Wittek, 1988). These two proteins (V4a and V4b) are the cleavage 
products of high molecular weight precursors (Katz and Moss, 1970). Cleavage of the 
high molecular weight precursors occurs during the formation of virus core. Rifampicin 
inhibits the cleavage of these precursors which results in interference of virus assembly 
suggesting that V4a and V4b core proteins play a major role in virus morphogenesis. 
1.4 Genome structure 
The genome of poxviruses consists of a single linear dsDNA molecule. The size of the 
genome varies from about 130kb (Parapoxviruses) (Robinson et al., 1987) to about 
300kb in Avipoxviruses (Coupar et al., 1990). The genomes of all poxviruses are 
characterised by a high A+T content of about 65-67% (Joklik, 1962a) with the exception 
of the parapoxvirus genomes which contains approximately 65% G+C content (Wittek 
et al., 1979). The application of electron microscopy, restriction endonuclease, 
recombinant DNA technology and sequencing techniques has enabled the basic 
architectural features of the virus genome to be determined. These features include 
terminal cross-links, an inverted terminal repetition, tandem repeats and a highly 
conserved central region. 
1.4.1 Cross-links 
The possibility of covalent cross-linking of poxvirus DNA was first considered 
because of the rapid renaturation of fowlpox and vaccinia virus DNA and the inability 
to separate the two DNA strands (Szybalski et al., 1963; Berns and Silverman, 1970). 
This `snap back' property has been explained by the presence of covalent links between 
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the complementary DNA strands. Electron microscopy of partially and completely 
denatured vaccinia virus DNA revealed that the cross-links were at the two ends of the 
molecule (Geshelin and Berns, 1974). Large single stranded circles were observed upon 
complete denaturation whereas partial denaturation resulted in a single stranded loop at 
each end of the DNA molecule. The nature of the cross-link was determined by direct 
sequencing of the ends of the genome (Baroudy et al., 1982). The two strands form one 
covalently continuous polynucleotide chain. The hairpin loops are unable to form a 
completely base paired structure, and exist in two isomeric forms that are inverted and 
complementary in sequence. The cross-links have also been identified in capripoxviruses 
using `snap-back' analysis (Black et al., 1986), however, nucleotide sequence of the 
terminal loops has not been carried out. The cross-links are believed to be a 
characteristic feature of all poxviruses. Similar covalent cross-linked terminal loops are 
found in the genome of African Swine Fever virus (Gonzalez et al., 1986). 
1.4.2 Inverted terminal repeats 
Strong cross-hybridization between the poxvirus DNA terminal restriction fragments 
suggested that poxvirus genomes contained identical but oppositely oriented sequences 
at the two ends of the genome (Wittek et at., 1978; Garon et al., 1978; Mackett and 
Archard, 1979). The lengths of the inverted long terminal repeats are shown to be 
variable within a genus. These repeats have been found to be present in orthopoxvirus 
(Esposito and Knight, 1985), parapoxvirus (Menna et al., 1979), leporipoxvirus 
(DeLange et al., 1984), capripoxvirus (Gershon and Black, 1987; 1988), and African 
Swine Fever virus (Sogo et al., 1984). In variola virus DNA the inverted terminal 
repetition is either very short or absent (Mackett and Archard, 1979; Esposito and 
Knight, 1985). 
1.4.3 Tandem Repeats 
Poxvirus genomes contain tandemly repeated short sequences near the ends of the 
molecule. The evidence for repetitive DNA sequences was obtained by reassociation 
kinetics of the DNA molecule (Grady and Paoletti, 1977). In vaccinia virus, there are 
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two sets of repeats separated by a unique 325bp segment (Wittek and Moss, 1980). The 
precise number of repeats varies from isolate to isolate but in a plaque purified isolate 
each end of the genome was found to contain a set of 13 tandem 70bp repeats, a set of 
18 tandem 70bp repeats, 2 tandem 125bp repeats, and 8 tandem 54bp repeats (Baroudy 
and Moss, 1982; Baroudy et al., 1982). Unequal crossing over within or between sets 
of repeats could result in variation in length of the terminal fragments of poxvirus DNA 
(Wittek et al., 1978). The tandem repeats have also been reported for a capripoxvirus 
(Gershon and Black, 1989a), parapoxvirus (Robinson et al., 1987) and leporipoxvirus 
(Upton et al., 1987). The repeats are fewer in number and less perfect in sequence: in 
the leporipoxvirus genome. 
1.4.4 Central region of the genome 
Approximately a 160 to 170kb central region of the genome is highly conserved in 
orthopoxviruses. The restriction map analysis of a large number of orthopoxvirus 
genomes has shown that within the central region the distribution of restriction sites is 
highly conserved. (Mackett and Archard, 1979; Esposito and Knight, 1985). It is 
therefore reasonable to assume that the genes encoding structural polypeptides (Weir and 
Moss, 1984; Wittek et al., 1984; Hirt et al., 1986) and enzymes involved in nucleic acid 
metabolism (Hruby and Ball, 1982; Bajszar et al., 1983; Jones and Moss, 1984) map 
within the conserved central region of the genome. The genes which are not essential 
for replication in tissue culture system and those involved in host range are located 
towards the ends of DNA molecule (Archard and Mackett, 1979; Dumbell and Archard, 
1980; Lake and Cooper, 1980; Moyer and Rothe, 1980; Esposito et al., 1981; Gillard et 
al., 1986). It has also been noted that the section of the central region is conserved 
amongst all the poxviruses and not only in the orthopoxviruses. A region of 
fowlpoxvirus DNA cross hybridises to the HindIII J fragment of vaccinia virus which 
contains a number of open reading frames including the TK gene (Drillien et al., 1987). 
Nucleotide sequence analysis of this fowlpoxvirus DNA segment showed that it 
contained several open reading frames that were present in the vaccinia virus Hindu J 
fragment. In addition, these open reading frames possessed the same orientation as those 
in vaccinia virus HindIIl J fragment. However, there was no homolog present to the 
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vaccinia virus TK gene. A gene homolog to TK was found to be located in a different 
region of the fowlpoxvirus DNA (Binns et al., 1988). Similar organisation of genes has 
been demonstrated for the leporipoxviruses (Upton and McFadden, 1986) and the 
capripoxviruses (Gershon and Black, 1989b), in these viruses the TK gene was present 
within the conserved corresponding section of genomes. 
1.5 Structure and organisation of the capripoxvirus genome 
The characteristic architectural features of genome of capripoxvirus appear to be similar 
to that of other poxviruses. Differences in size of genome, in lengths of terminal repeats, 
number of tandem repeats and gene organization have been observed. The length of 
capripoxvirus genome differs slightly between isolates (Gershon and Black, 1988). Pulse 
field agarose gel electrophoretic analysis of capripoxvirus DNA yielded a size of 154kb 
for the capripoxvirus genome (D N Black and P Bhatt, unpublished observation). 
Restriction endonuclease analysis of the genomes of a large number of capripoxvirus 
isolates from sheep, goats and cattle showed that they possess a high degree of sequence 
homology (Black et al., 1986; Gershon and Black, 1987; 1988). The HinduI restriction 
digest pattern of capripoxvirus DNA showed no similarity with that of HindIIl restriction 
patterns of vaccinia virus DNA or parapoxvirus DNA. The number of HindIIl restriction 
fragments of the capripoxvirus DNA are many more than those of either vaccinia DNA 
or parapoxvirus DNA Hindlll digests. This suggests that the genome sequences of the 
capripoxvirus are highly divergent from those of orthopoxviruses and parapoxviruses. 
Hindill, PstI, Aval and Sall restriction site maps of the genome of several capripoxvirus 
isolates were used to distinguish and to establish relationships between the isolates from 
sheep, goats and cattle (Gershon and Black, 1988). The analysis showed that the sheep 
and cattle isolates were more closely related to one another than either were to the goat 
isolate. This strongly indicates that the precursor of sheep and cattle isolates diverged 
from the goat isolate prior to diverging from one another. 
The existence of cross-links in the terminal fragments of the capripoxvirus genome was 
first demonstrated by Black et al. (1986). It was shown that the genome ends of 
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capripoxviruses contain common terminal sequences (Gershon and Black, 1987) and one 
of the isolates contains terminal repeats between 2.25 to 3.40kb long which were 
inverted with respect to one other (Gershon and Black, 1988). The nucleotide sequence 
analysis of the terminal fragment of the avirulent KS-1 isolate of capripoxvirus revealed 
the presence of four tandemly repeated segments of 81 and/or 82bp long (Gershon and 
Black, 1989a). Three open reading frames (T3A, T3C, T4) were identified within the 
inverted terminal repeats of this isolate. These are homologs of open reading frames 
shown to be present within the inverted terminal repeats of the leporipoxvirus (Upton 
et al., 1987), whereas the corresponding inverted terminal repeats of the virulent InS-1 
isolate of capripoxvirus revealed only two open reading frames (T3A, T4). Although the 
genomic region in InS-1 corresponding to the open reading frame T3C in KS-1 did not 
exhibit an intact open reading frame, the nucleotide sequences of these regions showed 
a homology of 92.4%. Within the InS-1 isolate genome the T3C open reading frame is 
degenerate due to the presence of several stop codons resulting from small frameshifting 
deletions and insertions in the sequence. A functional counter part of the degenerate gene 
was not found elsewhere in the genome of the InS-1 virulent virus, suggesting that this 
T3C gene is non-essential for the capripoxviruses. The non-essential nature of this gene 
is supported by the observation that T3C gene of KS-1 isolate can be insertionally 
inactivated without affecting the ability of KS-1 to replicate in tissue culture (Gershon 
and Black, 1989a). 
1.6 Comparison of capripoxvirus genome with other poxviruses genome 
A comprehensive comparison of the genome organisation of capripoxvirus with that of 
vaccinia virus genome has been made by cross-hybridizing the restriction fragments of 
both the viruses (Gershon et al., 1989). It was shown that a 100 to 115kb centrally 
placed section in both genomes was essentially collinear in organisation (Fig. 1.2). A 2kb 
fragment of capripoxvirus located near the right hand of the genome cross-hybridised 
with a vaccinia virus fragment placed near the left hand of the genome. The terminal 
regions of the genome of capripoxvirus failed to cross-hybridize with any of the 
fragment on the genome of vaccinia virus including terminal fragments. Similarly the 
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Figure 1.2 Comparison of the genomes of capripoxvirus (KS-1) and Vaccinia virus. The 
Hindill fragments of DNA both the viruses are used in cross-hybridisation studies. Filled 
triangles and rectangles are positioned on the probe fragments and are attached with 
lines to the cross-hybridising regions of the heterologous genomes which are identified 
with shaded boxes. Full details are given in J. Virol. 63,4703-4708, (1989). (From 
Gershon, David and Black, 1989). 
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vaccinia virus terminal fragments when used as probes did not hybridise,. ' with the 
capripoxvirus genome. These observations demonstrate that the genomes of both viruses 
are much more divergent from one another in sequences towarctheir termini than within 
the central region. Nucleotide sequence analyses of two centrally located segments of 
capripoxvirus DNA have shown a very similar gene organisation as compared with the 
corresponding cross-hybridising segments of the vaccinia virus DNA (Gershon and 
Black, 1989b; Gershon et al., 1989). One of these segments of the capripoxvirus DNA 
(HindIII-S fragment) contained three complete and two incomplete open reading frames. 
The two incomplete and two of 
, (complete 
open reading frames one of which was the 
gene for thymidine kinase (TK) (Gershon and Black, 1989b) showed a high sequence 
homology and order with those in the corresponding vaccinia virus fragment. However, 
the homolog of the cdmplete open reading frame located immediately downstream of the 
TK gene of capripoxvirus (KS-1) was absent from the vaccinia virus DNA. The gene 
organisation of the HindIII-M fragment of capripoxvirus (KS-1) DNA also showed 
strong homology with that of vaccinia virus genes mapped within the central part of the 
HindIII-A fragment (Gershon et al., 1989), except that the cowpoxvirus A Type 
Inclusion (ATI) body gene homolog present in the vaccinia DNA segment was absent 
from the capripoxvirus DNA segment. An ATI gene homolog was not detected anywhere 
on the genome of capripoxvirus (KS-1). 
1.7 Poxvirus DNA replication 
Poxviruses replicate in the cytoplasm of infected cells where they form discrete foci of 
replication called virus factories or virosomes (Cairns, 1960; Harford et al., 1966). The 
replication cycle of poxviruses can be roughly divided into three temporal stages: (a) 
early gene expression, (b) DNA replication and (c) late gene expression. A schematic 
representation of the replication cycle of poxviruses is shown in figure 1.3. Late gene 
expression does not occur until the onset of DNA replication and the replication of viral 
DNA is completely dependent on expression of early genes. One of the products of the 
early genes, a 23kd protein, has been reported to be an uncoating protein which possibly 
plays some role in the release of viral DNA from the cores into the cytoplasm of cell 
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Figure 1.3 An outline of the replication cycle of vaccinia virus (From Moss, 1990). 
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which is an essential step towards the onset of viral DNA replication (Pedley and 
Cooper, 1987). 
The time of DNA replication varies with different members of the Poxviridae family, 
for example the onset of DNA replication is observed between 4 to 6 hours post 
infection (hpi) with orf virus (Balassu and Robinson, 1987) and 12 to 16 hpi with 
fowlpoxvirus (Prideaux and Boyle, 1987). The onset of vaccinia virus DNA replication 
occurs between 2 to 3 hpi resulting in the generation of 10,000 genome copies (Joklik 
and Becker, 1964). The synthesis of capripoxvirus DNA has been reported to start 11 
to 12 hpi (Terrinha et al., 1965). To some extent the cell type and multiplicity of 
infection also affect the onset of DNA replication. 
Despite the detailed structural analysis of the virus genome and identification of the 
enzymes and proteins involved in DNA replication, the mechanism of poxviruses DNA 
replication is still not very well understood. It has been suggested that replication begins 
by introduction of nicks at each end of the genome (Esteban and Holowczak, 1977; 
Pogo, 1977,1980). This nicking occurs immediately after uncoating of the viral DNA 
and the nicks produced are sealed only late in infection (Pogo, 1977,1980). The 
introduction of these nicks will provide the 3'-OH end necessary for the initiation of 
DNA synthesis. The newly synthesized DNA then folds back on itself by base pairing 
of the inverted terminal repeat allowing DNA replication to proceed along the length of 
poxvirus genome in a similar manner to that proposed for the replication of single 
stranded parvovirus DNA (Tattersall and Ward, 1976). The resulting daughter molecules 
contain a loop at one end which represents inverted complementary copies of those 
present at the corresponding end of the parental molecule. This self-priming model was 
first proposed by Moyer and Graves (1981) for the replication of rabbitpoxvirus DNA 
and subsequently Baroudy et al. (1982) showed that such a model can also account for 
the flip-flop inversion of the terminal hairpin sequence of the vaccinia virus DNA. In 
addition, the self-primed replication could also account for the concatemeric 
intermediates in DNA replication. Assuming that the nick is introduced at only one end 
of the parental DNA molecule strand extension would give a complete copy of the 
genome and result in a dimeric molecule joined in a tail to tail configuration. The 
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process could then be repeated to generate a tetrameric concatamer. These replicative 
concatemeric intermediates cannot penetrate agarose gels during electrophoresis which 
suggests that they may be complex multibranched molecules (DeLange, 1989; 
Merchlinsky and Moss, 1989). Inhibition of late viral proteins synthesis causes an 
accumulation of these concatemeric forms of DNA (Delange, 1989). This accumulation 
is reversible on removal of the protein synthesis inhibitor indicating that the concatemers 
are replicative intermediates and are processed to the individual unit-length molecules 
by a late protein. Other studies also suggest that the unit-sized genomes are excised from 
the concatemeric intermediates (Delange et al., 1986). 
An important enzyme in this replication model is the site specific endonuclease. The 
enzyme should be capable of introducing nicks at defined locations within the DNA 
molecules before and after DNA replication. A good candidate for such an enzyme has 
been isolated from vaccinia virions (Lakritz et al., 1985). The purified enzyme not only 
introduces site-specific nicks but also reseals the two DNA strands of linear molecules 
obtained by prolonged incubation with the enzyme (Lakritz et al., 1985; Reddy and 
Bauer, 1989). This nicking joining enzyme fulfils the requirements needed for excision 
and cross-linking of progeny molecules from concatemeric intermediates. However, the 
possibility of more than one enzyme being involved in processing the concatemeric 
replicative intermediates to produce unit-length molecules cannot be ruled out. 
1.8 Gene expression in poxviruses 
1.8.1 Early gene expression 
The transcription of early genes, starting immediately after infection, is independent of 
de novo protein synthesis. The enzymes and factors required for early transcription are 
contained within the virus particle (Baroudy and Moss, 1980). The release of virus cores 
into the cytoplasm of infected cells initiates transcription of the early genes (Kates and 
McAuslan, 1967) which produces functional virus mRNAs of discrete lengths. The virus 
mRNAs closely resemble their cellular counterparts, despite their cytoplasmic site of 
formation. Functional early mRNA is polyadenylated (Kates and Beeson, 1970), capped, 
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and methylated (Wei and Moss, 1975) and can be detected in the cytoplasm of infected 
cells within minutes after infection. The cap structure on the 5'end of early mRNA is 
required for binding to the cellular ribosome (Muthukrishnan et al., 1978) and probably 
for mRNA stability. The function of 3'poly(A) tail is still poorly understood. DNA/RNA 
hybridization studies suggest that about half of the vaccinia virus genome is expressed 
prior to DNA replication (Kaverin et al., 1975; Boone and Moss, 1978). Early genes are 
found to be distributed throughout the length of the genome (Belle Isle et at., 1981; 
Goebel et at., 1990). Mapping and sequence analysis of early genes yielded information 
as to the nature of their promoter regions, as well as of the locations of the 3' and 5' 
ends of the corresponding transcripts (Venkatesan et at., 1981,1982). The results 
demonstrated that none of the early genes contain introns and the promoter sequences 
just upstream of the coding regions are extremely A and T rich. The analysis of early 
transcripts indicates that the sequence AAUAAA, which invariably appears about 20 
nucleotides before the polyadenylation site of eukaryotic mRNA (Proudfoot and 
Brownlee, 1976), is rarely present near the Tends of poxvirus mRNA. 
In order to identify the transcriptional signals, putative promoter regions were excised 
and ligated to various test genes, such as the chloramphenicol acetyltransferase (CAT) 
gene (Mackett et al., 1984). The chimeric structure was inserted in the thymidine kinase 
(TK) locus of the vaccinia virus genome by homologous recombination. Cells infected 
with the recombinant virus expressed CAT activity indicating that the promoter regions 
were translocatable (Mackett et al., 1984). Further studies with recombinant vaccinia 
viruses indicated that the promoters of early genes extend only about 30bp upstream of 
the RNA start sites (Cochran et al., 1985; Coupar et al., 1987). The sequence TI'I'I'I'NT 
has been shown to be the termination signal for early genes and shown to be present 30 
to 50bp upstream from the termination site. 
Highly purified vaccinia RNA polymerase was shown to be incapable of initiating 
transcription from vaccinia dsDNA templates in vitro (Baroudy and Moss, 1980). In 
contrast the less pure forms of this enzyme, isolated either by column chromatography 
or by sucrose gradient centrifugation, were capable of transcribing dsDNA templates 
(Broyles and Moss, 1987). This difference might have been due to the denaturation of 
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the purified enzyme or a need for additional factors. The latter possibility was found to 
be correct as purified RNA polymerase was found to be active when supplemented with 
the vaccinia early transcription factor (VETF) (Broyles et al., 1988). The VETF was 
shown to be a heterodimer of two polypeptides (77kd and 82kd). The viral genes 
encoding the 70kd and 82kd subunits of VETF have been identified and both are 
expressed late in infection (Gershon and Moss, 1990; Broyles and Fesler, 1990). VETF 
was found to be active with several different early promoters which indicated that it is 
a general early transcription factor (Yuen et al., 1987). DNA template with an early 
promoter, RNA polymerase, and VETF appear to represent the minimal components 
necessary for initiation and elongation of RNA molecules. 
1.8.2 Intermediate gene expression 
Recently a novel class of genes, termed intermediate genes, within the vaccinia virus 
genome have been identified (Vos and Stunnenberg, 1988; Keck et al., 1990). These 
genes have been shown to be expressed just following the onset of DNA replication but 
prior to the transcription of late genes. In addition, it has been shown that transacting 
factors essential for the transcription of intermediate genes are present in vaccinia virus 
infected cell extracts prepared prior to DNA replication (Vos and Stunnenberg, 1988). 
Extracts from cells infected with virus in the presence of hydroxyurea were found to be 
capable of transcribing intermediate genes but not late genes (Vos and Stunnenberg, 
1988). Extracts from vaccinia virus cores, however, were not capable of intermediate 
gene transcription. These findings indicate that the factors required for intermediate gene 
expression are not present in vaccinia virus core and are likely to be the early viral 
proteins, although some components might be released from the virion or derived from 
the host (Keck et al., 1990). Five intermediate genes have been identified. Vos and 
Stunnenberg (1988) and Keck et al. (1990) suggested that the intermediate gene products 
act as transactivators of late gene transcription. They also proposed a cascade model for 
the vaccinia virus gene expression in which intermediate genes play a regulatory role. 
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1.8.3 Expression of late genes 
A distinct shift in gene expression, from early to late, can be observed after the onset 
of DNA replication. Cells infected with poxvirus display a changing pattern of 
polypeptide synthesis within a few hours of infection (Moss and Salzman, 1968; 
Pennington, 1974). The changes can be readily demonstrated by SDS-PAGE analysis of 
polypeptides pulse labelled at intervals with radioactive amino acids (Pennington, 1974; 
Balassu and Robinson, 1987). Viral polypeptides are synthesized and synthesis of host 
cell proteins is shut off. The shut off of host cell protein synthesis probably results from 
competition by excess viral mRNA, as well as a specific shut down mechanism(s) 
involving degradation of cellular mRNA (Moss, 1968; Bablanian et al., 1981; Rice and 
Roberts, 1983). The time of synthesis of late proteins varies among members of the 
Poxviridae family, for example, vaccinia late proteins were detected between 4 to 6 hpi 
(Moss and Salzman, 1968) while fowlpoxvirus late proteins were detected 12 to 16 hpi 
(Prideaux and Boyle, 1987). The synthesis of late proteins is blocked by inhibitors of 
DNA replication, such as cytosine arabinoside, which provides definitive evidence that 
viral DNA synthesis is essential for expression of late genes. 
Although late genes are distributed through the length of the genome they frequently 
occur in clusters in the central region (Belle Isle et al., 1981; Goebel et al., 1990). Most 
of the virus structural proteins and many of the enzymes and factors involved in early 
gene transcription are synthesized late in infection (Paoletti et al., 1974; Gershon and 
Moss, 1990). Almost the whole of the genome was shown to be transcribed during the 
late times of infection despite the fact that synthesis of majority of the early proteins 
stopped after the onset of DNA replication (Paoletti and Grady, 1977; Boone and Moss, 
1978). However, some of the early mRNAs continue to be expressed at late times post 
infection (Boone and Moss, 1978). Nucleotide sequence analysis of vaccinia virus late 
genes reveals features that distinguish them from early genes. The occurrence of the 
sequence TAAAT at the start of open reading frame of late proteins is a characteristic 
feature of late genes (Rosel et al., 1986). Late mRNAs contain long heterogenous Tends 
and 5'poly A heads consisting of approximately 35 A residues (Boone et al., 1979; Mahr 
and Roberts, 1984; Schwer et al., 1987). The 5'poly A heads are not coded for by the 
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virus genome (Bertholet et al., 1987; Schwer and Stunnenberg, 1988) and possibly are 
formed during transcription by a mechanism involving slippage of the RNA polymerase. 
The three consecutive A residues of the conserved TAAAT motif have been shown to 
be responsible and necessary for the formation of 5' poly A head in late mRNA. 
Mutagenesis studies have provided support for an RNA polymerase slippage model. The 
5' poly A head was not present or limited to a few nucleotides when one of the three 
A residues was replaced or deleted (Davison and Moss, 1989). 
1.9 Maturation and Release of poxviruses 
During late times of replication the newly formed virus genome and structural proteins 
are assembled to produce progeny virus. This process occurs within the circumscribed, 
granular and electron dense areas of cytoplasm, which have been called virus factories 
(Cairns, 1960). The viral proteins synthesised elsewhere in the cytoplasm are transported 
to the virus factories where development of virus membrane take place. Morphological 
studies suggest that the viral membranes initially appear as a cupules and incomplete 
spheres, coated with spicules, without having any continuity with the cellular 
membranes. Formation of the viral membrane and spicule layer appears to be a 
concerted process, however, very short uncoated membrane segments could be seen in 
the presence of actinomycin D (Dales and Mosbach, 1968). A much more dramatic 
effect on the formation of these membranes was observed when the antibiotic rifampicin 
was included in the growth medium (Moss et al., 1969; Nagayama et al., 1970). 
Accumulation of irregular viral membranes occurred in the presence of rifampicin. These 
membranes lacked spicules and failed to progress in maturation (Grimley et al., 1970). 
The effect of the drug was shown to be reversible, within minutes of removal of 
rifampicin inhibition, the membranes became covered with spicules and regained their 
regular convex structure (Grimley et al., 1970). It seems that the membranes are covered 
by a layer of spicules which confer sufficient rigidity on the membrane to maintain its 
spherical shape. These spicules have been shown to be composed of a 65kd protein 
(Essani et al., 1982). Electron microscopic studies suggested that the nucleoprotein enters 
the viral membranes just before they are completely sealed (Morgan, 1976). During the 
process of maturation the spicules are replaced by the surface tubules that characterise 
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the surface of the outer membrane of mature nonenveloped virions (Essani et al., 1982). 
The surface tubules are considered to be the last components incorporated into the 
virion. The outer membrane also contains lipid, which is probably derived from the 
cellular pool. While these processes are occurring in the outer membrane, the 
viroplasmic matrix differentiates in the DNA containing core and the lateral bodies. The 
mature virions move out of the virus factory areas and accumulate in adjacent area of 
the cytoplasm. A proportion of the mature virus particles migrates to the Golgi bodies 
where they are wrapped within a double layer membrane structure (Morgan, 1976). This 
double layered membrane structure containing several virus encoded proteins is thought 
to be derived from the Golgi body membranes. The virus proteins are probably inserted 
into the Golgi membranes before they surround the mature virions. The double layered 
mature virion then migrates to the cell periphery where the outer layer fuses with the 
plasma membrane resulting in the externalization of the virion still enclosed by one layer 
of membrane (Payne and Kristensson, 1979). 
Recently, a 37kd protein has been shown to be involved in the formation of extracellular 
vaccinia virus and cell to cell virus transmission (Blasco and Moss, 1991). The 37kd 
protein is a major envelope protein of extracellular virus and is encoded by vaccinia 
virus open reading frame F13L (Hirt et al., 1986). This protein contains bound palmitic 
acid, and after synthesis is localised in Golgi body membrane (Hiller and Weber, 1985). 
Deletion of the gene encoding the 37kd protein prevented the formation of extracellular 
virus and inhibited cell to cell virus transmission. These results provide clear evidence 
that the 37kd protein is involved in externalization of extracellular virus from the host 
cell (Blasco and Moss, 1991). 
Despite a specific mechanism for virus release the majority of the progeny virus remains 
cell associated at the end of the growth cycle. The amounts of extracellular virus i. e. 
naturally released virus varies up to 30% of the total yield depending on the virus strain 
and cell type (Payne, 1979). For this reason the significance of the extracellular virus 
in the generation of the protective immune response and in virus pathogenesis is still 
unclear (Boutler and Appleyard, 1973; Payne, 1980). 
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1.10 Early events of Virus-Host Cell interaction 
Initial interactions between virus particles and the cell membrane which allow virus 
particles and/or virus genom, to enter the cytoplasmic compartment of the cell can be 
termed as the early events of virus-host cell interactions. It is generally believed that in 
the case of enveloped viruses the proteins localised in virus envelope are involved in 
these early events of virus-host cell interactions (Marsh and Helenius, 1989). Enveloped 
viruses gain entry into the cell either by pH-independent fusion with the plasma 
membrane or via a low pH-dependent endosomal route. Binding or attachment of virus 
particles to the cell membrane is an important step prior to fusion between the virus and 
cell membranes. The binding of virus particles with the cell membrane has been shown 
to be mediated through attachment sites (or receptors) present on the host cell membrane 
(Nemerow et al., 1985; Lentz et al., 1982). In poxviruses, it has been demonstrated that 
epidermal growth factor receptor can serve as a cellular attachment site for the entry of 
vaccinia virus into cells (Eppstein et al., 1985). Prior incubation of cell monolayers with 
purified epidermal growth factor inhibits the vaccinia virus replication cycle (Eppstein 
et al., 1985). However, the requirement of epidermal growth factor receptor for vaccinia 
virus entry is equivocal as replication proceeds normally in cells lacking the epidermal 
growth factor receptors (Stroobant et al., 1985). 
1.10.1 The attachment protein of vaccinia virus 
A 32kd protein of the envelope of vaccinia virus has been shown to bind to the 
cell surface of host cells (Maa et al., 1990). Maximum binding of the 32kd protein was 
observed with human HeLa cells and minimum with mouse L-929 cells. The extent of 
binding of the 32kd protein with different cell types was correlated with the ability of 
vaccinia virus to replicate in these cell lines. The binding of the 32kd protein to cell 
surfaces was inhibited by competition with purified vaccinia virus whereas neither 
purified vesicular stomatitis virus nor bovine serum albumin competed with the 32kd 
protein for binding to cells (Maa et al., 1990). These results indicate that the 32Kd 
protein may bind to the same cellular receptor as the virus. The presence in the virus 
envelope of many copies of the 32kd protein and other envelope proteins may stabilise 
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the interaction between the virus and the receptors on the cell surface. The presence of 
specific receptor molecules on the cell surface for the 32kd protein has not been 
identified. A gene with a potential coding capacity for a 35.4kd protein has been shown 
to code for this 32kd protein. The N-terminus of this protein has a high degree of amino 
acid sequence homology with carbonic anhydrase but competition experiments with 
purified carbonic anhydrase revealed no effect either on virus infectivity or binding of 
the 32kd protein with the cell surface (Maa et al., 1990). These results suggest that the 
carbonic anhydrase domain of the 32kd protein is not involved in the attachment of virus 
particles to the cell surface. The C-terminus of the 32kd protein contains a potential 
transmembrane sequence and a region with sequence homology to the attachment 
glycoprotein VP7 of rotavirus. It has been suggested that the C-terminal 50 amino acids 
contains a potential cell surface binding domain (Maa et al., 1990). This idea is 
supported by the observation that the cleavage of a large 29kd N-terminal segment of 
the 32kd protein with trypsin exposed the cell surface binding domain which results in 
an increase of virus infectivity. Although these findings indicate that the 32kd envelope 
protein is an attachment protein and that the cell surface binding domain at the C- 
terminus plays an important role in efficient binding of the virus particle to the cell 
surface, viruses lacking the 32kd protein or deficient in the C-terminal cell surface 
binding domain are infectious and replicate with normal kinetics (Niles and Seto, 1988). 
In addition, the E. coli-produced 32kd protein used in competition experiments failed to 
inhibit virus multiplication, which again supports nonessential role of this protein for 
virus replication in tissue culture (Maa et al., 1990). 
The synthesis of the 32kd protein starts after the onset of DNA replication and is 
reversibly inhibited by cytosine arabinoside indicating that it is a late protein. However, 
the common TAAAT motif which is a characteristic feature of late genes, was not 
present at the 5'end of the nucleotide sequence (Niles et al., 1986). This suggests that 
the presence of TAAAT motif at the 5'end is not essential for all late genes. It has been 
indicated that the synthesis of this protein occurs in membrane-free ribosomes without 
involving the endoplasmic reticulum (Maa et al., 1990). Using this route of synthesis it 
is likely that the 32kd protein remains un-glycosylated, despite the fact that four 
potential glycosylation site are present in the predicted amino acid sequence of this 
37 
protein. The lack of glycosylation of this protein has been confirmed by using 
glycosylation inhibitors in vivo and treatment of purified virus with glycosidases in vitro. 
The use these glycosidases does not result in a change of molecular weight of the 32kd 
protein, again confirming that the 32kd protein is not a glycoprotein. 
1.10.2 Entry of the virus particles or virus cores into the cytoplasm 
Subsequent to the attachment of the virus particle to the cell membrane, entry of the 
virion or virion cores is accomplished either by direct fusion of the virus membrane with 
the plasma membrane or by a phagocytic mechanism (viropexis). Evidence in support 
of phagocytic mechanism for entry of poxviruses has been provided by Dales and 
Kajioka (1964), who showed that virus particles fused with plasma membranes within 
the vacuoles formed by surface invagination followed by release of the virus cores into 
the cytoplasm. Armstrong et al. (1973) and Change and Metz (1976) showed that a 
phagocytic mechanism was not the actual mechanism by which poxviruses gain entry 
into the cytoplasm. Fusion of the poxvirus envelope with the plasma membrane of the 
cell is responsible for penetration and the first stage uncoating of the virus. After fusion, 
the virus envelope proteins disaggregate and randomly disperse as small patches 
throughout the plasma membrane (Change and Metz, 1976). Furthermore, it has been 
demonstrated that the entry mechanism of vaccinia virus is pH-independent, thus fusion 
of the virus envelope with the plasma membrane could occur in the presence of 
lysosomotropic agents (Janeczko et al., 1987). Lysosomotropic agents, such as 
chloroquine or methylamine inhibit the receptor mediated low-pH dependent endocytic 
mechanism of virus entry (White et al., 1981). These lysosomotropic agents were found 
completely inactive in blocking poxvirus infection. These results clearly indicate that 
poxvirus does not enter cells via a pH-dependent endosomal mechanism. However, the 
possibility that poxviruses may use a non acid pH-dependent endocytic mechanism 
cannot be excluded. 
Recently, Doms et al. (1990) further investigated the fusion of vaccinia virus with the 
plasma membrane. They considered that the work carried out by Janeczko et al. (1987) 
applied only to intracellular forms of vaccinia virus. Using intracellular as well as 
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extracellular virus Doms et al. (1990) demonstrated that both intra- and extracellular virus 
fused with Hela cells at neutral pH, suggesting that fusion between viral and plasma 
membranes is an important step during virus entry. In addition, it was shown that the 
extracellular virus fused more efficiently and with faster kinetics than the intracellular 
virus (Doms et al., 1990), which explains the more infectious nature of the extracellular 
virus. 
1.10.3 Fusion proteins of poxviruses 
Proteins localised in the envelope of virus are considered to be involved in the fusion 
of virus particles with the plasma membrane. The numerous tubular structures (surface 
tubules) present on the surface of the vaccinia virus are composed of a 58kd protein 
(Stem and Dales, 1976). These surface tubules, that elicit neutralising antibodies which 
suppress virus infectivity and cell-cell fusion, occur during late times of viral infection. 
Stem and Dales (1976) also proposed a role for these surface tubules in virus-cell fusion 
during the initial phases of virus penetration. Oie and Ichihashi (1987) prepared 
monoclonal antibodies against envelope proteins of vaccinia virus. Monoclonal 
antibodies against the 54kd, 34kd and 17-25kd envelope proteins neutralised the virus 
infectivity. On the basis of these results Oie and Ichihashi (1987) suggested that 54kd, 
34kd, and 17-25kd envelope proteins play some role in the penetration of virus particles 
into the host cell. The 54kd envelope protein corresponds to the 58kd surface tubule 
protein characterised by Stem and Dales (1976). 
Based on studies with monoclonal antibodies Rodriguez et al. (1985) identified a 14kd 
protein in the envelope of vaccinia virus. Monoclonal antibodies to the 14kd protein did 
not prevent the attachment of the virus particle to the host cell but strongly neutralised 
the virus infectivity by inhibiting the uncoating of the virus particle. In a subsequent 
study Rodriguez et al. (1987) showed that the 14kd envelope protein played an important 
role in virus penetration at the level of virus-cell fusion. It was shown that the 14kd 
protein forms covalently linked trimers on the surface of the virus and is also on the 
surface of infected cells during infection. Immunoblot and immunofluorescence studies 
showed that the 14kd protein is synthesized at about 6 to 7hpi and transported from the 
39 
cytoplasm to the cell surface. Rodriguez and Esteban (1987) identified the gene that 
encodes the 14kd protein by screening a lambda gtl1 library of rabbitpoxvirus DNA 
with monoclonal antibodies to the 14kd protein. The gene was mapped within the middle 
region of the Hindul A fragment of virus genome. The nucleotide sequence analysis 
revealed an open reading frame (A27L) with a coding capacity of 12.5kd protein, 
implying that post-translational modification occurred accounting for the l4Kd size as 
determined by SDS-PAGE. There is one glycosylation site (NVT, position 60 to 62) in 
the deduced amino acid sequence and two cysteine residues which are believed to be 
involved in cross-linking to form the homotrimeric structure on the virus envelope as 
well as on the surface of cells. The deduced amino acid sequence revealed regions of 
homology with the haemagglutinin precursor of influenza A virus, with the adenylate 
kinase enzyme of rabbit, bovine, pig and human, and with cytochrome c of 
Pseudomonas putida, Neurospora crassa and humans. Computer analysis of the 
hydrophobicity plot of the 14kd protein showed the existence of two hydrophobic 
regions, one at the C-terminus (11 amino acids) and the other at the N-terminus (5 
amino acids). 
It has been demonstrated that at low pH (4.4 to 5.0) the vaccinia virus triggers cell-cell 
fusion from without as well as fusion from within (Gong et al., 1990). The l4kd protein 
has been shown to be responsible for mediating these fusion processes. The cell-cell 
fusion from without or fusion from within was completely inhibited in the presence of 
monoclonal antibodies to the 14kd protein. Gong et al. (1990) provided direct genetic 
evidence for the role of 14kd protein in cell-cell fusion using vaccinia virus mutants 
(Dallo et al., 1987; Gong et al., 1989). The two viral mutants were shown to be unable 
to induce low pH-dependent cell-cell fusion. Introduction of the 14kd protein gene into 
the genome of these nonfusogenic viruses results in the generation of low pH-dependent 
fusogenic viruses. Nucleotide sequence analysis of the l4kd protein gene of one of the 
nonfusogenic viruses revealed that a mutation has been introduced in the 14kd gene. 
This mutation causes a 10 amino acid deletion from the 14kd protein, resulting in the 
removal of a small hydrophobic domain present at the N-terminus of this protein, which 
results in the generation of the nonfusogenic virus (Gong et al., 1990). The N-terminal 
amino acid deletion produces no effect on a number of other properties of the l4kd 
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protein such as disulphide linked-trimer formation, protein localisation on the cell 
surface and on the virus envelope, and the ability to induce antibodies to the 14kd 
protein in mice inoculated with nonfusogenic virus (Gong et al., 1990). These results 
strongly indicate that vaccinia virus mutants fail to induce low pH-dependent cell-cell 
fusion simply because of the N-terminal 10 amino acid deletion of the 14kd protein. This 
suggests that the putative fusogenic domain of the 14kd protein may be within the N- 
terminal 10 amino acids. An N-terminal motif, phenylalanine-proline-glycine at amino 
acids 6-8 of the 14kd protein shows a similarity with that of phenylalanine-x-glycine 
motif of the fusion protein of human and simian immunodeficiency viruses (Bosh et al., 
1989). This N-terminal motif has been suggested to be involved in the vaccinia virus 
induced cell-cell or virus-cell fusion process (Gong et al., 1990). 
Lai et al. (1990) cloned the l4kd gene in a plasmid expression vector and produced the 
14kd protein in a large amounts in E. co1i cells to study the properties of in vitro 
produced l4kd protein. The expressed l4kd protein displays structural and functional 
properties similar to that of native l4kd protein, such as apparent molecular mass, 
occurrence of disulphide-linked homodimers or homotrimers, reactivity with the l4kd 
monoclonal antibodies and, identity in N-terminal amino acid sequence with the 
predicted DNA sequence of the gene (Lai et al., 1990). In addition, the expressed l4kd 
protein binds with a variety of cells in culture. The binding was inhibited by purified 
vaccinia virus but not by bovine serum albumin. Although the expressed l4kd protein 
binds with cells it is not clear whether the l4kd protein can fuse with cells 
independently or it needs to interact with other viral proteins prior to fusion. Lai et 
al. (1990) indicated that large amounts of this protein can be obtained in a soluble form 
in E coli with similar conformation to the native protein. The availability in large 
amounts of this protein in native conformation may facilitate in elucidation of other 
biochemical properties and X-ray diffraction structure of the 14kd protein. 
Monoclonal antibodies to the 14kd protein prevent the virus induced fusion reaction 
(Rodriguez et al., 1987; Gong et al., 1990) which strongly suggests an important role 
of the 14kd protein in virus-host cell or cell-cell fusion process. However, these 
antibodies completely fail to inhibit fusion activity of the extracellular virus to the cell 
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membrane (Doms et al., 1990), suggesting that the l4kd protein does not occur on the 
outer envelope of the extracellular virus and is localised only on the envelope of 
intracellular virus. The 14kd protein may be present on the inner envelope of 
extracellular virus, but the additional envelope of extracellular virus probably masks 
those proteins that are present on the inner envelope of extracellular virus. Thus fusion 
of the extracellular virus is likely to be mediated by those protein(s) present on the outer 
envelope of the virus. 
Attempts to identify fusion proteins in other poxviruses have not been made. However, 
an open reading frame present within the Hindul M fragment of capripoxvirus (KS-1) 
genome shows homology to the l4kd fusion protein gene of vaccinia virus (Gershon et 
al., 1989). This open reading frame encodes for a l9kd protein. The predicted amino acid 
sequence of the 19kd open reading of the capripoxvirus (KS-1) shows a 32% amino acid 
identity with vaccinia virus 14kd fusion protein. In addition, the N-terminus of the 
predicted 19kd protein of capripoxvirus (KS-1) possesses a phenylalanine-proline-glycine 
motif at amino acid positions 8-10, which is identical to that of the N-terminal motif of 
the 14kd fusion protein of vaccinia virus. The N-terminal three amino acid motif of the 
14kd fusion protein of vaccinia has been shown to be involved in virus induced fusion 
(Lai et al., 1990) it is thus likely that the predicted 19kd protein of capripoxvirus (KS-1) 
may use the same motif for same activity. An orf virus gene coding for a 10kd protein 
shows a 31% amino acid identity with the l4kd fusion protein of vaccinia virus (Naase 
et al., 1991). The predicted secondary structure of both the proteins (of orf virus and 
vaccinia virus) is also similar. Whether these genes in capripoxvirus and in orf virus 
express proteins with functions similar to that of vaccinia 14kd fusion protein remains 
to be determined. 
1.11 Immunogenic proteins of poxviruses 
Salaman (1934) and Parker and Rivers (1936) showed that rabbits immunised with virus 
free filtrate from vaccinia infected skin or dermal pulp resulted in the production of a 
small amount of neutralising antibody. Appleyard (1961) demonstrated that the virus free 
soluble extracts of tissues from animals infected with rabbitpoxvirus or vaccinia virus 
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contain soluble antigenic components capable of reacting with neutralising antibody. 
Rabbits immunised with these soluble antigens produced virus neutralising antibody. The 
immunised rabbits showed partial resistance to infection when challenged with vaccinia 
virus or rabbitpoxvirus. These soluble antigens appear to contain the surface components 
of intracellular virus. The sera from rabbits immunised with these soluble antigens 
showed very high neutralising antibody titres against intracellular virus but were almost 
ineffective in neutralising the extracellular virus (Appleyard and Andrews, 1974). 
Appleyard et al. (1971) demonstrated that extracellular rabbitpoxvirus released naturally 
from infected cells differed antigenically from intracellular virus released by artificial 
disruption of cells. Antiserum prepared against live rabbitpoxvirus neutralised 
intracellular as well as extracellular virus whereas antiserum against inactivated vaccinia 
virus neutralised only intracellular virus. Vaccination with live virus produces both 
extracellular and intracellular virus during replication, thus both forms of virus were 
presented to the immune system. Inactivated intracellular virus, however, induces 
antibody only against intracellular viral components due to its inability to replicate. 
These observations and the results of Appleyard and Andrews (1974) suggest that 
antibody raised with live vaccinia virus is important for protection against poxvirus 
infection. 
Payne (1980) showed that in vitro released extracellular virus caused the long range 
spread of infection in cell cultures which results in secondary or tertiary plaque 
formation, whereas intracellular virus spreads from cell to cell and is thus able to 
produce only primary plaques. These observations were supported by the fact that 
antiserum to the purified extracellular virus envelope completely prevented the long 
range spread of plaques but did not inhibit the primary plaque formation Payne(1980). 
The antiserum to inactivated intracellular virus completely failed to suppress the spread 
of virus. These studies suggest that antibodies to extracellular virus envelope are 
sufficient to prevent in vitro dissemination of virus. The role of antibodies to purified 
envelope of extracellular virus in prevention of in vivo dissemination of virus is still not 
very well understood. 
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Demkowicz et al. (1992), by screening a lambda gtl l expression library of rabbitpoxvirus 
DNA with immune serum obtained either from human beings vaccinated against 
smallpox or from vaccinia virus immunised animals, identified six late vaccinia virus 
genes that encode highly antigenic proteins (62,39,32,25,21,14kd). The 62,39,25 and 
21kd proteins are part of the virus core, the 32 and l4kd proteins are localised in the 
virus envelope (Sarvo and Joklik, 1972; Maa and Esteban, 1987; Yang et al., 1988; Maa 
et al., 1990; Demkowicz et al., 1992). The 62kd is a major core protein and corresponds 
to the V4a protein described by Sarvo and Joklik (1972). A long lasting antibody 
response against this protein was observed in vaccinated humans. It has been suggested 
that the N-terminal domain of this protein is involved in the generation of B-cell 
memory (Demkowicz et al., 1992). 75% of mice vaccinated with this protein were 
protected on challenge with vaccinia virus suggesting that this is a highly immunogenic 
protein. This protein induces strong antibody responses which may be involved in an 
immune mechanism such as antibody dependent cell- mediated cellular cytotoxicity 
(ADCC). This mechanism has been shown to be involved in the recovery of mice from 
a generalised mousepoxvirus infection (Blanden and Gardner, 1976). In addition, this 
protein may stimulate cytotoxic T-lymphocytes (CTL) which have been shown to be 
involved in lysis and elimination of virus infected cells. The possibility of the 
involvement of these mechanisms, however, has not been examined. It is unlikely that 
antibodies which are induced against this protein will neutralise the virus due to the 
location of this protein in the virus core. 
The 39kd protein is expressed on the surface of vaccinia virus infected cells and high 
levels of antibodies that react with this protein were observed in vaccinated humans and 
animals (Demkowicz et al., 1992). The antigenic domain of this protein is contained 
within the 103 amino acids of C-terminal region (Demkowicz et al., 1992). Monoclonal 
antibodies to this protein have been shown to cross-react with cytoplasmic components 
of noninfected cells (Maa and Esteban, 1987). The deduced amino acid sequence of the 
39kd protein shows identity with cytoskeleton keratins at amino acids 227 to 231. It is 
possible that amino acids 227 to 231 constitute an antigenic epitope and that monoclonal 
antibody against this epitope cross-react with cytoskeleton keratins structures of 
noninfected cells. 50% of mice immunised with this protein were protected on challenge 
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with vaccinia virus, however the immune mechanism involved in protection of mice is 
not clear. ADCC may contribute to the protection since this protein has been shown to 
be expressed on the surface of infected cells. 
The 32kd and 14kd are envelope proteins and have been shown to be involved in 
inducing cellular and humoral immune responses in mice (Demkowicz et al., 1992). 
Strong humoral antibody responses to the 32kd protein were observed in vaccinia virus 
vaccinated humans or animals. Lymphocytes obtained from 32kd vaccinated mice 
showed proliferation in in vitro lymphoproliferation experiments suggesting that this 
protein stimulates cellular components of the immune system. Since 32kd vaccinated 
mice were not examined by challenge with vaccinia virus it is not clear whether the 
immune responses observed in the 32kd vaccinated animals were protective. The 14kd 
protein induces high levels of neutralising antibody in mice and confers complete 
protection against vaccinia virus challenge (Lai et al., 1991). Involvement of the 14kd 
protein in the generation of cellular as well as humoral immune responses strongly 
suggests that this protein plays a very important role in the host immune response to 
vaccinia virus. The proteins localised in the outer envelope of the extracellular virus 
have also been implicated to play an important role in the protective immune responses 
to poxviruses (Payne, 1980). These observations suggest that proteins of the intracellular 
virus envelope as well as extracellular virus envelope are involved in the protective 
immune responses against poxvirus infections. 
1.11.1 Immunogenic proteins of capripoxvirus 
Sambyal and Singh (1978) analysed the immunogenic nature of virus free soluble 
antigens of sheeppoxvirus (an isolate of capripoxvirus from sheep) prepared either from 
infected skin or lamb testis cell monolayers. These preparations with or without Freund's 
complete adjuvant (FCA) were used to vaccinate lambs. The animals vaccinated with 
soluble antigens mixed with FCA produced neutralising antibody and withstood 
challenge with a virulent sheeppoxvirus. The animals immunised with soluble antigens 
alone produced neutralising antibody, however, these animals were only partially protected 
against virulent sheeppoxvirus challenge. These results indicate that soluble antigens of 
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sheeppoxvirus are immunogenic in nature but require the incorporation of an adjuvant 
to induce immune responses. The number of antigenic proteins present in the soluble 
antigen preparation was not determined. In a subsequent study, Sambyal and 
Singh(1980) demonstrated that animals immunised with the soluble antigens mixed with 
FCA showed an Immediate Type (possibly Type I) of cutaneous hypersensitivity on 
intradermal challenge. This hypersensitivity reaction was not observed in mepyramine 
maleate pretreated animals, which suggests that the reaction was mediated by the release 
of histamine. 
Using primary lamb testis cell monolayers to study the presence of extracellular and 
intracellular forms of sheeppoxvirus during infection it was found that most of the 
progeny sheeppoxvirus remained cell associated and only 3% of the total yield was 
released as extracellular virus. Lambs immunised with both forms of virus showed low 
levels of neutralising antibody but were completely resistant to challenge with 
sheeppoxvirus (Srivastava and Singh, 1980a). Thus correlation could not be established 
between neutralising antibody titre and the immune status of the animals. These results 
indicate that perhaps cell-mediated immune responses are involved in inducing the 
immunity in vaccinated animals with either form of virus. 
Srivastava and Singh (1980b) demonstrated that passive transfer of the immune serum 
raised against live and inactivated extracellular or intracellular sheeppoxvirus to 
susceptible lambs conferred a partial protection on challenge with sheeppoxvirus by 
extending the incubation period by several days (5 to 10 days). Kitching (1986) showed 
that sheep given immune serum obtained from recovered animals completely resisted 
challenge with virulent sheeppoxvirus (capripoxvirus isolate from sheep). A possible 
explanation of these different findings could be the quantity and quality of serum 
passively transferred to the animals. Kitching (1986) used 200 ml of immune serum to 
immunise the animal in contrast to 45 ml used by Srivastava and Singh (1980b). In 
addition, Kitching (1986) demonstrated that sheep inoculated with immune serum 
although immune to challenge failed to inhibit local replication of challenged virus at 
the site of inoculation, whereas animals immunised with live virus vaccine quickly 
inactivate the challenged virus at the site of inoculation (Kitching et al., 1987). These 
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observations suggest that vaccination of animals with a live virus vaccine induces the 
cell-mediated immune responses in addition to neutralising antibody. 
Rai et al. (1985) used fluorocarbon extracted sheeppoxvirus to identify the various viral 
proteins by SDS-polyacrylamide gel electrophoresis (SDS-PAGE). They observed four 
protein bands in the gel of which three reacted with sheeppox hyperimmune serum. The 
were 
immunogenic nature of these four proteins ' examined in rabbits. The rabbit inoculated 
with the 22kd protein (VP3) showed development of virus neutralising antibody and cell- 
mediated immune responses. In a subsequent study Rai et al. (1986) showed that the 
"VP3" protein mixed with Freund's incomplete adjuvant when inoculated into sheep 
induced a high level of humoral and cell-mediated immune responses. Two of the three 
sheep were protected on challenge from the virulent sheeppoxvirus 21 days post 
vaccination. None of the control sheep or sheep inoculated with incomplete adjuvant 
were protected. They concluded that a single immunogenic polypeptide is capable of 
inducing protective immunity in sheep. Although it has been shown that a single protein 
of a virus can induce a protective immunity (Crick and Brown, 1969; Laporte et 
al., 1973) Rai et al. (1986) were only able to separate the structural proteins of 
sheeppoxvirus into four `proteins' despite the fact that more than 20 proteins have been 
observed in the purified sheeppoxvirus (Al-Bana, 1978; Kitching et al., 1986). Thus the 
assumption that the "VP3" protein band was a single protein is extremely misleading and 
hence it is difficult to explain in detail these results of Rai et al. (1986). 
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The objectives of this study 
The genus capripox of the family poxviridae consists of sheeppoxvirus, goatpoxvirus and 
lumpy skin disease virus of cattle (Neethling). These viruses show host preference under 
natural conditions and are thus named accordingly. However, many workers have shown 
that single isolates of capripoxvirus are capable of infecting all three species (Capstick, 
1961; Al-Bana, 1978). Kitching & Taylor (1985) showed that the isolates of 
capripoxvirus from different parts of the world were indistinguishable on the basis of 
clinical signs, heterologous serum neutralisation and cross-protection studies. A single 
vaccine has been shown to protect sheep, goats and cattle from capripoxvirus infection 
(Kitching et al., 1987; Kitching, personal communication). These studies indicate that 
the different isolates of capripoxvirus from any of the three animal species (sheep, goats 
and cattle) possess common immunogenic components which are responsible for the 
generation of immunity in all the three species. Proteins which are localised on the 
envelope of virus particle could be immunogenic in nature and perhaps are involved in 
early events of virus-host cell interaction. Therefore the analysis of envelope proteins of 
the virus with respect to their biochemical and immunological functions is important. 
The objective of this study was to characterise the envelope proteins of capripoxvirus 
to determine whether one or more envelope proteins are involved in early events 
of virus-host cell interactions and to study their involvement in immune response to 
infection. A knowledge of functional properties of such an envelope protein(s) would 
help us in formulating a hypothesis to explain common immunological relationship, 
limited host range, cross-infection or early events of virus host cell interactions of 
capripoxvirus isolates. 
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CHAPTER 2 
2.1 Reagents and Buffers 
Materials and Methods 
The majority of chemicals used were purchased from Sigma Chemical Co. and BDH 
Chemicals, Ltd., unless otherwise stated. Immunochemicals were purchased from 
Dakopatts. Restriction endonucleases, DNA modifying enzymes and incubation buffers 
were obtained from either Promega or Boehringer Mannheim Biochemicals. 
Radiochemicals were supplied by New England Nuclear (Dupont). A list of solutions 
and buffers used is given below. 
TE 10mM Tris-HC1, pH8 
1 mM EDTA 
T0.1E 10mM Tris-HC1, pH8 
0.1 mM EDTA 
TEN 10mM Tirs-HC1, pH8 
1mM EDTA 
10mM NaCl 
TBE(10x) 
TAE(50X) 
Denaturating solution 
Neutralising solution 
SSC(20x) 
89mM Tris-base 
89mM Boric acid 
2mM EDTA 
2M Tris-base 
4M Sodium acetate 
2mM EDTA 
1.5M NaCl 
0.5M NaOH 
1.5M NaCl 
0.5M Tris-HC1, pH7.2 
1mM EDTA 
3M NaCl 
0.3M tri-sodium citrate 
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Denhardt's solution(50x) 
Prehybridisation solution 
Agarose gel loading 
buffer(6x) 
2%(w/v) BSA 
2%(w/v) Ficoll 
2%(w/v) Polyvinyl Pyrollidone 
6x SSC 
0.5x Denhardt's solution 
0.5% SDS 
100pg/ml denatured salmon sperm DNA 
0.25% bromophenol blue 
0.25% Xylene cyanol FF 
15% Ficoll 
TSS 10% PEG-3000 (w/v) 
5% dimethyl sulphoxide (v/v) 
30mM MgC12 
in LB broth 
Kinase buffer(lOx) 0.5M Tris-HC1, pH7.6 
0.1M MgC12 
50mM DTT 
1mM EDTA, pH8 
1mM Spermidine hydrochloride 
Solution A 0.1% SDS 
1 mM EDTA 
2.5mM DTT 
125mM Tris-HC1, pH6.8 
Laemmli lysis buffer(2x) 50mM Tris-HC1, pH6.8 
10% glycerol 
4% SDS 
200mM DTT 
0.2% bromophenol blue 
Electroblotting buffer 
Envelope disruption buffer 
Core dissolving buffer 
48mM Tris-base 
39mM Glycine 
0.037% SDS 
20% Methanol NO 
50mM Tris-HC1, pH8.4 
50mM DTT 
0.5% nonidet P-40 
50mM Tris-HCI, pH8.4 
50mM DTT 
250mM NaCl 
0.2% sodium deoxycholate 
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STE 100mM NaCl 
10mM Tris-HCI, pH8 
1mM EDTA 
Solution I 50mM glucose 
25mM Tris-HC1, pH8 
10mM EDTA 
Solution II 0.2M NaOH 
1% SDS 
Solution III 60m1 5M potassium acetate 
11.5m1 glacial acetic acid 
28.5m1 water 
OLB(5x) 250mM Tris-HC1, pH8 
25mM MgC12 
5mM 2-mercaptoethanol 
2mM each dATP, dCTP, dTTP 
1M HEPES, pH6.6 
lmg/ml hexanucleotides 
Stop buffer 50mM Tris-HC1, pH7.5 
50mM NaCl 
5mM EDTA, pH8 
0.5% SDS 
Dephosphorylation buffer(10x) 
Exonuclease III buffer (10x) 
10mM ZnC12 
10mM MgC12 
100mM Tris-HCl, pH8.3 
500mM Tris-HC1, pH8 
50MM MgC12 
10mM DTT 
SI buffer(lOx) 300mM sodium acetate, pH4.6 
40mM ZnC12 
3M NaCl 
SI stop buffer 50mM EGTA 
200mM Tris-HC1, pH8 
100mM EDTA 
T4 DNA polymerase buffer(10x) 333mM Tris-acetate, pH8 
666mM Potassium acetate 
100mM MgC12 
5mM DTT 
1mg/ml BSA 
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T4 DNA ligase buffer (10x) 
Loading buffer 
(sequencing gel) 
2.2 Virus and Cells 
500mM Tris-HC1, pH7.6 
100MgC12 
100mM DTT 
500ug/ml BSA 
98% Formamide, 
0.25% xylene cyanol FF, 
0.25% bromophenol blue, 
10mM EDTA, pH 8.0 
Kenya sheep and goat pox virus (0240), originally isolated by Davis (1976) from a 
mixed flock of sheep and goats, was used throughout the study. The isolate has been 
developed as a vaccine and used successfully to control both sheeppoxvirus and 
goatpoxvirus infections (Kitching et al., 1987). This vaccine isolate has been designated 
KS-1 (Gershon et al., 1989). 
2.2.1 Lamb testis (LT) cell monolayers: Primary lamb testis cell monolayer cultures were 
prepared from prepubertal lambs by a modification of the method of Plowright and 
Ferris (1958) and Al-Bana (1978). The cells, after trypsinisation, were grown in plastic 
tissue culture flasks in Glasgow modified Eagle's medium (GMEM) supplemented with 
10 per cent foetal bovine serum, sodium penicillin( 10001U per ml) and streptomycin 
sulphate (lmg per ml). On confluency the monolayers were trypsinised and passaged 
further by dividing one flask into three. After the third or fourth passage cells were 
stored down in liquid nitrogen (storage medium: 90% foetal bovine serum + 10% 
dimethyl sulphoxide). 
2.2.2 Ovine kidney (OK) cell monolayers: The OK cell monolayers were obtained from 
Dr. J. Lecomte, INSTITUT ARMAND-FRAPPIER, Quebec, Canada (received at the 52nd 
passage level). They were grown in the recommended culture medium (45% Medium 
199 with Hank's salts + 45% Minimum essential medium, Earle's salts + 10% Foetal 
bovine serum) with antibiotics as above and passaged by dividing one flask into ten. 
This cell line was used for serum neutralisation assays and, in some experiments, for 
virus titrations. 
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2.3 Experimental animals 
Out bred rabbits (2.5 to 3.0 kg. weight) were obtained from the Foxfield Rabbits (UK) 
Ltd., Petersfield, Hampshire, and maintained at the small animal facilities at the Pirbright 
Laboratory. Sheep were purchased from the local sheep breeding farms and housed in 
high security isolation units at the Pirbright Laboratory. 
2.4 Preparation of hyperimmune serum (HIS) 
Two monozygotic sheep, bred at the Pirbright Laboratory facilities, were used to raise 
hyperimmune serum against the KS-1 isolate of capripoxvirus. One of the monozygotic 
sheep was inoculated with KS-1 at 4 different sites in the flank regions. The sheep was 
killed on the 8th day following inoculation and skin samples from all four sites were 
collected for use as the source of virus for the second monozygotic sheep. A 20% 
suspension of the skin samples prepared in PBS was used to inoculate the second 
monozygotic sheep. The sheep was boosted at monthly intervals over a period of 10 
months. Adjuvant was not used at any stage of the preparation of the hyperimmune 
serum. Ten days after the last injection the sheep was killed and the maximum possible 
blood was collected. The serum was prepared and stored in the aliquots at -20°C. 
Hyperimmune serum prepared in sheep against Ranipet strain of sheeppoxvirus (an 
Indian isolate of a capripoxvirus) was obtained from Veterinary College, Banglore, India. 
This had been prepared with the incorporation of FCA in the booster doses (personal 
communication Prof R Raghavan, Banglore, India). 
2.5 SDS-polyacrylamide gel electrophoresis (SDS-PAGE) 
Proteins were separated on a vertical 15cm gel using the discontinuous SDS-PAGE 
system (Laemmli, 1970). The stacking gel contained 4% acrylamide in 125mM Tris-Hcl 
pH6.8,0.1%SDS, and the separating gel contained 12% or 14% acrylamide in 375mM 
Tris-Hcl pH8.8,0.1%SDS. The running buffer was 250mM Tris, 192mM-glycine, 
0.1%SDS. Electrophoresis was carried out at a constant voltage of 60V till the 
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bromophenol blue marker dye had migrated to the bottom of the gel (16-18 hours). The 
gel was stained with coomassie brilliant blue or with 0.3M cupric chloride solution or 
the proteins were transferred to nitrocellulose membrane if immunoblotting was to be 
performed. 
2.5.1 Coomassie blue staining 
The gel was transferred to a fixing solution (45% methanol and 9% acetic acid) for 1 
hour, proteins were stained for 2 hours or overnight with 0.25% coomassie brilliant blue 
(RG-250) prepared in the fixing solution. Destaining of the gel was carried out with a 
solution containing 30% methanol and 9% acetic acid to remove the background 
staining. 
2.5.2 Cupric chloride staining 
The cupric chloride staining method was essentially that described by Lee et al. (1987). 
The gel was washed for 30 seconds (x2) with deionised water and transferred to a 
freshly prepared 0.3M cupric chloride solution. The gel was gently agitated at room 
temperature for 5 minutes and then washed for 10 minutes with deionised water. The 
protein bands were identified by viewing the gel against a dark background. 
2.6 Immunoblotting 
Proteins were transferred from SDS-PAGE gel to nitrocellulose membrane (NCM) 
(0.45uM, Schleicher & Schuell) by the semi-dry method of electro-blotting as described 
by Kyhse-Anderesen (1984) using a Nova Blot Electrophoretic Transfer Unit of 
Pharmacia. The gel was incubated for 10-15 minutes in electroblotting buffer at room 
temperature and then placed onto the NCM. Transfer of proteins was obtained within 
one hour by employing 0.8mA current per cm2 of the gel. After transfer the NCM was 
rinsed in PBS and immersed in 5% (w/v) non-fat dry milk powder dissolved in PBS 
(Blotto) for 1/ hours to block the unsaturated sites on the NCM. The NCM was then 
incubated with primary antibody (1: 50 in Blotto) at 37°C for 1 hour with gentle shaking. 
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After three 5 minutes washes in PBS-Tween (PBS-0.05% Tween-20) the NCM was 
incubated with anti-species immunoglobulin horse radish peroxidase enzyme conjugate 
(1: 2000 in Blotto) for one hour at 37°C with gentle shaking. The NCM was washed as 
described above and placed in 50mM Tris-HC1 pH7.5 for 10 minutes. The NCM was 
finally incubated in freshly prepared substrate solution (10mg diaminobenzidine 
tetrahydrochloride tablet dissolved in 50m1 of 50mM Tri-Hcl buffer pH7.5 with the 
addition of 20gl of 30%(v/v) H20) for approximately 4-5 minutes to allow the 
development of antibody reactive bands. The reaction was stopped by washing the NCM 
in deionised water. 
2.7 Virus DNA synthesis analysis 
Confluent LT-cell monolayers in 35mm petri dishes were infected with KS-1 virus at 
m. o. i. of 10 and incubated at 37°C for 1 hour in 5% CO. atmosphere. Cell monolayers 
were washed twice with pre-warmed Eagles' medium to remove the unadsorbed virus 
and incubation in Eagles' medium was continued. At different times post infection the 
cell monolayers in a petri dish was washed twice with ice cold PBS and harvested by 
scraping in 0.5m1 of Tris buffer, pH9 (lOmM Tris-HC1 containing 2mM EDTA). The 
samples were frozen and thawed once, trypsin was added (final concentration 200 tg/ml) 
and the samples incubated at 37°C for 30minutes. Two fold serial dilutions of each 
sample were made in Tris buffer, pH9. The DNA in the samples was denatured by the 
addition of 40u1 of 2N sodium hydroxide, following brief mixing, 25ul of 8M 
ammonium acetate was added to the each sample to neutralise the alkali. The samples 
were transferred to NCM, which had been pre-soaked in 1M ammonium acetate, using 
a Bio-Dot micro-filtration apparatus. The NCM was washed with 1M ammonium acetate 
and baked in vacuo for 2 hours at 80°C. Prehybridisation for was carried out in a roller 
bottle containing 25m1 prehybridisation solution for 3hours. Hybridisation of the DNA 
samples on the membrane was carried out by incubating the NCM with prehybridisation 
solution containing a [32P] labelled probe prepared from KS-1 capripoxvirus DNA by the 
random primer method (Feinberg and Vogeslstein, 1983,1984). The membrane was 
washed two times, 15 minutes each, with 2xSSC and once with 2xSSC containing 0.1% 
SDS for 30 minutes. All incubations and washing steps were carried out at 65°C. The 
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washed membrane was air dried and exposed to X-ray film at -70°C. Uninfected LT-cell 
monolayers processed in a similar fashion were included as a negative controls. Standard 
amounts of KS-i capripoxvirus DNA were included as positive controls. 
2.8 Time course analysis of viral protein synthesis 
LT-cell monolayers in 35mm dishes were infected as described above (2.7) and 
incubated in Eagles' medium in the presence or absence of cytosine arabinoside 
(25 tg/ml). At specific times post infection petri dishes were removed, monolayers were 
washed with pre-warmed methionine free Eagles' medium and re-incubated in a medium 
containing [35S] methionine (35RCi/ml). After 1 hour monolayers were washed twice 
with PBS, harvested in 200u1 Laemmeli lysis buffer, heated in a boiling water bath for 
3 minutes and 35pl of each sample were analysed by SDS-PAGE. The separated proteins 
were fixed (in 45% methanol, 9% acetic acid) for 45 minutes, gel was dried overnight 
and exposed to a X-ray film. In addition, the proteins from these samples, after SDS- 
PAGE separation, were transferred to NCM and analysed by immunoblotting using 
hyperimmune serum or monospecific serum as described earlier (2.6). 
2.9 Purification of the virus 
Secondary LT-cell monolayers grown in Roux flasks were used to propagate the 
capripoxvirus (KS-1). The monolayers were infected at m. o. i. of 1 and incubated at 
37°C. The monolayers were frozen when approximately 90% of the cells were showing 
cytopathic effects. Following thawing the suspension was centrifuged at 600xg for 20 
minutes and the supernatant retained for virus purification using the method described 
by Kitching et al. (1986) with some modifications. The supernatant was centrifuged at 
80000xg for one hour at 4°C. The resultant pellet was resuspended in one ml of cold 
PBS pH 7.2, and incubated at 37°C for 15 minutes with DNase at a final concentration 
of 25 tg/ml, followed by a further 15 minutes incubation at 37°C with trypsin (final 
concentration 100 tg/ml). The solution was then cooled to 4°C and trypsin inhibitor 
added at a final concentration of 75pg/ml. The virus suspension was layered on to a 
36%(w/v) sucrose cushion and centrifuged at 4°C at 85000xg for 90 minutes. The 
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resultant pellet was resuspended in a minimal amount of TE buffer, layered on to a 40% 
to 60%(w/v) sucrose gradient in TE buffer and centrifuged at 58000xg at 4°C for 1 hour. 
The virus concentrated in two opaque bands which form at approximately one-third and 
two-thirds of the distance from the top of the sucrose gradient. Both bands appear to 
contain the virus (R P Kitching and CM Smale, unpublished data). The upper virus 
band, which was much lighter than the bottom virus band, appeared to be the 
extracellular virus. These opaque bands were removed with a sterile Pasteur pipette and 
diluted at least five times with the TE buffer. The virus was recovered by centrifugation 
at 82000 xg at 4°C for 60 minutes and the pellet of purified virus suspended in 0.5 ml 
of TE buffer, pH 8.0. The amount of protein per ml of purified viral preparation was 
determined by measuring the OD260 (10 ODU = 0.65mg, Joklik, 1962b). The treatment 
of crude virus pellet suspension with trypsin was omitted when/effect of this enzyme on 
viral proteins was analysed. 
2.10 Preparation of envelope and core fractions of virus 
Purified virus (20 ODU) was pelleted at 13000xg for 5 min at 4°C in a microfuge. The 
resultant pellet was resuspended in 200µl envelope disruption buffer and incubated at 
37°C for one hour. The subviral cores were collected by centrifuging the suspension at 
13000xg for 5 minutes at 4°C and the supernatant removed carefully. This supernatant 
was used as the virus envelope preparation. The pellet was resuspended in 250µl core 
dissolving buffer and incubated at 4°C for 30 minutes (Baroudy and Moss, 1980). The 
suspension was centrifuged as described above and the supernatant used as the soluble 
core proteins. 
2.11 Preparation of monospecific serum 
Polyclonal monospecific sera to specific viral proteins (69kd, 66-67kd, 32kd, 26kd and 
19-20kd) were prepared in rabbits. The envelope and core proteins were prepared as 
described above (2.10) then separated into individual proteins by SDS-PAGE. Proteins 
were visualised by staining with 0.3M cupric chloride solution (2.5.2) and specific 
protein bands were precisely cut from the gel. These protein bands were processed for 
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inoculation by intradermal route into rabbits as described by Harlow and Lane (1988). 
After two booster doses at intervals of three weeks rabbit sera were prepared and tested 
for monospecificity by immunoblot analysis. Rabbits showing a negative response were 
boosted two more times and retested. 
2.12 Titration of virus 
Titration of the virus was carried out either on OK-cell or LT-cell monolayers grown in 
24 well plates. The virus did not produce appreciable plaques on either monolayer. 
However, on the OK-cell monolayers, the virus below 1000 TCID501 well, produced 
characteristic aggregated cell foci which can be identified using a low power microscope. 
To titrate virus, ten fold dilutions were prepared in the Eagle's medium and 250µ1 
volumes were added into each well, four wells were used for each dilution. After one 
hour incubation period at 37°C in 5% CO2 atmosphere the virus suspension was replaced 
with 1.5m1 fresh Eagle's medium. After 5 days incubation at 37°C in 5% CO2 
atmosphere the monolayers were fixed in 10% formalin, stained in 0.2% methylene blue. 
The virus titre was calculated using the method of Karber (1931). 
2.13 Virus neutralisation assay 
LT-cell or OK-cell monolayers grown in 24 well plates were used in the assay. Ten fold 
dilutions of inactivated sera (56°C for 30 min) were mixed with equal volumes of virus 
suspension containing 200 TCID50 of the virus, incubated at 37°C for 2 hour and a 
further 14 hour at 4°C. Each dilution was inoculated into 4 wells (250µ1/well) and the 
plates were incubated in 5% CO2 atmosphere at 37°C. After an incubation for one hour 
at 37°C in 5% CO2 atmosphere the inoculum was replaced with 1.5ml fresh Eagles' 
medium. On the 5th day the monolayers were fixed with 10% formalin, stained with 
0.2% methylene blue. Pre-inoculation rabbit sera processed in a similar fashion were 
used in the assay as negative controls. Reduction in foci numbers on 0K cell 
monolayers or suppression of c. p. e. in the case of LT cell monolayers caused by 
monospecific serum were used to determine the virus neutralisation. 
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The virus neutralisation assay was also carried out using the 32kd monospecific serum 
and varying amounts of purified virus. Ten fold serial dilutions of purified virus were 
mixed with equal volumes of 32kd monospecific serum (1: 20 dilution) and processed 
to infect the LT-cell monolayers as described above. Neutralisation titres were calculated 
after an incubation of 5 days. 
2.14 Trypsin treatment of virus 
Virus was purified as described above (2.9) with the trypsin treatment step omitted. This 
preparation (200µg in 200µ1) was incubated with trypsin (final concentration 10O tg/ml) 
at 37°C in a water bath. At 5,10,20 and 40 minutes intervals 50µl samples were 
removed, 50µ1 of 2x Laemmeli lysis buffer added and the samples heated in a boiling 
water bath for two minutes. The samples and untreated virus were analysed on 
SDS-PAGE. In addition, the purified virus was treated with trypsin for 15 minutes as 
described above. The trypsin was inactivated by cooling the mixture on ice and adding 
trypsin inhibitor (final concentration 75µg/ml). Ten fold serial dilutions of this 
preparation were prepared and infectivity titres were determined in the presence or 
absence of the 32kd monospecific serum (1: 20 dilution) as described above (2.13). 
2.15 Cellular expression of viral proteins 
The indirect fluorescence antibody technique was used to examine the cellular expression 
of virus proteins. LT cell monolayers growing on glass cover slips were infected with 
KS-1 virus. At 48 hpi cells were washed 3 times with PBS and fixed under conditions 
that made the cells (i) non-permeable (4% formaldehyde- 0.1% glutaraldehyde in PBS 
at 4°C for 45 min) and (ii) permeable (acetone at -20°C for 15 minutes). Subsequent 
treatments were carried out at room temperature. Cells were washed 3 times with PBS, 
incubated with 1% bovine serum albumin in PBS for Ih followed by Ih incubation with 
dilutions of monospecific serum prepared in 1% bovine serum albumin. The cells were 
then washed 5 times with PBS and incubated for 30 min with affinity-purified 
anti-rabbit immunoglobulin G conjugated with Fluorescine isothiocynate (FITC) at a 
1: 25 dilution in 1% bovine serum albumin. The cells were finally washed 5 times with 
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PBS and the cover slips were mounted in glycerol-PBS (1: 1 vol/vol) on a microscope 
slide. Excess buffer was removed, and the cover slips were sealed with nail polish. Cells 
were visualised and photographed using a Zeiss fluorescence microscope. 
2.16 Preparation of plasma membrane from capripoxvirus (KS-1) infected cells 
Plasma membranes from infected LT-cell or 0K cell monolayers were isolated and 
purified by the two phase polymer method of Brunette and Till (1971). A similar 
technique has been previously employed to prepare and characterise plasma 
membranes from vaccinia virus infected cells (Weintraub and Dales, 1974; Mallon and 
Holowczak, 1985). Briefly, monolayers (grown in 25 cm2 flask) showing 90% c. p. e. 
were harvested by scraping and washed 3 times in 0.9% NaCl. Cells were swollen in 
2m1 of 1mM ZnC12 for 5 minutes at room temperature, then for an additional 5 minutes 
on ice and homogenized in a small Dounce homogenizer with a tight fitting pestle. 
Plasma membranes, nuclei, and the few remaining unbroken cells were pelleted for 15 
minutes at 350xg. The pellet was resuspended in 2 ml of top phase (dextran T-500, 
polyethylene glycol-6000, ZnC12, sodium phosphate buffer, pH6.5, and distilled water; 
Brunette and Till, 1971), mixed well with 2 ml of bottom phase (sodium phosphate 
buffer, Ph 6.5; distilled water, Brunette and Till, 1971) and centrifuged for 10 minutes 
at 5000xg. The pellet was discarded and the two phases and the band of membrane 
material at the interface were decanted together into a fresh tube, remixed, and 
recentrifuged. This sequence was repeated and the band of plasma membranes which 
separated at the interface was removed, diluted 8 times with distilled water, and 
centrifuged for 15 minutes at 650xg. The resultant pellet was resuspended in 0.5m1 of 
distilled water and, stored at -70°C or analysed by immunoblotting. Plasma membranes 
from mock infected monolayers were also prepared. 
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2.17 Virus protein: specific T-cell proliferation assay 
The T-cell responses against virus proteins were analysed with peripheral blood 
lymphocytes obtained from capripoxvirus (KS-1) vaccinated sheep and the following 
antigen preparations. 
2.17.1 Inactivated virus antigen 
Purified virus suspended in Eagles' medium was treated with U. V. light for 5 minutes 
under a R-52 U. V. lamp (Ultra-violet products, Inc. CA) kept about 8mm above the 0.8 
to lmm thick virus suspension layer. After this treatment infective virus was not 
detected in the preparation. The preparation was stored at 4°C until required. 
2.17.2 Virus envelope and core proteins antigen preparation 
Virus envelope and core proteins were prepared from 3mg of purified virus as described 
above (2.10). The detergent in both the of antigen preparations was removed by passing 
through the Extracti-Gel D columns (Pierce, IL). 0.5m1 antigen preparation was loaded 
onto the column, eluted with PBS and 0.5m1 fractions were collected. Fractions were 
checked for proteins (Bradford, 1976) and those containing proteins were pooled. 
Separate columns were used for each antigen preparation in order to avoid cross 
contamination of envelope and core proteins. The antigen preparations were filter 
sterilised and stored at 4°C until required. 
2.17.3 Nitrocellulose bound protein antigen preparations 
Virus proteins separated by SDS-PAGE were transferred onto NCM. The NCM was 
rinsed in distilled water, incubated with excess PBS supplemented with 0.3% Tween-20 
at 37°C for 30 minutes with gentle shaking and washed 5 minutes (x3) in 0.3% 
Tween-20 solution at room temperature. The blot was rinsed briefly with distilled water, 
stained with Aurodye (Janssen Biotech. N. V., Olen, Belgium) for 3 hours at room 
temperature, washed again and air dried. Five major structural proteins (69kd, 66-67kd, 
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45kd, 32kd, 26kd) were identified and NCM containing these proteins was processed for 
bound antigen preparation as described by Lamb et al. (1988). Briefly, the NCM pieces 
containing the individual proteins were dissolved in dimethyl sulphoxide and incubated 
for 1 hour at room temperature, the NCM bound antigen was precipitated with 0.5M 
carbonate-bicarbonate buffer (pH 9.6). The precipitate was washed 3 times in Hanks' 
balanced salt solution and suspended in Iscove's minimal essential medium containing 
10% foetal bovine serum. These antigen preparations were stored at -20°C until required. 
2.17.4 Nonidet P-40 extracted 32kd protein antigen 
The NP-40 extracted 32kd protein antigen was prepared from a preparation of envelope 
proteins. The preparation of envelope proteins is described above (2.17.2), but the 
fractions eluted from the column were analysed by SDS-PAGE and commassie blue 
staining. The envelope proteins were found to be eluted up to the sixth fraction but the 
last two fractions were found to contain only 32kd envelope protein. These two fractions 
were pooled and designated as NP-40 extracted 32kd protein. 
2.17.5 SDS-PAGE gel extracted 32kd protein antigen 
The 32kd protein was also extracted from SDS-PAGE gels. The virus proteins were 
separated by SDS-PAGE and 1 cm wide strips from either side of the gel were stained 
with 0.3M cupric chloride solution as described earlier(2.5.2). The strips were aligned 
with the main gel and the gel band corresponding to the stained 32kd protein in the 
strips was cut out from the unstained gel. The gel slice was boiled and then agitated at 
37°C overnight in a buffer containing 1% SDS, 1% 2-mercaptoethanol, 1 mM phenyl 
methylsulfonyl fluoride (PMSF) and 100mM Tris-HC1 (pH8.0). Excess SDS was 
removed from the eluted protein by dialysis (Microdialyzer Systems 500 Pierce, IL) of 
the supernatant or by passage through an Extracti-Gel D column (Pierce, IL). 
2.17.6 Immunisation of sheep 
Ten cross-bred sheep (6 to 12 months old) were vaccinated by intradermal inoculation 
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either with purified KS-1 virus (104 TCID50) or by KS-1 vaccine(104 TCID, 5O) (Kitching 
et al., 1987). All animals were housed in insect proof and capripoxvirus secure 
accommodation at the Pirbright Laboratory. 
2.17.7 Preparation of peripheral blood mononuclear cells(PBMC) 
Blood from vaccinated sheep was collected in heparinised tubes and the PBMC were 
isolated by Lympho-paque(Nyegaard & Co., Oslo, Norway) gradient centrifugation 
(Takamatsu and Jeggo, 1989). Briefly, the blood was centrifuged at 850xg at 4°C for 10 
minutes and the buffy coat between plasma and red blood cells was transferred to 10 ml 
Hank's balanced salt solution in a 25m1 vial. The cell suspension was underlaid with 9ml 
Lympho-paque and centrifuged at 18°C for lhour at 400xg. The PBMC fraction at the 
interface was removed, washed 4-5 times with the Hank's balanced salt solution and 
finally suspended in culture medium (Iscove's minimal essential medium containing 10% 
bovine foetal serum and antibiotics). The cell number was determined by counting in a 
haemocytometer and adjusted to 4x 106 cells/ml. 
2.17.8 Antigen specific lymphocyte proliferation assay 
The PBMC (2 x 103 cells/well) were cultured with two fold serial dilutions of the 
different antigen preparations described above or medium alone in 96-well round 
bottomed microtitre plates. The cells were cultured for 96 hours at 37°C in 5% CO2 
atmosphere, 0.2jCi of tridated thymidine ([3H]-TdR) added to each well and incubation 
continued for a further 16 hours. Cells were harvested onto glass fiber filters and 
[3H]-TdR incorporation was determined by liquid scintillation spectrometry (1209 
Rackbeta, LKB, Turku, Finland). Experiments were carried out in triplicate. 
2.17.9 Virus specific antibody production in vitro 
Virus specific antibody production in vitro was performed by the method described by 
Lane et al. (1981). 0.5ml PBMC (3-5 x 106 cells/ml) were cultured in 24 well plate with 
2 tg/m1 of different antigens or medium alone for 8 to 10 days. The virus specific 
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antibody in culture fluids was measured by an indirect ELISA. 
2.17.9.1 Enzyme linked immunosorbent assay (ELISA) 
Fifty microlitres of 50mM carbonate bicarbonate buffer (pH9.6) containing purified 
KS-1 capripoxvirus (10 tg/ml) were added to each well of the flat bottomed microtitre 
plate. The plate was incubated at 37°C for 2 hours to coat of the well surface with the 
virus particles. The virus suspension was removed and blocking of the unsaturated sites 
was accomplished by adding the Blotto-T (5% milk powder dissolved in PBS containing 
0.05% Tween-20) to each well and incubating for 2 hours at 37°C. The wells were 
washed twice with PBS containing 0.05% Tween-20 (PBS-T) and 50µl of the cultured 
fluid was added. Incubation was carried out at 37°C for a further of 2 hours and the 
wells were washed (x4) with PBS-T. To each well 50µ1 of diluted rabbit anti-sheep Ig 
horseradish peroxidase conjugate (1: 2000 in Blotto; Dakopatts) was added. After an 
incubation at 37°C for 2 hours the wells were washed (x4) with PBS-T and 50µl of a 
freshly prepared substrate solution was added to the each well. The substrate solution 
was prepared by dissolving orthophenyl diamine tetrahyhrochloride (OPD) in 50mM 
Phosphate-citrate buffer, pH 5.4 (0.4mg/ml) with the addition of 30%(V/V) hydrogen 
peroxide (H202) (final concentration 0.006%). The plate was incubated at room 
temperature for 20 minutes and reaction was stopped by adding 50µl of 2M sulphuric 
acid. The OD495 was measured in a Multiskan ELISA reader. 
2.18 The 32kd protein in virus specific diagnosis 
2.18.1 Purification of Viruses: 
The KS-1 isolate of capripoxvirus was purified using sucrose gradient centrifugation as 
described earlier (2.9). The orf virus was obtained as a dried scab ground in sterile sand 
from Dr. D. McKeever, Moredun Research Institute, Edinburgh, UK. Two sheep were 
experimentally infected by scarification on the groin region, skin scabs were collected 
between 10 to 14 days of infection and processed for the purification of orf virus 
(Esposito et al., 1978; Robinson et al., 1982). 3-4 grams scab material in 15ml TE buffer 
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were mixed with carborundum, grounded using a pestle and mortar and the resulting 
material was centrifuged at 1500xg for 30 minutes at 4°C. The supernatant was loaded 
onto a 2.5ml 36% sucrose (w/v) cushion in an 18 ml tube and centrifuged in a Beckman 
SW-28.1 rotor at 45000xg for 30 minutes. The pellet was suspended in 1 ml of TE 
buffer and carefully layered onto a composite gradient consisting of a 25-50% sodium 
diatrizoate gradient overlaid with 10% dextran T-10 and recentrifuged at 45000xg for 
18 hours. The visible virus band at about 2/3 distance from the top of the centrifuge tube 
was aspirated and diluted 1: 5 in TE buffer. The virus was recovered by centrifuging the 
diluted virus through a 36% sucrose cushion. The protein content of both the virus 
preparations was determined. 
2.18.2 Serum samples 
Serum samples from two sheep experimentally infected with orf virus, as described 
above, were collected at weekly intervals up to 6 weeks. Pre-immune serum samples 
from both the sheep were also collected. The serum samples from capripoxvirus (Nigeria 
sheeppoxvirus) infected sheep have been described earlier (Kitching et al., 1986). This 
sheep was infected with Nigeria sheeppoxvirus isolate and sera were prepared thereafter 
every week. Two batches (38 and 43 samples) of sheep serum were submitted by the 
G. R. M. International Pty. Ltd., Australia for capripoxvirus antibody screening. 
Hyperimmune serum against orf virus was prepared from the infected sheep described 
above. On the 16th and 18th week after primary inoculation, both sheep were given 
booster doses in Freund's complete adjuvant (2.5 ml of 20% autogenous orf scab in PBS 
mixed with 2.5m1 of adjuvant) by the intramuscular route. Sheep were bled 10 days after 
the second booster-doses and serum was prepared. The hyperimmune serum against the 
KS-1 isolate of capripoxvirus has been described earlier (2.4). 
The preparation of polyclonal monospecific sera to the 26kd and 32kd proteins of 
capripoxvirus (KS-1) has been described (2.11). 
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2.18.3 Agar gel inimunodiffusion test (AGID) 
The AGID test using the KS-1 capripoxvirus soluble antigen was carried out as 
described by Kitching er al. (1986). Soluble orf virus antigen for the AGID test was 
prepared from the scabs obtained from experimentally infected sheep. Approximately 1 
gram of scab material was ground with carborundum in 5m1 of PBS. The suspension was 
centrifuged at 1000xg for 30 minutes at 4°C. The supernatant was concentrated to lml 
by counter-dialysis using polyethyleneglycol (PEG-6000). The dialysate was again 
centrifuged at 13000xg for 1 hour at 4°C. The supernatant was used as an antigen in the 
AGID test. 
2.18.4 Immunoblot analysis 
The proteins of both viruses were separated on the same gel using two 5.5cm wide slots, 
one containing purified orf virus and second capripoxvirus (KS-1). After transfer of the 
proteins onto NCM, 3-4 mm wide strips were cut from the blot and individual strips 
were incubated with specific serum samples. The strips were incubated with rabbit anti- 
sheep Ig conjugate and antibody labelled proteins were visualised by immunoperoxidase 
staining (2.6). 
2.19 Cell surface attachment protein of the virus 
2.19.1 Radioiodination of envelope proteins with [' I] 
Envelope proteins were prepared from lmg of purified virus as described above (2.6) 
and detergent in the preparation was removed by passing it through an Extracti Gel-D 
columns (2.17.2). The envelope proteins were labelled with ['uI] using lodo-Beads 
method as described by Markwell(1982). Two Iodo-Beads (Pierce, IL) were washed twice 
with 2m1 phosphate buffer (50mM disodium hydrogen phosphate, pH7.4) and dried on 
Whatman filter paper. l0µ1 of ['"I] solution containing 1mCi of radioactive iodine was 
diluted to 200µ1 with phosphate buffer and the dried lodo-Beads were incubated with 
this radioactive mixture at room temperature for 5 minutes. 100ug of envelope proteins 
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in 300µ1 PBS were added to the vial containing lodo-Beads and radioiodination was 
performed for 10 minutes at room temperature. Free iodine was removed using a 
sephadex G-50 column prepared in 5m1 syringe. The column was equilibrated with five 
bed volumes of PBS containing 0.1% bovine serum albumin fractionV (BSA) and loaded 
with the radioiodinated envelope proteins preparation. The column was washed with PBS 
and 10 fractions of 0.5m1 each were collected. An aliquot from the each fraction was 
transferred to the glass fiber filters and radioactivity was measured using a scintilation 
counter. The fractions containing the iodinated proteins were pooled and stored at -70°C. 
2.19.2 Binding of envelope proteins to cell monolayers 
A twenty four-well tissue culture plate containing confluent LT-cell monolayers was 
placed on ice for 1 hour. Cells were washed with cold PBS (x2), 200µl radio-iodinated 
envelope proteins (2.19.1) in PBS containing 1x106 cpm added to each well and the plate 
was replaced on ice. At specific time intervals cell monolayers were washed five times 
with cold PBS and harvested in 200µl of Laemmli lysis buffer. The samples were heated 
in a boiling water bath for 3 minutes and analysed by SDS-PAGE. For competition 
binding experiments the cell monolayers were preincubated on ice with 2001i1 PBS 
containing different amounts of purified virus or 3% BSA for 1 hour. The monolayers 
were washed with cold PBS as above and 2000 of labelled envelope proteins containing 
lxlO6cpm were added to each well. After an incubation of 30 minutes on ice the cells 
were washed, harvested, lysed and analysed by SDS-PAGE. 
2.20 Isolation and partial cleavage of the 32kd protein for N-terminal sequencing 
Virus proteins from a purified virus preparation were separated on a 12% SDS-PAGE. 
The gel was stained for 5 minutes with 0.25% coomassie brilliant blue R-250 prepared 
in 50% methanol and 10% acetic acid and destained with 50% methanol and 10% acetic 
acid for 30 minutes. The gel was then dried overnight and the 32kd protein band was 
excised from the gel. The partial cleavage of the 32kd protein was carried out with V8 
protease in an SDS-PAGE gel as described by Cleveland et al. (1977) and modified by 
Sambrook et al. (1989). An SDS-PAGE gel was prepared with the following 
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modifications: (i) 1mM EDTA was included in all gel mixes (ii) the separating gel was 
made up with 16% polyacrylamide solution, and (iii) the stacking gel was about 3 
centimetres from the bottom of the well to the top of the separating gel. The slots in the 
stacking gel were filled with the solution A. After removing backing paper from the 
dried gel slices they were loaded into wells and allowed to swell for 10 minutes at room 
temperature. The gel slices were overlaid with the 20µl of solution A containing 20% 
glycerol. The 20% glycerol mix was overlaid with the lOµ1 of solution A containing 
10% glycerol, 0.001% bromophenol blue and V8 protease. Several lanes were used with 
the differing amounts of V8 protease in individual wells. Electrophoresis was carried out 
at 125 volts until the bromophenol blue dye had migrated about two-thirds of the 
distance into the stacking gel. Electrophoresis was stopped and the 32kd protein was 
allowed to digest for 30 minutes at room temperature. Electrophoresis was then 
continued until the dye front reached the bottom of the gel. The cleavage products in the 
gel were transferred onto the ProBlott membrane (Applied Biosystems). The membrane 
was immersed in methanol for a few seconds and then placed in a dish containing 
electroblotting buffer (10mM 3-cyclohexylamino-1-propanesulfonic acid [CAPS], pH 11 
in 10% methanol). The gel was equilibrated in the electroblotting buffer for 10-15 
minutes and placed on the membrane. Transfer of proteins was carried out for 1 hour 
at room temperature as described earlier (2.6). The blot was rinsed with distilled water 
and processed for protein staining. The blot was saturated with 100% methanol for few 
seconds, stained for one minute with 0.1% coomassie blue in 40% methanol 1% acetic 
acid and immediately transferred to 50% methanol for destaining. The blot was destained 
for 5 minutes, extensively washed in distilled water and was air dried. The stained 
protein bands were cut out and submitted for N-terminal amino acid sequencing to the 
AFRC Institute of Animal Physiology & Genetic Research, Cambridge Research Station, 
Babraham, Cambridge. 
2.21 Mapping of the gene encoding the 32kd protein 
2.21.1 Preparation of mixture of oligonucleotides 
A mixture of oligonucleotides based on a short amino acid sequence of one of the V8 
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protease cleavage products of the 32kd protein was prepared using an automated oligo 
synthesizer. This method provides oligonucleotides bound to resin beads in a column. 
The oligonucleotides from the resin beads were eluted with 0.4m130% ammonia solution 
by incubating for 10 minutes (x3). The oligonucleotide mixture in ammonia solution was 
kept at 56°C for 8 hours, cooled to room temperature and then the ammonia solution was 
evaporated in a speedivac. The pellet was dissolved in 0.4m1 of water by vortexing and 
undissolved material was removed by centrifugation at 12000 rpm in a microfuge for 5 
minutes. Approximately 20 OD260 units of the oligonucleotide mixture were mixed with 
equal amounts of formamide and heated to 55°C for 5 minutes. This mixture was loaded 
on a 10 cm wide slot of a 20% denaturating polyacrylamide gel and electrophoresed at 
1500 volts until the xylene cyiol FF dye had run approximately two thirds the length 
of the gel. The gel was placed on a fluorescent thin layer chromatographic plate and 
examined under U. V. light. The oligonucleotide band excised from the gel was cut into 
small pieces and transferred to a vial containing 5 ml of distilled water. The vial was 
incubated at 62°C for 4 hours with vigorous shaking. The supernatant was removed and 
the gel pieces were reincubated overnight in 5ml of water. The supernatants were pooled 
and volume was reduced to approximately 0.5ml by three extractions with equal volumes 
of n-butanol. 
A G-50 sephadex column in a 10ml plastic syringe was prepared and equilibrated with 
five bed volumes of distilled water. The oligonucleotide mixture (0.5m1) was loaded onto 
the column, eluted with distilled water and 1 ml fractions were collected. The OD2. of 
each fraction determined and the fractions containing oligonucleotides were pooled. The 
quantity of oligonucleotides in the pooled fractions was calculated using the following 
formula: 
Total OD, w 
----------------------------------------- = jimoles oligonucleotide present 
lOxlength of oligonucleotide in the solution 
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2.21.2 Radiolabelling of oligonucleotide mixture 
Seven pmoles of the oligonucleotides were mixed with 2µl of lOx kinase buffer, 20 
pmoles (lOµ1) of [y 32P] ATP and lµ1 (10 units) of bacteriophage T4 polynucleotide 
kinase. The reaction volume was adjusted 20µl with water and incubated at 37°C for 45 
minutes. The enzyme was inactivated by heating the reaction mixture at 70°C for 10 
minutes. 
2.21.3 Isolation and purification of capripoxvirus (KS-1) DNA 
Purified virus pellet suspended in TEN was treated with RNase (final concentration 20 
pg/ml) at 37°C for 20 minutes followed by incubation with Proteinase K (final 
concentration 500 pg/ml) at 37°C for 30 minutes. The suspension was made 0.5% with 
Sarkosyl and incubated at 4°C overnight. To the disrupted and partially digested virus 
suspension an equal volume of phenol/chloroform (V: V:; 1: 1) was added and gently but 
thoroughly mixed for 1 minute. The mixture was centrifuged for 3 minutes at 12000 rpm 
in a microfuge at room temperature and the upper aqueous phase was transferred to a 
fresh microfuge tube. The phenol/chloroform extraction was carried out four to five 
times until the interface between the phenol/chloroform and upper aqueous solution was 
clear. The aqueous phase was then extracted twice with chloroform/ isoamyl alcohol 
(V: V 24: 1) and sodium acetate (pH5.4) added to a final concentration of 0.3M. The 
DNA was precipitated by adding 2.5 volumes of cold ethanol (-20°C). The DNA which 
precipitated out as a stringy precipitate, was washed twice by decantation with cold 70% 
ethanol. The DNA pellet was dried by leaving the tube open at room temperature and 
the dried pellet was dissolved in 0.5ml of TE. The DNA solution was stored at 4°C. The 
amount of nucleic acid in the preparation was determined at OD, « . 
2.21.4 Digestion of DNA with restriction enzymes 
Approximately 1.5µg of DNA was incubated overnight with 5-10 units of a specific 
restriction endonuclease and manufacture's recommended buffer in a 60gl reaction 
volume at 37°C. The digested DNA was either used immediately for agarose gel 
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electrophoresis or stored at -20°C after inactivating the enzyme at 70°C for 10 minutes. 
2.21.5 Agarose gel electrophoresis of DNA 
Agarose gel electrophoresis was carried out in a horizontal gel electrophoresis system 
Model H4 (BRL, Maryland). A 300 ml 0.7% agarose gel was prepared in TAE buffer 
containing 15u1 of ethidium bromide (10mg/ml). The gel was allowed to solidify at room 
temperature, then placed in the electrophoresis apparatus and TAE buffer added until the 
gel was covered to a depth of 1-2mm. One fifth volumes of gel loading buffer were 
mixed with the one volume of the digested DNA sample and loaded into the sample 
well. Electrophoresis was carried out at 55 volts for 16 hours at room temperature. The 
DNA restriction fragments in the gel were visualised using a U. V. light and permanent 
records were made by a U. V. polaroid camera system. 
2.21.6 Southern transfer of DNA fragments 
The gel was placed in 500 ml 0.25M solution of HCl for 15 minutes and then in 500 ml 
denaturating solution. The solution was changed after 15 minutes and incubation was 
continued further for 15 minutes. The solution was removed and the gel was incubated 
with neutralising solution for 30 minutes. All these steps were carried out with a gentle 
shaking at room temperature. The restriction fragments were transferred to a nylon 
membrane overnight by the capillary blotting procedure of Southern (1975) using lOx 
SSC. The transferred DNA fragments were fixed to the membrane by irradiating with 
U. V. light for 4 minutes. 
2.21.7 Prehybridisation and hybridisation of the blot 
The blot was incubated with 25 ml prehybridisation solution containing 0.3% sodium 
pyrophosphate for 4 hours at 37°C. The blot was further incubated in 12m1 hybridisation 
solution containing ['y 32P] labelled oligonucleotide mixture at 37°C for 36 hours. The 
composition of the hybridisation solution was identical to that of prehybridisation 
solution except that the SDS was excluded from the solution. The blot was washed 4 
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times, 10 minutes each, in 6x SSC containing 0.2% sodium pyrophosphate at 37°C and 
then autoradiographed for overnight at -70°. 
2.22 Cloning of the HindIIl QI fragment of capripoxvirus (KS-1) DNA 
The HindIH QI capripoxvirus (KS-1) DNA fragment was obtained from the Pstl F 
fragment of capripoxvirus (KS-1) DNA. E. coli cells containingpUC9/PstI F recombinant 
plasmid were grown overnight at 37°C on L. B. ampicillin agar plate (ampicillin 50pg/ml 
of agar) using a -70°C stock prepared by Gershon and Black (unpublished data). 
Individual colonies were inoculated into 5 ml of L. B. ampicillin broth (ampicillin 
50pg/ml) and incubated at 37°C overnight with shaking at 250 rpm. The recombinant 
plasmid DNA was isolated by a alkali lysis method as described by Sambrook et 
al. (1989). 1.5 ml of each culture were centrifuged at 12000xg for 1 minute and the cell 
pellet resuspended in 100µl of the solution I. This was followed by the addition of 
200gl of freshly prepared solution II and gently mixed. 150µ1 of the solution III was 
added and the tube vortexed vigorously. After an incubation on ice for 5 minutes the 
samples were centrifuged at 12000xg in a microfuge for 5 minutes at 4°C to remove the 
bacterial DNA, proteins and cell wall complexes. The supernatant was transferred to a 
clean microfuge tube and extracted with an equal volume of phenol/chloroform (1: 1; 
V: V). The aqueous phase was extracted with an equal volume of chloroform/isoamyl 
alcohol (24: 1; V: V). The DNA was precipitated by the addition of 2.5 volumes of cold 
ethanol. The tube was incubated on ice for 10 minutes, the DNA was recovered by 
centrifugation (12000xg at 4°C) for 10 minutes and washed with 1 ml of cold 70% 
ethanol. The DNA pellet was dried at room temperature, dissolved in 50gl TE containing 
DNase free pancreatic RNase (20pg/ml) and stored at -20°C. 
2.22.1 Analysis of the recombinant plasmid 
Two minipreps of recombinant plasmid DNA were analysed for the HindIII QI fragment. 
2µl of the plasmid DNA was digested with 5-6 units of PstI or HindIII enzymes in 
manufacture's recommended buffer in a reaction volume of 10µl at 37°C for 2 hours. 
2µl of gel loading buffer was added to the each digest before loading onto a mini 
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agarose gel system. 
A 50ml 0.7% agarose solution was prepared in 0.5x TBE with 2.5pg/ml ethidium 
bromide, poured in a mini gel tray and allowed to solidify at room temperature. The 
samples were loaded into wells. The Hindu ! and EcoRI digests of capripoxvirus (KS-1) 
DNA were used as marker. Electrophoresis was carried out at 90 volts in 0.5x TBE at 
room temperature for 2 hours. The DNA fragments were examined under U. V. light and 
photographed for a permanent record. The gel was processed for the transfer of DNA 
fragments to the nylon membrane (2.21.6) and prehybridisation for 4 hours and 
hybridisation for overnight at 65°C was carried out in roller bottles (2.21.7). The 
hybridisation solution was containing a [32P] labelled probe prepared from EcoRI 0 
fragment (see below) of KS-1 DNA. The blot was washed two times, 15 minutes each, 
with 2x SSC, once with 2x SSC containing 0.1% SDS for 30 minutes at 65°C and then 
exposed to X-ray film overnight. 
2.21.2 Preparation of [32P] labelled DNA probe 
A 50m1 0.7% low melting point (LMP) agarose gel was prepared in TAE buffer as 
described above. In addition, the gel was placed at 4°C for 1 hour before use. KS-1 
DNA digested with EcoRI enzyme was loaded into sample wells and electrophoresed at 
70 volts for 2.5 hours. The restriction fragments were examined under U. V. light and the 
EcoRI 0 fragment was excised from the gel. 3m1 of water for every gram of gel was 
added and the tube was heated in a boiling water bath for 7 minutes. A 50, ul aliquot of 
the melted agarose containing denatured EcoRI 0 fragment was maintained at 37°C prior 
to further processing. The rest was stored in 50u1 aliquots at -20°C. 
Radiolabelling of the DNA in the presence of melted agarose was carried out by mixing 
solutions in the following order: lOgI of 5x oligonucleotide labelling buffer (OLB), 2µl 
BSA (10mg/ml), 30-32µl melted agarose containing denatured DNA, 3-5µl [32P] dATP 
(10tCi/µl), and 1µl (5 units) of Klenow fragment of E. coli DNA polymerase I. The 
reaction volume was adjusted to 50»l with water and incubated overnight at room 
temperature. The reaction was terminated by addition of 200µ1 of stop buffer. The 
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reaction mixture was heated in a boiling water bath for 5 minutes, cooled immediately 
on melting ice and transferred to the hybridisation buffer (Feinberg and Vogelstein, 
1983,1984). 
2.22.3 Isolation of the HindIIl QI fragment from the agarose gel 
Ten microlitres of pUC9/Pstl F plasmid DNA was digested with Pstl enzyme (5-10 
units) using the recommended buffer for 2 hours at 37°C. The digested DNA was 
extracted once with an equal volume of phenol/chloroform (1: 1; V: V), once with an 
equal volume of chloroform and the DNA precipitated by adding sodium acetate pH5.4 
(final concentration 0.3M) and 2.5 volumes of cold ethanol. The DNA was recovered 
by centrifugation, washed with 70% ethanol, dried at room temperature and dissolved 
in 24µl of water. The DNA was then digested with 5-10 units of Hindu enzyme in a 
30µ1 reaction volume at 37°C for 2 hours and DNA fragments were separated in a 0.7% 
LMP agarose gel as described above. The DNA fragments were visualised by U. V. light 
and the DNA fragment of approximately 2.8kb in size was excised from the gel. The gel 
was melted at 70°C for 5 minutes and the volume was made up to 400µl with TE buffer. 
40µl of 5M ammonium acetate plus 20mM EDTA solution were added and kept at 70°C 
for a further 2 minutes. An equal volume of phenol (saturated with TE) was added to 
the tube, vortexed for 30 seconds and left on ice for 5 minutes. The tube was centrifuged 
at 12000xg and the aqueous phase was re-extracted with phenol. Three volumes of cold 
ethanol were added to the aqueous phase and then kept in a dry ice/methanol bath for 
10 minutes. The DNA was recovered by centrifuging at 12000xg for 10 minutes and the 
pellet was dissolved in 50µ1 of TE buffer. The DNA was re-precipitated by adding 
sodium acetate pH5.4 (final concentration 0.3M) and 3 volumes of cold ethanol and the 
tube was kept again in a dry ice/methanol bath for 10 minutes. The DNA was recovered 
by centrifugation, dried at room temperature and dissolved in 254l of TE. An aliquot of 
the isolated DNA was checked on the mini agarose gel system to ensure that the 
extraction was successful. 
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2.22.4 Dephosphorylation of plasmid DNA 
KS+ plasmid DNA (lOµg) was digested with 25-30 units of HindIII enzyme in a 
recommended buffer in a 100µl volumes for 2 hours at 37°C. The DNA was extracted 
once with an equal volume of phenol/chloroform, precipitated with ethanol, recovered 
by centrifugation and dissolved in 90µl of lOmM Tris-HC1 pH8.3. To this DNA solution 
lOµl of lOx dephosphorylation buffer and 1 unit of CIP enzyme (calf intestinal alkaline 
phosphatase) were added and the reaction mixture was incubated at 37°C for 30 minutes. 
To this mixture EDTA and SDS (final concentrations of 5mM and 0.5%, respectively) 
were added. The CIP enzyme was inactivated by Proteinase K (final concentration 
100, ug/ml) digestion at 56°C for 30 minutes and the DNA was extracted once with an 
equal volume of phenol/chloroform and precipitated using sodium acetate, pH7 (final 
concentration 0.3M) and 2.5 volume ethanol. The washed and dried DNA pellet was 
dissolved in 10Oµ1 TE buffer and stored at -20°C in aliquots. 
2.22.5 Ligation of the HindIII QI fragment with the linearised plasmid DNA 
Approximately 200ng of the HindI1l QI fragment were mixed with the l00ng of 
dephosphorylated linearised plasmid DNA in a volume of 7µl of water. The mixture was 
kept at 45°C for 5 minutes and then chilled on ice. To the 7µl mixture lµl lOx 
bacteriophage T4 DNA ligase buffer, 1 unit bacteriophage T4 DNA ligase and lµ15mM 
ATP were added and ligation was carried out at 15°C for 14 hours. The mixture was 
used for transformation of E. coil cells. 
2.22.6 Transformation of E. coli cells 
Fresh competent cells of E. co1i (strain DH5cc) were prepared as described by Chung et 
al. (1989). A single colony of E. coli cells was amplified in a 5ml LB broth overnight at 
37°C with shaking (250 rpm). 0.5 ml overnight culture was added in 50 ml prewarmed 
LB broth (1: 100 dilution) and the cells were incubated at 37°C with shaking to a cell 
density of 0.3-0.4 ODD units. 25m1 of this culture were centrifuged at 1000xg for 10 
minutes at 4°C and cells were resuspended in 2.5m1(1/10 of the original volume) of ice 
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cold transformation and storage solution (TSS). 100µ1 of cells were transferred into 
polypropylene tube containing 5µl of different dilutions of the ligation mixture as 
prepared above (2.22.5). The cells/DNA suspension was mixed gently and incubated on 
ice for 30 minutes. To each tube 0.9m1 of LB broth containing 20mM glucose was 
added and the cells were agitated at 37°C for 1 hour to allow expression of the antibiotic 
resistance gene. Dilutions prepared from each tube were spread onto LB ampicillin agar 
plates (250pl/plate). The inoculum was adsorbed at room temperature and the plates 
incubated at 37°C for overnight. X-gal (5-bromo-4-chloro-3indolyl-ß-D- 
galactopyranoside) and isopropylthio- ß-D-galactoside (IPTG) were included in the LB 
agar to differentiate recombinant (white colonies) and non-recombinant (blue colonies) 
colonies. Stock cultures from individual white colonies were prepared on LB ampicillin 
agar plates and stored at 4°C. 
Recombinant plasmid DNA was prepared by alkali the lysis method from the several 
white colonies (2.22), digested with HindIII or EcoRI enzyme and electrophoresed using 
the mini agarose gel system. The DNA fragments were transferred to a nylon membrane 
and hybridised with a [32P] labelled probe prepared from the EcoRI 0 fragment as 
described above (2.21.2). 
2.23 Maxi-prep of the recombinant plasmid DNA 
Ten millilitres of LB broth containing 50pg/ml ampicillin was inoculated with the stock 
cultures of a single white colony and shaken for 6 hours at 37°C. This culture was added 
to 200 ml of prewarmed LB ampicillin broth and incubated at 37°C for 16 hours with 
shaking. The cells were harvested by centrifugation (5000 rpm for 15 minutes at 4°C in 
a Sorvall GS3 rotor). The bacterial pellet was suspended in 100 ml ice cold STE solution 
and recentrifuged as above. The pellet was thoroughly suspended in 10 ml of solution 
I, lml of a freshly prepared solution of lysozyme (10mg/ml in 10mM Tris-HC1, pH8) 
added and incubated for 10 minutes at room temperature. 20 ml of the freshly prepared 
solution II was added and mixed by inverting the tube several times and the resultant 
kept at room temperature for 10 minutes. 15 ml of solution III was added, mixed 
vigorously and the resultant incubated for 10 minutes on ice. The flocculent white 
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precipitate was removed by centrifugation for 15 minutes at 5000rpm. The supernatant 
was filtered through the four layers of cheesecloth and the DNA was precipitated with 
0.6 volumes of isopropanol at room temperature for 10 minutes. The DNA was 
recovered by centrifugation (at 5000 rpm for 15 minutes at room temperature) rinsed 
with 70% ethnol and air dried. 8 grams caesium chloride was dissolved in 8m1 of TE 
buffer and then added to the DNA pellet and mixed thoroughly. 0.8m1 of ethidium 
bromide solution (10mg/ml) were added and mixed immediately. The turbid solution was 
centrifuged at 8000 rpm (Sorvall GS3 rotor) and the clear red solution was transferred 
to a 14m1 polycarbonate ultracentrifuge tube. The tube was filled with liquid paraffin and 
the sealed tube was centrifuged at 55000 rpm for 36 hours at 22°C (Beckman 70.1Ti 
rotor). The visible plasmid DNA band was removed from the gradient with a needle and 
syringe and the solution was extracted 6 times with an equal volume of isoamyl alcohol 
to remove the ethidium bromide. The solution was diluted 3 times with water, sodium 
acetate (pH 5.4) (final concentration 0.3M) added and the DNA was precipitated with 
two volumes of ethanol. The DNA pellet recovered by centrifugation was dried at room 
temperature, dissolved in TE buffer and stored at-20°C. The amount of DNA in the 
preparation was determined by measuring OD260. 
2.24 Sequencing of the Hindul QI fragment 
A directed approach in which sequences of target DNA were obtained in a systemic 
fashion was used to sequence the HindIIl QI fragment. A set of clones containing 
overlapping target DNA fragments was generated using the method of Henikoff (1984). 
2.24.1 Generation of a nested set of deletions mutants 
Twelve micrograms of CsC12-purified recombinant plasmid DNA were digested with 20 
units of BstXI enzyme in recommended buffer in 10091 volume. The digestion was 
carried out at 55°C overnight and an aliquot of the digest was examined by mini agarose 
gel electrophoresis to ensure complete digestion. 90gl of water, 10µl of lOx 
recommended buffer and 20 units of Notl enzyme were added to the above digestion 
mixture and incubated at 37°C for another 8 hours. Preliminary digests had shown that 
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there were no BstXI and Not! sites within the inserted HindIll QI fragment of 
capripoxvirus (KS-1) DNA. The digested DNA was once extracted with an equal volume 
of phenol/ chloroform and precipitated by addition of sodium acetate (pH 5.4)(final 
concentration 0.3M) and 2.5 volumes of cold ethanol. The pellet was dissolved in water 
and the DNA re-precipitated. The dried DNA pellet was dissolved in 11741 of water and 
l3µ1 of lOx ExonucleaselII buffer were added. The solution was warmed to 37°C and 
500 units of ExonucleaselII were added to the DNA solution. Twelve aliquots of 10µl 
each were transferred at 30 seconds interval to tubes on ice containing 150W of SI 
nuclease reaction mixture. The SI reaction mixture was prepared by adding 70-80 units 
of SI nuclease to each ml of SI buffer. The tubes were then incubated at 37°C for 30 
minutes to digest the single stranded DNA ends created by Exonuclease III. 401il of SI 
stop buffer containing lpg of t-RNA was added and the SI enzyme was inactivated at 
70°C for 10 minutes. The mixtures were cooled to room temperature and DNA in each 
tube was phenol/chloroform extracted and ethanol precipitated as above. The dried DNA 
pellets were dissolved in 10µl of water. and the ends were repaired with the 
bacteriophage T4 DNA polymerase enzyme. To each tube l0pl of 2x bacteriophage T4 
DNA polymerase buffer containing 1 unit of T4 DNA polymerase and 0.5mM dNTPs 
(dATP, dCTP, dTTP, dGTP) were added and then incubated at 37°C for 1 hour. The 
enzyme was inactivated at 70°C for 10 minutes. 40gl of T4 DNA ligase mixture (5µl of 
lOx T4 DNA ligase buffer, lgl (lunit) of T4 DNA ligase, 4µl 5mM ATP and 30gl of 
water) was added to each 10µl DNA solutions and incubated at 15°C overnight. 5µl of 
the ligation mixture was used to transform freshly prepared competent E. coll TG-2 cells 
(2.22.6). 
2.24.2 Analysis of the deletion mutants 
Four colonies from each deletion reaction time point were selected and minipreps of the 
DNA were prepared (2.22). The plasmid DNA from each preparations was digested with 
the Asp718 and Sacl enzyme at 37°C for 2 hours and analysed by electrophoresis in a 
0.7% agarose gel for the overlapping DNA fragments. 12 clones showing overlapping 
deletions of approximately 250-300bp were selected and the recombinant plasmid DNA 
from each of these clones was prepared by caesium chloride gradient centrifugation 
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(2.23). 
2.24.3 Alkali denaturation of the DNA 
5µl of IN NaOH/lmM EDTA were mixed with 20µl solution containing 4-5µg of DNA 
and incubated at room temperature for 5 minutes. The denatured DNA solution was 
loaded onto a sepharose-6CBL spin dialysis column (see below) and centrifuged at 
1000xg for 3 minutes in a centrifuge to remove alkali from the solution. The elute which 
contained the single stranded DNA templates was used in the sequencing reaction. 
2.24.3.1 Sepharose-6BCL spin dialysis column 
Fifty millilitres of Sepharose-6BCL was equilibrated in TO. 1E buffer by washing 3 times 
with an equal volume of buffer. The washed sepharose-6BCL was stored at 4°C in a 
final volume of 75m1 TE buffer (gel: buffer; 2: 1). Spin dialysis columns were prepared 
in a 0.5m1 microfuge tube. The bottom of the 0.5m1 tube was pierced with a 24G syringe 
needle and a small amounts (equivalent to a 2Oµ1) of water-washed sterile 200 micron 
glass beads were added to the tube. The tube was placed in a 1.5m1 microfuge tube and 
0.5m1 of sepharose-6BCL was added to the 0.5m1 tube. The column was centrifuged at 
1000xg for 4 minutes, several times, by placing the 1.5 ml tube in a 30m1 universal vial 
until the buffer from the column was eluted completely. 
2.24.4 Di-deoxy sequencing of the DNA 
The alkali denatured DNA was sequenced by the Sanger di-deoxy mediated chain 
termination method (Sanger et al., 1977) using the Multi-Well Sequencing Kit System 
(Amersham). Briefly, single stranded template from 4-5µg plasmid DNA was mixed with 
lOng of M13 primer in a volume of 32µ. l and incubated at 37°C for 15 minutes in an 
annealing buffer in a microtitre plate well. The contents were mixed and transferred to 
the enzyme well, label well and reaction well sequentially. The primer extension reaction 
was carried out for 2 minutes at 37°C and then terminated by transferring the reaction 
mixture to the four wells each containing a termination mix for one particular nucleotide. 
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The termination reaction was carried out for 5 minutes at 37°C and 4µl sequencing gel 
loading buffer was added to each of the reaction wells. The samples were analysed using 
denatured 6% polyacrylamide buffer gradient gels (Sambrook et al., 1989). 
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CHAPTER 3 
Analysis of Structural Proteins of Capripoxvirus (KS-1) 
3.1 Introduction 
Capripoxvirus (KS-1), as with other poxviruses, consists of a large number of proteins. 
20 to 25 proteins have been shown to be associated with the capripoxvirus (Al-Bana, 
1978; Kitching et al., 1986). A 67kd protein has been shown to be a major common 
precipitating antigen of the virus. Preliminary results indicated that this protein was 
localised in the envelope of virus particle (Kitching et al., 1986). Previous workers 
reported that capripoxvirus soluble antigens contained a large number of proteins 
(Pandey and Singh, 1972; Sarkar et al., 1976; Al-Bana, 1978; Subba Rao and Malik, 
1983; Subba Rao et al., 1984). The soluble antigens were prepared either from infected 
animal tissues or tissue cultures (Subba Rao and Malik, 1983; Kitching et al., 1986) and 
thus contained both structural and non-structural proteins of the virus. 
In the present work the structural proteins of KSlcapripoxvirus have been analysed with 
respect to the time course of their synthesis during the virus replication, their antigenic 
nature and location within the virus particle. In addition, the immunogenic nature of 
some of the structural proteins of the virus has been investigated. 
3.2 Results 
3.2.1 The synthesis of virus proteins in KS-1 virus infected cells 
The synthesis of virus proteins in infected LT-cell monolayers was followed by 
metabolic pulse labelling with [35S] methionine and analysis by SDS-PAGE and 
fluorography. Early and late virus proteins were characterised on the basis of: (i) the 
and 
synthesis of proteins in the presence of inhibitors of virus DNA synthesis k(ii) the time 
of onset of virus DNA synthesis. The synthesis of early proteins begins prior to the onset 
of virus DNA synthesis and thus the synthesis is not inhibited by the virus DNA 
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synthesis inhibitors, whereas the synthesis of late proteins is completely dependent on 
the virus DNA synthesis and thus is inhibited in the presence of inhibitors of virus DNA 
synthesis. 
The synthesis of proteins in infected and mock infected LT-cells was followed over a 
50 hour period (2.8). SDS-PAGE analysis revealed a distinctive pattern of virus proteins 
synthesis, 35 to 40 virus proteins ranging from l2kd to 200kd can be seen in 
fluorograph (Fig. 3.1). The 25kd and 20kd proteins can be classified an early proteins 
because the synthesis of these proteins was not inhibited by the cytosine arabinoside 
(Ara-C), indicating that virus DNA replication was not essential for the synthesis of 
these two proteins. The synthesis of both of these proteins was first detected at 4 bpi and 
their synthesis continued up to 50 bpi. The synthesis of majority of the virus proteins 
began at 10 to 12 bpi and their synthesis was completely inhibited by Ara-C showing 
that the synthesis of these proteins was dependent on virus DNA replication thus these 
are late proteins. In addition, the results of this analysis indicate that the onset of virus 
DNA synthesis occurs before 10 bpi. This assumption was tested by infecting LT-cell 
monolayers with virus and monitoring the virus DNA synthesis over a period of 20 
hours by a specific hybridisation with a [32P] labelled capripoxvirus (KS-1) DNA 
probe (2.7). A specific hybridisation signal was seen at 6 bpi and a gradual increase in 
the intensity of the signal was observed with the samples harvested subsequent to 6 bpi 
(Fig. 3.2). These results clearly showed that the onset of capripoxvirus (KS-1) DNA 
synthesis occurred between 4 to 6 bpi. The weak hybridisation signals observed with the 
samples harvested at 2 and 4 bpi were of the same order as those obtained with non- 
infected controls, and thus were not considered to represent the virus DNA synthesis. 
On the basis this analysis it can be inferred that the synthesis of early proteins begins 
prior to 6 bpi and synthesis of late proteins begins after 6 bpi. This provides further 
evidence that the 25kd and 20kd proteins were early proteins as the synthesis of these 
two proteins was seen at 4 bpi, and that all proteins whose synthesis began at 10 bpi or 
later were late proteins. The infection time in all above analyses is measured from the 
end of the 1 hour incubation period. 
The synthesis of virus proteins was also examined using immunoblot analysis (2.6,2.8). 
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This method identified the antigenic proteins of the virus. Separate aliquots of the 
samples which had been used for fluorography were used for immunoblot analysis. 
Proteins separated by SDS-PAGE were transferred to nitrocellulose membrane (NCM) 
and probed with capripoxvirus hyperimmune serum obtained from India (2.4). Virus 
proteins which reacted with antibodies were visualised by secondary antibody conjugate 
and immuno-peroxidase staining. The pattern of the synthesis of virus proteins observed 
by immunoblot analysis was very similar to that seen with [35S] labelling (Fig. 3.3). The 
results of immunoblot analysis showed that a large number of proteins synthesised 
during virus replication are antigenic in nature, the late proteins in particular produced 
a very strong immunostaining signal. A 31.5kd protein which had not been detected by 
[35S] labelling, was identified by immunoblot analysis. The synthesis of this protein was 
first detected at 4hpi and was not inhibited by Ara-C. The 31.5kd protein is thus an early 
antigenic protein. It appears that this protein contains few, if any, methionine residues as 
it was not labelled by [35S] methionine. However, the two early proteins (25kd and 20kd) 
as detected by [35S] labelling did not react in immunoblot system indicating that these 
proteins possibly do not induce antibodies in sheep during infection. 
3.2.2 Structural proteins of the virus 
The structural proteins of capripoxvirus (KS-1) were separated by SDS-PAGE. 30 to 35 
proteins were identified in a coomassie brilliant blue stained gel, 12 of which appeared 
to be the major proteins of the virus. The molecular weights in kilodaltons (kd) of the 
major structural proteins of the virus are shown in the Figure 3.4. The protein band at 
66-67kd position appeared to contain 2 or 3 proteins. 
3.2.3 Identification and location of antigenic structural proteins of the KS-1 virus 
Virus proteins separated by SDS-PAGE were transferred to NCM. Homologous or 
heterologous hyperimmune sera were used to identify the antigenic proteins. A large 
number of the virus proteins were shown to be antigenic in nature (Fig. 3.5). Both of the 
hyperimmune sera reacted equally strongly with the 66-67 kd, 32kd and 26kd proteins 
but the intensity of reaction of homologous hyperimmune serum with the 20kd, 19kd and 
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17kd proteins was much less than that observed with the heterologous serum. The 
homologous hyperimmune serum failed to react with the 14kd, 24kd, 27kd, 29kd, and 
69kd proteins. 
Treatment of the virus with nonidet-P40/ DTT selectively removed the 32kd, 27kd, and 
l9kd proteins (Fig. 3.5, lane 2& 5) and treatment of the subviral core with sodium 
deoxycholate /DTT /sodium chloride solubilised the 66-67kd, 29kd, 26kd, 24kd, 20kd, 
17kd, and l4kd protein (figure 3.5, lane 1& 4). These results clearly showed that the 
32kd, 27kd and 19kd proteins are localised within the envelope of the virus and that the 
66-67kd, 26kd, 24kd, 20kd, 17kd, and 14kd proteins are localised within the core. A 
small fraction of the 26kd, 20kd and l7kd proteins was removed by nonidet-P40/DTT 
treatment, however the majority of these proteins remained associated with the core and 
are only completely released following sodium deoxycholate/DTT/ sodium chloride 
treatment thus they were considered to be core proteins. The 69kd was considered to be 
the envelope protein of the virus because the majority of this protein was removed by 
nonidet-P40/DTT treatment. 
3.2.4 Identification of immunogenic protein(s) of the virus 
The structural proteins, 69kd, 66-67kd, 32kd, 26kd, and 19-20kd, were chosen for 
immunogenic studies. These are major structural antigenic proteins of the virus. An 
SDS-PAGE gel purified preparation of these proteins was used to raise polyclonal 
monospecific sera in rabbits. The 19-20kd proteins were taken together because it was 
not possible to separate them cleanly. The rabbits inoculated with 69kd, 32kd and 26kd 
proteins responded after two booster doses, however, the two rabbits injected with 66- 
67kd and 19-20kd proteins did not produce antibodies even after four booster doses. The 
monospecificity of the three sera was examined by immunoblot analysis (Fig. 3.6). The 
sera against 32kd and 26kd proteins produced good monospecific reactions on 
immunoblots. The anti-69kd serum appeared to contain some contaminating antibodies. 
These three sera were further examined for their ability to neutralise virus. 
The results of the neutralisation assay using either with OK-cells or LT-cells are shown 
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in Table 31100 TCID50 of the virus as used in the serum neutralisation assay produced 
approximately 200 foci of infection on the 0K cell monolayers. A 1: 1000 dilution the 
anti-32kd monospecific serum reduced the number of foci by 50%. The anti-69kd and 
anti-26kd monospecific sera did not show any effect on the number of foci at any 
dilution. Similar results were observed using the LT-cell monolayers. In this case 
suppression of the c. p. e. was used as a criteria for the neutralising character of the 
serum. These results showed that the gel isolated 32kd envelope protein induced virus 
neutralising antibodies in rabbits but the gel isolated 69kd envelope and the 26kd core 
proteins did not. 
3.3 Discussion 
The analysis of viral proteins is important for an understanding of the different 
biological functions and properties of the virus. To date information on the capripoxvirus 
proteins has been based mainly on AGID (Bhambani and Krishna Murthy, 1963; Sharma 
and Dhanda, 1971a; Pandey and Singh, 1972; Sarkar et al., 1976; Sambyal and Singh, 
1978; Kitching et al., 1986), immunoelectrophoresis (Pandey and Singh, 1972; Sarkar 
et al., 1976; Subba Rao et al., 1984) and electro-immunodiffusion (Subba Rao and 
Malik, 1983). These methods simply identified the number of antigenic components, 
which can be either structural or non-structural proteins. Moreover using these assays 
only soluble antigenic proteins which form precipitation lines, by reacting with antibody, 
can be detected. Kitching et al. (1986) showed that the 67Kd protein is a major structural 
protein of the virus which is involved in immunoprecipitating reactions. Antibodies 
against this protein have been shown to be present in animals infected with different 
isolates of capripoxvirus (Kitching et al., 1986). In addition, this protein was shown to 
react with the serum obtained from an orf virus infected sheep. These results show that 
the 67kd protein contains cross-reactive antigenic determinants. Preliminary results 
indicated that the 67kd protein is possibly located in the envelope of the virus (Kitching 
et a!., 1986). The results of structural analysis of virus proteins carried out in the present 
study show that the 67kd protein is a major structural protein of the virus and antigenic 
in nature. However, in contrast to the results of Kitching et al. (1986), this protein was 
found to be located within the core of the virus particle. In addition, 29kd, 26kd, 24kd, 
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20kd, 17kd, and 14kd proteins were found to be localised in the virus core (Fig. 3.5) 
The 32kd, 27kd, and l9kd proteins were removed completely by the treatment of 
nonidet-P40/ DIT, which shows that these proteins are localised in the envelope of virus 
(Fig 3.5). A 69kd protein also appeared to be associated with the envelope as this 
protein is relatively sensitive to the nonidet-P40/DTT treatment (i. e. although some 69kd 
protein always seen in the core fraction the majority was removed with the envelope). 
The location of this protein is complicated by the fact that its detection in western blots 
with hyperimmune serum varies with the particular serum used. The homologous 
hyperimmune serum did not react with this protein, the heterologous hyperimmune 
serum obtained from India showed a weak reaction, and another heterologous serum 
(obtained from Dr. R. P. Kitching) gave strong reaction (data not shown). 
A gene within the Hindill M fragment of the capripoxvirus (KS-1) genome shows 
homology to the 14kd fusion protein gene of vaccinia virus (Gershon et al., 1989). A 
gene in the orf virus genome which shows homology with that of vaccinia virus and 
capripoxvirus fusion protein genes has also been identified (Naase et al., 1991). The 
14kd fusion protein, which is localised in the envelope of vaccinia virus, has been 
studied in detail (Rodriguez et al., 1985; Rodriguez and Esteban, 1987; Gong et al., 
1990), whereas the fusion protein of capripoxvirus (KS-1) or orf virus still remains to 
be identified. The fusion gene of capripoxvirus (KS-1) has a potential coding capacity 
for a l9kd protein. It would not be unreasonable to speculate that this gene encodes the 
l9kd protein identified in the present study. The location of 19kd protein in the envelope 
of capripoxvirus would support the assumption. 
Differences were observed with the reactions of the homologous serum and the 
heterologous serum (obtained from India) with some of the virus proteins. The 
homologous serum showed very weak reaction with the 20kd, l9kd and 17kd proteins 
and did not react with the l4kd, 24kd, 27kd, 29kd and 69kd proteins. All of these 
proteins showed reactions with the heterologous serum. The differences in these 
reactions, produced by the homologous and heterologous sera, is probably due to the 
methods used to prepare them. The homologous serum was raised without adjuvant 
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whereas the heterologous serum was prepared with adjuvant (personal communication, 
Prof. R. Raghavan, Banglore, India). These results indicate that some of the structural 
proteins of the virus require adjuvant to produce appreciable amounts of high affinity 
antibodies. The use of Freund's complete adjuvant in booster doses has also been 
advocated by Pandey and Singh (1972) to obtain antibody responses against the 
complete spectrum of antigenic components of the sheeppoxvirus. The homologous 
serum showed strong reactions with the 66-67kd, 32kd and 26kd proteins and the degree 
of reaction was similar to that obtained with the heterologous serum. The strong 
reactions of the 66-67kd, 32kd and 26kd proteins with the homologous serum (i. e. 
hyperimmune serum raised without the use of adjuvant) indicated that these proteins are 
strongly antigenic. 
Several investigators have shown that the protein synthesis in poxviruses is temporally 
regulated and can be clearly classified into early and late classes (Moss and Salzman, 
1968; Pennington, 1974; Prideaux and Boyle, 1987; Balassu and Robinson, 1987). The 
early proteins include several enzymes involved in nucleic acid metabolism (Jungwirth 
and Joklik, 1965) and some structural proteins (Holowczak and Joklik, 1967b). In the 
present study three early virus proteins (21kd, 25kd, 31.5kd) were identified, one of these 
was antigenic in nature. The synthesis of these three early proteins continued to late 
times in infection; whether they are incorporated into the virus particle is not clear. It 
has been reported that capripoxvirus DNA synthesis begins 10-11 hpi and that structural 
proteins are synthesised 7-8 hours thereafter (Terrinha et al., 1965). However, in the 
present work the virus DNA synthesis is observed between 4-6 hpi and the synthesis of 
late proteins at 10 hpi (Fig 3.1,3.2,3.3). This discrepancy in results can be attributed 
to the different cells, isolates of capripoxvirus or methods of detection used in the 
studies. The preliminary results of the present study indicate that the expression of 
capripoxvirus (KS-1) early and late proteins is temporally controlled and operates in a 
similar fashion to that of other poxviruses. In addition, a large number of the late 
proteins were antigenic in nature suggesting that the immune system reacted against 
these proteins and that perhaps some of these proteins may be involved in inducing 
immunity against capripoxvirus infections in animals. Recently, Demkowicz et al. (1992) 
showed that six late proteins of vaccinia virus are immunogenic in nature. 
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A successful immunising agent whether in a form of whole virus particles or a single 
protein molecule, is likely to induce both humoral and cell mediated immune responses 
to provide protective immunity to an animal. Viral subunits or a single viral protein has 
been shown to protect animals from the disease by inducing the neutralising antibodies 
(Crick and Brown, 1969; Laporte et al., 1973; Kaaden et al., 1977). However, these 
workers did not analyse the role of these proteins in inducing cell-mediated immunity. 
Thus the possibility of the role of cell-mediated immune responses in the above studies 
can not be ruled out. The role of a single protein in providing protective immunity by 
inducing neutralising antibodies has also been suggested in poxvirus infections 
(Appleyard, 1961; Stern and Dales, 1976; Lai et al., 1991). For example, Lai et al. 
(1991) showed that the 14kd envelope protein of vaccinia virus produced a high levels 
of virus neutralising antibody in mice and that the vaccinated mice were protected when 
challenged with lethal doses of wild type vaccinia virus. Recently, the 14kd protein has 
been shown to induce cell-mediated immune responses in mice (Demkowicz et at., 
1992). These results suggest that the 14kd protein of vaccinia virus contains T cell 
epitopes, in addition to the epitopes that induce neutralising antibodies. The strongly 
antigenic nature of the 32kd envelope protein of capripoxvirus (KS-1) was observed 
during the examination of the structural antigenic proteins (by homologous as well as 
heterologous hyperimmune sera). This protein contains epitopes that induces neutralising 
antibodies in rabbits, suggesting that this protein is immunogenic in nature. The 32kd 
protein used to raise the serum was obtained from a SDS-PAGE gel, thus the antibody 
responses were against the linear epitopes. Neutralisation of the virus by the 
monospecific serum clearly showed that these linear epitopes are exposed on the surface 
of the virus envelope. The strong antigenic nature and the presence of the epitopes, that 
induce neutralising antibodies, on the 32kd protein strongly suggest that this protein is 
involved in mediating the immune responses. In the case of 69kd envelope protein the 
linear epitopes, probably, do not produce neutralising antibodies. The 69kd envelope 
protein may contain confirmational epitopes which could induce the neutralising 
antibodies. It is unlikely that the 26kd, being a core protein, would induce neutralising 
antibodies. 
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The location of the 32kd protein on the envelope of virus and the neutralisation of the 
virus by monospecific antibodies to this protein indicates that the 32kd protein plays an 
important role in the early events of virus host cell interactions such as attachment or 
fusion of virus particle to the cell membrane. Further analysis of the 32kd protein is 
important to elucidate the above possibilities. The characterisation of other biochemical 
properties and the study of T-cell responses against the 32kd protein would be helpful 
in understanding the role of this protein in immunity against capripoxvirus infections. 
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Table 3.1 Virus neutralisation ability of monospecific sera 
in vitro 
No. Location of Molecular Serum Neutralising 
protein weight ability 
1 Envelope 69kd Monospecific -ve 
2 Envelope 32kd Monospecific +ve 
3 Core 26kd Monospecific -ve 
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Figure 3.1 Fluorograph showing the synthesis of the proteins of capripoxvirus (KS-1) 
in infected LT-cells in the presence or absence of cytosine arabinoside (Ara-C). Pulse 
labelling with [35S] methionine was for 1 hour commencing at the times indicated. M= 
Markers in kilodalton (kd), hpi = hours post infection, Controls = uninfected cells. 
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Figure 3.2 Dot-blot analysis of the synthesis of capripoxvirus (KS-1) DNA in LT-cells. 
A [32P] labelled capripoxvirus (KS-1) DNA probe was used to indentify the newly 
synthesised DNA. Dilution refers to the serial two fold dilutions of the cell lysates 
applied to the nitrocellulose membrane. C= uninfected cells, CPV DNA = two fold 
dilutions of 200 ng capripoxvirus (KS-1) DNA. 
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Figure 3.3 The analysis of the synthesis of capripoxvirus (KS-1) proteins in the presence 
or absence of cytosine arabinoside (Ara-C) by immunoblot analysis using hyperirnnune 
serum. Reactions with the majority of the proteins with the hyperimmune serum become 
apparent between 10-16 hpi. Lane V represents the purified virus. M= Molecular weight 
markers in kilodalton (kd). 
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Figure 3.4 Structural proteins of capripoxvirus (KS-1). Purified virus was analysed on 
12.5% SDS-PAGE gel and the separated proteins were visualised by staining with 
coomassie brilliant blue. Lane V and M represent the purified virus and molecular 
weight marker, respectively. The molecular weight of the major virus structural Proteins 
indicated. kd = kilodalton. 
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Figure 3.5 Antigenic analysis of the envelope and core fractions of capripoxvirus 
(KS-1). Lanes 1,2 and 3 were probed with the heterologous hyperimmune serum and 
lanes 4,5 and 6 with the homologous hyperimmune serum. Lanes 1 and 4 represent 
core fractions, lanes 2 and 5 envelope fractions and, lane 3 and 6 purified virus. M_ 
Molecular weight markers in kilodaltons (kd). 
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Figure 3.6 Immunoblot analysis of the monospecific sera produced in rabbits against 
individual virus protein. Monospecific sera were prepared using SDS-PAGE gel Purified 
proteins. Five panels (A, B, C, D& E) are shown in the figure. Each panel contains 
three lanes ( purified virus, envelope and core from left to right). The panels A, g c, 
D and E were probed with sera obtained from the rabbits inoculated with the 69kd, 66- 
67kd, 32kd, 26kd and 19-20kd proteins, respectively. 
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CHAPTER 4 
Lymphocyte Proliferation Studies Using Capripoxvirus (KS-1) 
Structural Proteins With a Particular Emphasis on The 32kd 
Envelope Protein 
4.1 Introduction 
The immune effector mechanisms against poxvirus infection or vaccination appear to be 
a complex interaction which involves a number of cell types of lymphoid system. The 
generation of specific antiviral antibody by B lymphocytes and virus specific cytotoxic 
T lymphocytes (T , delayed type hypersensitivity T cells (TDTH) and helper T 
lymphocyte (TH) have been demonstrated in poxvirus infections (Hapel and Gardner, 
1974; Kreeb and Zinkernagel, 1980a, 1980b; Issekutz, 1984,1985; Issekutz et at., 1986; 
Takai et al., 1985). The generation of virus specific CTLs in ectromelia virus infections 
was first demonstrated by Hapel and Gardner (1974), and subsequent studies revealed 
a positive correlation between CTL activity and clearance of virus in vivo, which 
suggested that CTLs were responsible for protection (Blanden and Gardner, 1976). 
Although the primary generation of poxvirus specific CTLs has been shown in mice, 
rats, rabbits and sheep (Hapel and Gardner, 1974; Zinkernagel et al., 1977; Issekutz, 
1984) classical CTLs have not been demonstrated in poxvirus infections of the rhesus 
monkey and human beings (Perrin et al., 1977; Stitz et al., 1984; Graham et al., 1991). 
It was shown that the mechanisms such as ADCC (antibody dependent cell-mediated 
cytotoxicity) and natural killer cell (NK cell) activity were involved in lysing the virus 
infected cells in the absence of CTLs in vaccinia infected humans (Moller-Larsen and 
Haahr, 1978). Helper T cells have been shown to play an important role in the 
generation of antiviral specific antibody by B lymphocytes and the virus specific CTLs 
by providing accessory factors (Stevens, et al., 1988; Balkwill and Burke, 1989). The 
virus specific TDT cells have been shown to be involved in mediating the recruitment 
of inflammatory cells into a lesion (Issekutz et al., 1986). 
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Despite all poxviruses being complex in structure and consisting of a large number of 
proteins, it has been possible to identify immunogenic proteins. For example a vaccinia 
virus l4kd envelope protein which plays an important role in the virus-host cell fusion 
process, has also been shown to be immunogenic (Lai et al., 1991). E. coli expressed 
14kd envelope protein induced a high levels of neutralising antibody in mice and 
conferred protection against challenge with wild-type vaccinia virus. Recently, this 
protein has also been shown to be involved in inducing the cell-mediated immune 
responses in mice (Demkowicz et al., 1992). 
The role of neutralising antibody as well as cell mediated immune responses has been 
suggested to be important in recovery from capripoxvirus infections (Kitching, 1986). 
Passive transfer of immune serum obtained from an animal recovered from capripoxvirus 
infection was shown to protect sheep from challenge with virulent capripoxvirus isolates, 
however, local virus replication occurred at the site of inoculation. Sheep recovered from 
vaccination or infection show delayed type hypersensitivity reaction on challenge and 
undetectable local virus replication at the at the site of inoculation (Kitching and Taylor, 
1985; Kitching et al., 1987). These results indicate that the cell-mediated immune 
responses are perhaps essential for recovery from primary capripoxvirus infections and 
the antiviral antibody produced by B lymphocytes appears to be important in preventing 
reinfection. 
For a more complete understanding of the immunity against capripoxvirus infection, and 
to identify the capripoxvirus proteins involved in T-cell immunity, the cell-mediated 
immune responses of vaccinated sheep were analysed using an in vitro proliferation 
assays. Purified virus, envelope proteins, core proteins and the 32kd major envelope 
protein were used for these studies. 
98 
4.2 Results 
4.2.1 Lymphocyte proliferation with capripoxvirus (KS-1) structural proteins 
Ten sheep were used in the present study, however representative results of in vitro 
lymphocyte proliferation assay obtained with three sheep using three antigen preparations 
i. e purified virus, envelope proteins and soluble core proteins are shown in Figure 4.1. 
Antigen specific proliferation was observed in all the animals, however, the pattern of 
lymphocyte stimulation against the three virus antigen preparations in the animals was 
different. Although the magnitude of the responses fluctuated between assays, the 
general trend of the response remained constant between 1 to 12 weeks post vaccination 
(period of study). The maximum lymphocyte stimulation was observed with the purified 
virus preparation in all three animals followed by soluble core proteins. The stimulation 
obtained with the envelope protein preparation was comparatively lower than that 
observed with the whole virus and core protein preparations. In the all experiments the 
controls, which comprised of either bluetongue virus grown in the LT-cells or growth 
medium, were included. The stimulation of lymphocytes caused by these controls was 
insignificant and regarded as a background stimulation. The results of these studies 
clearly indicate that the sheep respond to virus and induce antigen specific lymphocytes. 
The lymphocyte proliferation to virus protein appeared to be concentration dependent. 
As shown inFigure 4.2, the optimum concentration of protein for lymphocyte stimulation 
was different for each of the antigen preparations. The whole virus preparation required 
the highest concentration of protein (approx. 64g/ml) to produce maximum stimulation, 
and the envelope preparation required the lowest concentration of antigen 
(approx. 1.5pg. /ml). The amounts of protein for stimulation were intermediate in the case 
of core antigen preparation (approx. 3 tg/ml). 
4.2.2 Lymphocyte proliferation with nitrocellulose bound viral proteins 
As shown above both the core and the envelope proteins of capripoxvirus (KS-i) were 
recognised by T-cells. To identify which of the viral protein(s) are responsible for T-cell 
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proliferation five major structural proteins of the virus were chosen (Table 4.1). Two of 
these are virus envelope proteins and two of the core, the location within the virus of 
the fifth protein is still not clear. The results of lymphocyte proliferation experiment 
with the nitrocellulose bound antigen showed that none of the nitrocellulose bound viral 
protein stimulated the lymphocyte population effectively (Fig. 4.3). The reasons why the 
nitrocellulose bound viral proteins failed to stimulate the lymphocytes effectively were 
not investigated further. 
4.2.3 The 32kd major envelope protein induced T-cell proliferation 
Involvement of the 32kd envelope protein in inducing the cell-mediated immune 
responses was studied using the isolated protein in in vitro lymphocyte proliferation 
assays. The 32kd protein was either extracted from SDS-PAGE gel, a method which has 
been used successfully for bluetongue viral proteins/ sheep T-cell proliferation assays 
(Takamatsu et al., 1990), or obtained with NP-40/DTT extraction. The lymphocyte 
proliferations observed with SDS-PAGE gel isolated 32kd protein and NP-40/DTT 
extracted 32kd protein are shown in figure 4.4. The 32kd protein extracted from SDS- 
PAGE gel strongly stimulated the lymphocytes from vaccinated sheep. 50p. g/ml of this 
protein produced 17 x 103 cpm incorporation of 3H-TdR; background incorporation was 
1.5 x 103 cpm (Fig. 4.4). The incorporation of 3H-TdR was proportional to the 
concentration of the 32kd protein. These results clearly showed that the 32kd envelope 
protein possessed T-cell epitopes which were recognised by capripoxvirus (KS-1) 
specific T-cells in in vitro proliferation assays. On the other hand, the 32kd protein 
extracted with NP-40/DTT stimulated the lymphocytes less efficiently. It is possible that 
this preparation was still contaminated with detergent NP-40 which produced a 
deleterious effect on the proliferation assays. 
4.2.4 Demonstration of virus-specific antibody production in vitro 
Inactivated whole virus, envelope proteins and core proteins were used for in vitro 
antibody production experiments. The presence of virus-specific antibodies in the culture 
supernatant was analysed by indirect ELISA. The results of two separate experiments 
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are shown in table 4.2. All three antigen preparation induced capripoxvirus (KS-1) 
specific antibody production in vitro. There was little difference in 0D values between 
the cultures in an individual experiments, and antibodies were not detected in the 
cultures without antigen stimulation. These observations indicated that both the envelope 
and the core proteins contained B-cell epitopes in addition to the T-cell epitopes and that 
each antigen preparation alone could induce antibody production effectively. 
4.3 Discussion 
The levels of capripoxvirus (KS-1) specific neutralising antibody clearly have an 
important role in protection (Kitching, 1986). In order to induce antigen specific 
antibodies, B-cells require antigen specific helper T-cells. Also the isotype of the 
antibody produced is influenced by lymphokines which are produced by the helper T-cell 
(Stevens et al., 1988). Although some antigens can induce antibody production without 
T-cell involvement (T-cell independent antigen) such antigens are usually polymers and 
do not induce high affinity antibody. In addition, the antibody response against these 
antigens has very poor immunological memory (Harlow and Lane, 1988). Capripoxvirus 
specific antibody production has not been shown to be T-cell independent. However, 
many observations support the view that capripoxvirus-specific antibody induction is T- 
cell dependent. For example capripoxvirus vaccination (or infection) induced high 
affinity neutralising antibody with a strong immunological memory (Kitching and Taylor, 
1985; Kitching et al., 1987). In addition, a delayed type hypersensitivity reaction can be 
observed in recovered or vaccinated sheep (Srivastava and Singh, 1980b; Kitching and 
Taylor, 1985). It is possible that helper T-cells (helper TDTh) play an important role in 
these reactions, as has been shown that helper TDm are involved in delayed type 
hypersensitivity reaction in vaccinia virus infections in mice (Takai et al., 1985). 
The results of lymphocyte proliferation assays obtained in the present study showed that 
the core proteins, envelope proteins and the 32kd major envelope protein contained T- 
cell epitopes which were recognised by capripoxvirus specific T-cells. Since inactivated 
virus or isolated proteins were used in lymphocyte proliferation assays, it was unlikely 
that these exogenous antigens were presented to T-cells in association with class I MHC 
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molecules because exogenous antigens (e. g. non-infectious virus antigens) have been 
shown not to be processed efficiently for class I presentation (Germain, 1986). On the 
other hand, exogenous or endogenous antigens following processing can be presented 
by class II MHC molecules. The processing of exogenous antigens for class II 
presentation has been shown to be much more efficient than the endogenous antigens 
(Braciale et al., 1987). Hence the antigen preparations used in this study were most 
probably processed within the endosome by antigen presenting cells (APC) and the 
resulting peptides combined with class II MHC molecules (Germain, 1988; Gerlier and 
Rabourdin-Combe, 1989). These complexes of peptide and class II molecules are then 
transported to the cell surface for recognition by T-cells (Germain, 1986; Unanue and 
Allen, 1987). The T-cells which were stimulated by the antigens in the present work 
were thus most probably the helper T-cells (CD4 positive CD8 negative phenotype) 
because antigen specific activation of the helper T-cell phenotype has clearly shown to 
be restricted by class II MHC gene products (Zinkernagel and Doherty, 1979). These 
observations suggested that the envelope and the core proteins of the virus contained 
helper T-cell epitopes. The envelope and the core proteins induced antibody production 
effectively in vitro, which clearly indicated that, in addition to helper T cell epitopes, 
these proteins contained B-cell epitopes. Thus it is possible that immunization with each 
antigen alone may induce effective immunity. The induction of antibody production in 
vitro by the 32kd protein alone was not studied. However, many properties such as: (a) 
the 32kd is a major envelope protein, (b) the 32kd protein is strongly antigenic, (c) the 
SDS-PAGE gel isolated 32kd protein gave strong lymphocyte stimulation, and (d) the 
SDS-PAGE gel isolated 32kd protein induced neutralising antibody production in vivo, 
strongly suggested that the 32kd envelope protein contained both B-cell and helper T- 
cell epitopes. On the basis of all these properties of the 32kd protein it can be concluded 
that this protein may be a very useful for use in vaccination procedures. 
In this study capripoxvirus (KS-1) proteins were analysed to determine whether they 
contained helper T-cell determinants. Other immune mechanisms which may involved 
in capripoxvirus infections, such as CTL were not examined. However, the lymphocyte 
proliferation experiments of the present study also demonstrated that the core proteins 
are strongly immunogenic. The antibody dependent cell mediated cytotoxicity (ADCC) 
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and complement mediated antibody dependent cell lysis have been demonstrated as an 
important immune mechanisms in viral infections. In fact, ADCC has been shown to be 
an important immune mechanism in vaccinia infected humans (Moller-Larsen and Haahr, 
1978; McFarland et al., 1980). Therefore not only CTL but also the functional analysis 
of antibodies and the role of core proteins in immunity should be considered for further 
studies. 
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Figure 4.1 In vitro proliferation of lymphocytes from 
capripoxvirus (KS-1) vaccinated sheep 
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Figure 4.2 Lymphocyte proliferation assay using whole virus, 
envelope and core proteins 
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Figure 4.3 Lymphocyte proliferation assay using nitrocellulose 
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Figure 4.4 Lymphocyte proliferation assay using gel extracted and NP-40 
extracted 32kd protein of capripoxvirus (KS-1) 
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Table 4.1 Nitrocellulose bound viral proteins used in the 
lymphocyte proliferation assay 
Fraction M. W. Location 
number (kd) Envelope Core 
5 69 ++ ± 
6+7 66-67 + ++ 
11 45 ?? 
17 32 ++ - 
19 26 + ++ 
++, majority of the protein present in this fraction; +, minor 
quantity of the protein present in this fraction; -, not present; 
?, location is not known 
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Table 4.2. In vitro production of capripoxvirus (KS-1) 
specific antibody 
0 D+S. D 
Without Whole virus Envelope Core 
particle proteins proteins 
Exp. 1 0.07 0.33 0.34 0.43 
+0.00 +0.01 +0.03 +0.01 
Exp. 2 0.12 1.37 1.02 1.24 
+0.00 +0.05 +0.06 +0.04 
Peripheral blood mononuclear cells from capripoxvirus (KS- 
1) vaccinated sheep were stimulated in vitro with or without 
capripoxvirus (KS-i) proteins up to 10 days. The culture 
supernatant were tested by ELISA against capripoxvirus (KS-1) 
whole proteins. 
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CHAPTER 5 
The Role of The 32kd Protein in Serological Differential Diagnosis of 
Capripoxvirus and Contagious Pustular Dermatitis Virus (Orf Virus) 
Infections of Sheep 
5.1 Introduction 
The serological relationships between capripoxviruses and contagious pustular dermatitis 
virus of sheep (Orf) are well documented (Dubey and Sawhney, 1979; Sharma and 
Dhanda, 1971b; Subba Rao and Malik, 1979; Subba Rao et al., 1984; Kitching et al., 
1986). Both viruses produce mild to severe pox disease in sheep and goats and it is 
difficult to differentiate between them on the basis of clinical signs (Robinson and 
Balassu, 1981). These viruses are quite different from each other structurally, if 
examined under the electron microscope, (Nagington et al., 1964) and also in their 
genomic (G+C content) compositions (Wittek et al., 1979). However, a major common 
precipitating antigen in all the capripoxvirus isolates which also cross-reacts with the orf 
virus positive serum has been identified (Kitching et al., 1986). Many sero-diagnostic 
assays such as agar gel immunodiffusion, complement fixation, counter- 
immunoelectrophoresis, or the ELISA are not reliable for the differential diagnosis of 
these infections, because they detect total antibody response, including that from cross- 
reactive antibodies. It is thus difficult to determine herd status or the epidemiological 
situation of these infections using the above serological assays. However, it is important 
to have a serological assay for the differential diagnosis of capripoxvirus and orf virus 
infections because the presence of virus specific antibodies in the serum sample indicates 
past or recent exposure of the animal with the virus. 
Recently Australian sheep being exported to the Middle East were reported to be 
infected with capripox despite the fact that Australia is free from this disease (New 
Scientist, 1989). In this situation serological screening was necessary to show the 
presence or absence of capripoxvirus because the isolation of the virus or its 
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demonstration by electron microscopy is not always successful. Moreover the 
demonstration of one virus agent by electron microscopy does not exclude the possibility 
of the involvement other viruses. Also in other areas free from capripox it is important 
to be able to distinguish, serologically, capripox from orf which is enzootic worldwide. 
In countries where disease surveillance is poor, serological testing may still be the only 
method by which animal diseases are assessed. The purpose of this study was to 
determine whether capripox and orf of sheep could be differentiated from each other by 
the use of immunoblot analysis of serum samples from sheep with naturally acquired 
infections and sheep infected experimently with the viruses. 
5.2 Results 
5.2.1 Agar gel immunodiffusion test (AGID) 
Cross-analysis of capripox and orf hyperimmune sera with their homologous and 
heterologous soluble antigens in AGID test clearly showed the strong serological 
relationships between the two viruses. Both of the hyperimmune sera produced 
precipitation lines with both of the antigens. The major precipitation band of capripox 
homologous antigen antibody system showed a line of identity with a major precipitation 
band between the capripoxvirus soluble antigen and orf hyperimmune serum. Similar 
results were observed when orf virus soluble antigen was allowed to react with orf and 
capripox hyperimmune sera. None of the soluble antigen produced a positive reaction 
with either of the preimmune sera (data not shown). 
Serum samples collected weekly from two experimentally infected sheep with orf virus 
were also tested in AGID test using orf virus skin soluble antigen and capripoxvirus 
soluble antigen. Both sheep showed positive reactions with homologous antigen from the 
second week of infection, however, with the capripoxvirus antigen one sheep gave a 
positive reaction on the third week the other on the fourth week of infection. Serum 
samples taken previously from two sheep infected with capripoxvirus (Kitching et at., 
1986) were also tested with both of the antigens. Here again positive reactions were 
observed from the second week of infection with both antigens. The results were similar 
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to those observed earlier (Kitching et al., 1986), despite the sera having been stored for 
more than six years at -20°C. 
Serum samples obtained from Australia were also tested with both of the antigens. Out 
of 81 sera, 41 were found to be positive with orf antigen: 31 of which gave positive 
reactions with capripoxvirus soluble antigen in AGID test. Some of the samples from 
Australia were submitted as whole blood and were received about 9 days after 
collection. The majority of these samples were haemolysed. Despite a high haemoglobin 
content, it was possible to detect precipitation lines with both the antigens (data not 
shown). However, after 3 days incubation, washing for 24 hours in PBS with three 
changes, greatly enhanced the visibility of the precipitation lines. 
5.2.2 Immunoblot analysis 
Figure 5.1 shows results of cross-immunoblot analyses of purified viral preparations of 
both capripox and orf viruses using both hyperimmune sera. For comparison, equal 
amounts of protein of both the viruses (40pg/slot) were separated by SDS-PAGE and 
transferred to NCM. The analysis revealed that the capripoxvirus hyperimmune serum 
reacted with several proteins of both the homologous virus (67kd, 32kd, 26kd, 19kd and 
l7kd) and the heterologous virus (67kd, 42kd, 32kd and 18kd). However, the 
capripoxvirus hyperimmune serum failed to react with any orf virus protein of same 
electrophoretic mobility corresponding to the 26kd protein of capripoxvirus (KS-1) but 
gave fairly good reactions with the other orf virus proteins. Similarly, the orf 
hyperimmune serum showed strong reactions with many proteins of the homologous 
virus and with several capripoxvirus (KS-1) proteins including an intense reaction with 
the capripoxvirus (KS-1) 26kd protein. However, no reaction was observed with the 
32kd protein of capripoxvirus (KS-1). 
Results obtained with the hyperimmune sera were extended by cross-immunoblot 
analysis of serum samples prepared at weekly intervals from two sheep inoculated with 
capripoxvirus and two sheep inoculated with orf virus. To eliminate possible problems 
caused by protein migration variation, preparations of capripoxvirus (KS-1) and orf virus 
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were separated on the same gel, transferred to NCM, and the membrane cut into thin 
strips so that the proteins could be reacted with individual specific sera. The results of 
the analysis are shown in Figure 5.2. Strips 1 to 16 contained orf virus proteins, strips 
3 to 8 and 11 to 15 show the reactions with serum samples from orf virus and 
capripoxvirus (KS-1) infected sheep, respectively. Strip 1 shows reactions with orf 
hyperimmune serum and 2 with pre-immune serum sample. Strip 9 and 10 show 
reactions with capripox hyperimmune serum and pre-immune sera, respectively. From 
the second week of infection the serum samples from orf virus infected sheep react 
strongly with many of the orf virus proteins. From the third week of infection the serum 
samples from capripox infected sheep reacted weakly with some of the orf virus 
proteins. However, no reaction was observed with the capripoxvirus positive serum 
samples with any orf virus protein at the position equivalent to the 26kd protein of 
capripoxvirus (KS-1). 
Strips 17 to 32 contained capripoxvirus (KS-1) proteins. Strip 18 was reacted with 
capripox pre-immune serum and 19 to 24 with serum samples obtained from capripox 
infected sheep; strip 27 to 32 were probed with orf virus serum samples and strip 26 
with orf pre-immune serum sample. Strips 17 and 25 showed reactions with 
capripoxvirus and orf hyperimmune serum, respectively. Again strong reactions with 
many of the proteins were seen in the homologous system from the second week of 
infection. In the heterologous system none of the serum samples reacted with the 32kd 
protein of capripoxvirus (KS-1), however, reactions with other proteins (26kd, 42kd, 
67kd) can be seen from the third week of infection (Fig. 5.2). 
The results of the immunoblot analysis of some of the serum samples from Australia 
tested with capripoxvirus (KS-1) antigen are shown in igure 5.3. Each strip shows the 
reaction of an individual serum sample. The strips marked S were developed with 
capripoxvirus HIS and strips marked 0 were developed with orf virus HIS. It can be 
seen that none of the clinical sera reacted with the 32kd protein of the capripoxvirus 
(KS-1). However, the majority of the serum samples showed reactions with other 
proteins, including the 26kd protein of capripoxvirus (KS-1). The reaction pattern of 
these serum samples on immunoblots was very similar to that observed between 
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capripoxvirus (KS-1) proteins and orf virus experimental serum samples or orf 
hyperimmune serum indicating the Australian sheep had been infected with orf virus. 
5.2.3 Identification of cross-reactive proteins 
Monospecific polyclonal rabbit sera to the 32kd envelope protein and 26kd core protein 
of capripoxvirus (KS-1) were used to identify putative cross-reactive proteins of the orf 
virus by immunoblot analysis. This analysis revealed reactions of anti-26kd 
capripoxvirus protein antibodies with the 67kd and 42kd proteins of orf virus, but the 
anti-32kd protein antibodies failed to recognise any orf virus proteins (Fig. 5.4). These 
results were clearly suggestive that 26kd protein of capripoxvirus (KS-1) possessed some 
antigenic epitopes similar to that of 67kd and 42kd proteins of orf virus, whereas 32kd 
protein is totally capripoxvirus specific. 
5.3 Discussion 
The results of cross-AGID tests on sera from sheep with naturally acquired infections 
and sheep inoculated experimentally with the viruses revealed the high extent of 
serological cross-reactions between the two viruses. These results were similar to those 
reported by several other workers (Dubey and Sawhney, 1979; Sharma and Dhanda, 
1971; Subba Rao et al., 1984; Kitching et al., 1986). Soluble antigens used in AGID 
tests were prepared from the tissue culture or skin scab material, thus it was difficult to 
determine whether cross-reactive antibodies were directed against structural proteins or 
non-structural proteins of the virus. 
The analysis of capripoxvirus (KS-1) proteins has revealed that the 32kd is an envelope 
protein and that the 26kd and 67kd are core proteins (chapter 3). These proteins are 
strongly antigenic and induce antibody production efficiently in infected animals. The 
monospecific serum against the SDS-PAGE gel isolated 32kd protein of capripoxvirus 
(KS-1) did not react with any of the orf virus proteins suggesting that this protein is 
totally capripoxvirus specific. Thus antibody response against this protein should only 
be seen in capripox infected animals not orf infections. As can be seen none of the 
114 
serum samples obtained from orf infected sheep including orf hyperimmune serum 
reacted with the 32kd protein in immunoblot analysis. The 67kd protein is a major 
common precipitating antigen and antibodies against this protein have been shown to be 
present in all animals infected with different isolates of capripoxvirus. In addition, the 
67kd protein cross-reacts with serum obtained from orf infected sheep (Kitching et 
a1., 1986) indicating that cross-reactive antigenic epitopes are present on this protein. In 
the present study, serum samples obtained from orf infected sheep and the majority of 
the Australian sheep showed reaction with the 67kd protein of capripoxvirus (KS-1) in 
immunoblot analysis. Using monospecific serum against the 26kd protein of 
capripoxvirus (KS-1) it was possible to identify cross-reactive proteins of orf virus. Two 
proteins of orf virus, 42kd and 67kd, showed cross-reactions with 26kd monospecific 
serum in immunoblot analysis. These results clearly show that the 26kd protein of 
capripoxvirus (KS-1) shares antigenic epitopes with these two orf virus proteins. The 
above results indicate that possibly the envelope proteins of these viruses are virus 
specific whereas core proteins contains cross-reactive antigenic epitopes. Cross-reactive 
proteins localised in the virus core have also been shown with other poxviruses 
(Woodroofe and Fenner, 1962). 
Because purified virus preparations of capripoxvirus (KS-1) and orf virus were used in 
the immunoblot analysis, the antibody responses were indicative of the structural proteins 
of the virus(es). Orf virus hyperimmune serum did not react with the 32kd protein of 
capripoxvirus (KS-1) and capripoxvirus hyperimmune did not recognise the 26kd protein 
of orf virus. However, orf virus hyperimmune serum showed strong reaction with the 
26kd protein of capripoxvirus (KS-1) and capripoxvirus hyperimmune serum reacted 
with a 32kd protein of orf virus. Similar patterns of reaction were observed with cross- 
immunoblot analysis on serum samples obtained from animals experimentally infected 
with orf virus or capripoxvirus. This unique pattern of reactions in immunoblot analysis 
provides an easy definitive method for the differential diagnosis of these two infections. 
Use of both virus preparations in immunoblot analysis is unnecessary for the serological 
differential diagnosis of capripox and orf infections, because serum samples obtained 
from capripox or orf infected sheep produced distinguishable reactions with the proteins 
of each virus. 
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The antibodies to 32kd protein have been detected in capripoxvirus (KS-1) vaccinated 
or infected animals from the 2nd week of infection by immunoblot analysis (data not 
shown). However, AGID test frequently failed to detect capripoxvirus (KS-1) antibodies 
in mild capripoxvirus infections or in vaccinated animals (Kitching, 1985; Kitching et 
al., 1987). Thus the presence of anti-32kd protein antibodies in the test serum (as 
detected by immunoblot analysis), irrespective of AGID test results, clearly suggests that 
capripoxvirus infection has occurred to the animal. Whereas the absence of anti-32kd 
antibodies in serum samples determined by immunoblot analysis and positive reaction 
in AGID test with soluble antigens indicates that orf infection has occurred. 
Many serum samples from the Australian sheep had positive reactions with both the 
antigens in the AGID test, but none reacted with the 32kd protein of capripoxvirus in 
immunoblot analysis. However, the majority of the sera reacted with the 26kd and other 
proteins of capripoxvirus. These results were similar to those obtained by use of sera 
from orf virus infected sheep or orf virus hyperimmune serum, and clearly indicated that 
the Australian sheep had not been infected with capripoxvirus (KS-1) but with orf virus. 
From the results presented here it can be concluded that immunoblot analysis of the 
32kd protein specific antibody response provides a reliable method for serological 
differential diagnosis of capripoxvirus (KS-1) and orf virus infections. 
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Figure 5.1 Immunoblot analysis of capripoxvirus (KS-1) and orf virus proteins. Lane 2 
&4 contain capripoxvirus (KS-1) proteins and 3&5 orf virus proteins. Lane 2&3 
show reactions with the capripoxvirus hyperimmune serum and 4&5 with the orf virus 
hyperimmune serum. Lane 1 shows molecular weight markers. 
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Figure 5.2 Immunoblot analysis of serum samples from orf and capripox infected sheep. 
Strips 1 to 16 contain orf virus proteins and 17 to 32 capripoxvirus proteins. Strips I& 
25 probed with the orf hyperimmune serum and 9& 17 with the capripox hyperirnrnune 
serum. Strip 3 to 8 and 27 to 32 were reacted with the serum samples from orf infected 
sheep and 11 to 16 and 19 to 24 with the serum samples from capripox infected sheep. 
Strip 2& 26 were reacted with orf pre-immune serum and 10 & 18 with capripox pre_ 
immune serum. 
The serum samples from orf virus (strips 3 to 8 and 27 to 32) and capripoxvirus (strips 11 
to 16 and 19 to 24) infected sheep were obtained at weekly intervals up to 6 weeks. 
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Figure 5.3 Immunoblot analysis Australian sheep serum samples using capripoxvirus 
(KS-1) proteins. Each strip shows the reaction with an individual serum sample. Strips 
0 and S show reactions with the standard orf and capripox hyperimmune, respectively. 
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Figure 5.4 Analysis of the proteins of orf virus using monospecific sera to the 
capripoxvirus (KS-1) 32kd and 26kd proteins. Lane 2&4 contain capripoxvirus proteins 
and 3&5 orf virus proteins. Lane 2&3 show reactions with the 32kd monospecific 
serum and 4&5 with the 26kd monospecific serum. Lane 1 shows molecular weight 
markers. 
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CHAPTER 6 
The 32kd Envelope Protein of The KS-1 Virus 
6.1 Introduction 
The initial stages in the infectious cycle of a virus can be divided in two events: (i) the 
attachment of the virus particle to the plasma membrane of the host cell and (ii) the 
entry of the virus particle followed by release of the genome of the virus into the 
cytoplasmic compartment of the cell by one of several suggested mechanisms (Lonberg- 
Holm and Philipson, 1974; Marsh and Helenius, 1989). The proteins localised in the 
envelope of virus are considered to play important roles in these events. In poxviruses, 
the situation appears to be much more complicated due to the existence of intracellular 
virus (single layer envelope) and extracellular virus (double layer envelope). Although 
both forms of virus have been shown to be infectious (Appleyard et al., 1971; Boulter 
and Appleyard, 1973) the polypeptide composition of the outer envelope of the 
extracellular virus differ significantly from the envelope of the intracellular virus 
(Payne, 1978). Recently it has been shown that the extracellular virus fuses with the 
plasma membrane more efficiently and with faster kinetics than the intracellular virus 
(Doms et al., 1990). It is not known which of the outer envelope protein(s) of the 
extracellular virus are involved in the early events of virus host cell interaction. On the 
other hand, some of the envelope proteins of the intracellular virus which are involved 
in initial stages of poxvirus host cell interaction have been identified. For example, in 
vaccinia virus, a 32kd envelope protein has been shown to be an attachment protein 
which binds to the surface of the host cell (Maa et al., 1990) and a l4kd envelope 
protein mediates the fusion process which leads to the entry of the virus genome into 
the cell (Rodriguez et al., 1987; Lai et al., 1990). It has also been suggested that the 
58kd surface tubule protein is involved in the cell surface binding reaction of the virus 
(Stern and Dales, 1976). 
A gene homologous to that of the l4kd fusion protein gene of vaccinia virus has been 
identified within the Hindill fragment M of the capripoxvirus (KS-1) genome (Gershon 
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et al., 1989). There is a 32% identity between the deduced amino acid composition of 
the capripoxvirus (KS-1) protein and the vaccinia virus l4kd fusion protein. Whether this 
gene encodes a protein with similar functions to that of vaccinia l4kd fusion protein is 
not known. To determine which proteins are involved in early events of the virus-host 
cell interactions such as binding or fusion of the virus particle to the cell membrane, the 
envelope proteins of capripoxvirus (KS-1) have been analysed. 
6.2 Results 
6.2.1 The cell surface binding proteins 
The possible cell surface binding properties of proteins in the virus envelope were 
studied using iodinated envelope proteins of the virus (2.19.2). In the envelope 
preparation 4-6 proteins including the 32kd protein were iodinated, however only the 
32kd protein was found to bind to the LT-cell monolayers (Fig. 6.1). The amounts of the 
32kd protein bound to the LT-cell monolayers increased with the time of incubation. The 
specificity of the binding of the 32kd protein was studied using competitive assays with 
3% BSA or purified capripoxvirus (KS-1). It can be seen that the BSA had no effect on 
the affinity of the 32kd protein cell binding reaction, however, the addition of purified 
virus caused a marked inhibition of the binding (Fig. 6.1). The degree of inhibition was 
proportional to the quantity of competing virus. The binding of the 32kd protein with 
the cells was almost completely inhibited when cells were preincubated with 500 or 
50µg/ml purified virus and by approximately 50% with 5 tg/ml of purified virus. These 
results demonstrated that the 32kd envelope protein is a cell surface binding protein of 
capripoxvirus (KS-1) and the binding reaction between the 32kd protein and cell surface 
involves a virus specific mechanism. 
6.2.2 Trypsin sensitivity of the 32kd envelope protein 
Trypsin treatment (100µg/ml final concentration) of the capripoxvirus (KS-1) resulted 
in the almost total degradation of the 32kd binding protein and the concomitant 
appearance of a 22kd protein (Fig. 6.2). Some other proteins were minimally affected. 
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Trypsin degraded the 32kd protein into a 22kd fragment, however, it was not possible to 
identify the other products which were generated. Trypsin cleaved the 32kd protein in 
less than 5 minutes (Fig. 6.2). The 22kd fragment was detected in the pellet fraction of 
the virus obtained after centrifugation of the trypsin treated virus (data not shown). 
These results show that the trypsin treatment of the virus cleaves the 32kd protein and 
the cleavage product 22kd fragment remains virus associated. 
The trypsin treated virus samples were also studied by immunoblot analysis using 32kd 
monospecific serum. It can be seen that in the trypsin treated samples some residual 
32kd protein was still present as identified by the immunostaining signal (Fig. 6.3). These 
results showed that a small proportion of the 32kd protein remained unaffected even 
after 40 minutes trypsin treatment. The 22kd cleavage product easily seen on the 
coomassie blue stained gel (Fig. 6.2), only produced a weak signal in immunoblot 
analysis. These results show that the active antigenic site of the 32kd protein is present 
within the external fragment which is removed on trypsin treatment of the virus, or other 
possibility could be that the active antigenic site of the 32kd protein was present at the 
trypsin cleavage site. 
6.2.3 The effect of trypsin on virus infectivity 
The effect of trypsin treatment on the virus infectivity of the purified virus was studied. 
Trypsin treatment is routinely used in poxvirus purification at the stage of the crude 
virus pellet, the effect of trypsin on the infectivity of the crude virus pellet was also 
determined. The trypsin treatment decreased the virus titre of purified virus as well as 
that of crude virus pellet by at least ten fold (Table 6.1). In addition, the effect of the 
32kd protein (SDS) monospecific serum was studied on the infectivity of the trypsin 
treated virus. The results of the neutralisation assay are shown in Table 6.2. The 32kd 
monospecific serum decreased the virus titre by ten fold whereas the titre of the trypsin 
treated virus remained unaffected. These results clearly showed that the trypsin and the 
32kd monospecific serum decreased the virus infectivity. However, the 32kd 
monospecific serum was ineffective to decrease the infectivity of the trypsin treated 
virus. 
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6.2.4 Time of synthesis of 32kd protein during infection 
Pulse labelling of viral proteins or immunoblot analysis using hyperimmune serum 
showed that the 32kd was a late protein (Chapter 3). To provide more precise data on 
the time of synthesis of this protein immunoblot analysis was carried out using 
monospecific serum to the 32kd protein (2.8). The results immunoblot analysis clearly 
showed that the synthesis of this protein began at 10 hpi which was completely inhibited 
in the presence of Ara-C (Fig. 6.4). These results were virtually identical to those 
obtained previously by using the hyperimmune serum which strongly corroborated the 
concept that the 32kd is a late protein. 
6.2.5 Cellular location of the 32kd protein 
The indirect fluorescence antibody technique with 32kd monospecific serum was used 
to examine the cell surface expression and cellular location of the 32kd envelope 
protein in the infected cells. The cell surface expression of the 32kd protein was 
examined using non-permeable infected cells. The cells were fixed with a solution of 
paraformaldehyde and glutaraldehyde which makes cells non-permeable to the 
antibody/staining system. The cells after staining exhibited a bright greenish-yellow 
surface fluorescence (Fig. 6.5 A). Control uninfected cells did not show any type of 
fluorescence (Fig. 6.5 Q. The presence of fluorescence on the surface of cells indicated 
that the 32kd envelope protein was present on the cell surface of the infected cells. 
Infected cells fixed with acetone, which allows antibody to enter into the cytoplasm, 
revealed a diffused intense yellowish-green fluorescence throughout the cytoplasm of the 
infected cells (Fig. 6.5 B). Within this diffused fluorescence, intense local areas can be 
seen which represent the cytoplasmic inclusion bodies. The fluorescence was detected 
neither in the nucleus of the infected cells nor in control cell preparations. The presence 
of 32kd protein specific fluorescence in the cytoplasm and on the surface of infected 
cells strongly suggests that the 32kd binding protein after synthesis in the cytoplasm is 
transported to the surface of cells. 
The cell surface expression of the 32kd binding protein indicated that this protein, after 
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synthesis, could become inserted into the plasma membrane of the infected cells prior 
to its transport to the cell surface. To test this hypothesis the purified plasma membranes 
obtained from virus infected 0K cell or LT-cell monolayers, mock infected plasma 
membranes and purified virus were examined by immunoblot analysis using 
hyperimmune serum. An abundance of the 32kd binding protein was detected in the 
infected cell plasma membranes (Fig. 6.6). It can be seen that the purified infected 
plasma membrane produced a strong reaction at the position of 32kd binding protein but 
no reaction at the positions of 69kd, 20kd and l9kd proteins. These results clearly 
indicate that the signal at the 32kd position is not due to the contaminating virus. 
Reactions with the 90kd, 67kd and 29kd protein positions were also observed. The 90kd 
protein cannot have arisen from contaminating virus as this protein is not detectable 
(using immunoblot analysis) in purified virus preparation. Reaction at the 67kd position 
was also detected in the mock infected plasma membranes which must be due to a non- 
virus specific reaction of the serum. Thus the reaction at the 67kd position in the 
infected plasma membranes is also probably non-virus specific. The results of analysis 
of the infected plasma membranes indicate that during the replication of the virus in the 
cytoplasm significant amounts of the 32kd protein are transported to the cell plasma 
membrane. 
6.3 Discussion 
Binding of a virus particles to the cell surface is a first step in the early events of virus- 
host cell interactions (Marsh and Helenius, 1989). Binding occurs through interactions 
between the surface proteins of the virus and structures on the target cell, `virus 
attachment' sites. By analyzing the capripoxvirus (KS-1) envelope proteins in binding 
experiments it was possible to identify a 32kd envelope protein of the virus which was 
found to bind LT-cells. The binding of the 32kd envelope protein with cultured cells was 
selectively inhibited with purified capripoxvirus (KS-i) but not by bovine serum albumin 
suggesting that the 32kd protein binds to the same `virus attachment' site on the cell 
as the virus. The presence of multiple copies of the 32kd protein in the envelope of the 
virus and the possibility of a large number of `virus attachment' site on the cell surface 
could stabilise the interaction between the virus particle and the cell membrane. 
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Trypsin has been routinely used to remove host cell contaminating proteins during the 
stages of purification of poxviruses (Joklik, 1962b) including capripoxvirus (Al-Bana, 
1978; Kitching et al., 1986). However, it has been shown that trypsin affects the virus 
proteins (in addition to degrading the host cell proteins) and enhances the virus 
infectivity (Kim et al., 1969; Moss et al., 1973). Although the increase in the infectivity 
may be partly due to disruption of viral aggregates Ichihashi and Oie (1980) have shown 
that trypsin cleavage at the glycosylated end of a 37kd protein of vaccinia virus 
increases the infectivity of the virus. In capripoxvirus, Al-Bana (1978) has reported that 
trypsin treatment (100 µg/m1) slightly increased the virus titre (6.32x106 to 9.14x106) but 
concentrations of trypsin above 400 gg/ml reduced the titre. Contrary to this, we have 
found that trypsin even at 100 tg/ml concentration reduced the infectivity of 
capripoxvirus (KS-1) at least by ten fold. We have shown that trypsin degrades the 32kd 
cell surface binding protein of the virus into 22kd fragment which remains virus 
associated. These results clearly show that the trypsin treatment of the virus removes an 
approximately 10kd externally exposed fragment of the 32kd protein which results in the 
decrease of virus infectivity. These results strongly support the hypothesis that the cell 
surface binding domain is located within the l0kd external fragment of the 32kd protein. 
This hypothesis was further confirmed by examining the effect of 32kd monospecific 
serum on the virus infectivity. The 32kd monospecific serum reduced the virus 
infectivity by ten fold which is similar to the effect of trypsin on virus infectivity. 
However, the 32kd monospecific serum did not affect the infectivity of the trypsin 
treated virus indicating that the 32kd monospecific serum contains antibodies against the 
10kd external fragment of the 32kd protein and that these antibodies interfere with the 
binding of the virus particle to the cell surface by masking or altering the cell surface 
binding domain of the 32kd envelope protein. The 22kd fragment of the 32kd protein 
although remaining associated with the virus appears not to play a role in binding of the 
virus to the cell. 
Trypsin cleaved the 32kd binding protein in less than 5 minutes but at least 5-10% of 
the 32kd protein remained unaffected even after much longer incubation times (40 
126 
minutes). This could be due to the existence of 5-10% extracellular virus within the 
virus preparation. Possibly the outer envelope of the extracellular virus masks the 32kd 
protein localised on the inner envelope of the virus. Alternatively some of the 32kd 
protein is buried within the envelope thus being inaccessible to the trypsin. 
The poxvirus-specified antigens which become associated with the plasma membrane of 
infected cells, have been divided into three categories (Oie and Ichihashi, 1981b) (i) 
virion antigens, transferred to the plasma membrane as a result of fusion of the viral 
envelope with plasma membrane during adsorption and penetration of virus particles into 
the cells (Armstrong et al., 1973; Hapel et al., 1980; Oie and Ichihashi, 1981b), (ii) early 
viral antigens, encoded by the viral genome which are expressed prior to the onset of 
virus DNA synthesis (Ueda et al., 1969; 1972) and (iii) late viral antigens which are 
expressed during or after viral DNA replication (Weintraub and Dales, 1974; Shida and 
Dales, 1981,1982; Mallon and Holowczak, 1985). The most important function of 
poxvirus specified cell surface antigens has been shown to be their participation in 
activating the cell-mediated and humoral components of the immune system 
(Zinkernagel and Oldstone, 1976). The role of cell-mediated immune responses and 
neutralising antibody have been suggested in capripoxvirus infections (Srivastava and 
Singh, 1980a; Kitching, 1986) the proteins involved in these immune mechanisms are 
not known. However, we have shown that the 32kd protein stimulates both humoral and 
cell-mediated immune responses (chapter 4). Here it is shown that the 32kd protein after 
synthesis is transported to the plasma membrane and is also expressed on the surface of 
the infected cells during the virus multiplication. The association of the 32kd protein 
with the plasma membrane and its expression on the cell surface supports the concept 
of the involvement of this protein in immune responses. 
127 
Figure 6.1 Autoradiograph showing the cell surface binding proteins of capripoxvirus 
(KS-1). Lanes 1 to 4 show 5,10,15 and 30 minutes incubation times, respectively, of 
iodinated envelope proteins with LT-cell monolayers. Lanes 5 to 8 show results of 
competition binding assays. Lane 5 represents LT-cell monolayers incubated with 3% 
BSA, and lanes 6 to 8 represent LT-cell monolayers incubated with 500µ. g, 50µg and 
5 tg/ml purified capripoxvirus (KS-1), respectively. Monolayers were incubated for 1 
hour with competitor prior to incubation with iodinated envelope proteins for 30 minutes. 
E= iodinated envelope proteins, M= Molecular weight markers. 
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Figure 6.2 Effect of trypsin on virus proteins. Virus purified with the trypsin treatment 
step omitted was incubated with the trypsin (final conc. 100 . tg/ml) at 37°C. Aliquots 
were removed at 5,10,20 and 40 minutes. The samples along with a sample of 
untreated virus were separated in duplicate sets on the same SDS-PAGE gel. Half of the 
gel was stained with coomassie blue. The proteins from the second half of the gel were 
transferred to nitrocellulose membrane (see figure 6.3). 
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Figure 6.3. Effect of trypsin on virus proteins (immunoblotting). The proteins on the 
second half were transferred to nitrocellulose membrane. The membrane was probed 
with the 32kd monospecific serum. M= Molecular weight markers. 
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Figure 6.4 The analysis of the synthesis of the 32kd envelope protein in the presence or 
absence of cytosine arabinoside (Ara-C) by immunoblot analysis using monospecific 
serum. Infected LT-cell monolayers harvested at various time intervals up to 50 hpi were 
examined for the synthesis of the 32kd protein. Lane V represents the purified virus and 
M molecular weight markers. 
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Figure 6.5 Fluorescent antibody staining of infected LT-cell monolayers with the 32kd 
monospecific serum and anti-rabbit immunoglobulin FITC conjugate. (A) Examination 
of the cell surface expression of the 32kd protein. Infected cells were made non- 
permeable by fixing with a 4% formaldehyde and 0.1% glutaraldehyde, and incubated 
with the 32kd monospecific serum and anti-rabbit immunoglobulin FITC conjugate. C= 
uninfected LT-cells 
(B) Examination of the cytoplasmic location of the 32kd protein. The cells were fixed 
in acetone which made the cells permeable and allows penetration of the antibodies into 
the cells. 
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Figure 6.6 The immunoblot analysis of the virus (KS-1) proteins present in the plasma 
membranes of infected LT-cells using capripoxvirus hyperimmune serum. Lanes 1 and 
3represent plasma membranes from mock infected and infected cells, respectively. Lane 
2 represents purified virus. Lane M shows molecular weight markers. 
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Table 6.1 Effect of trypsin on virus infectivity 
Preparation Titre before trypsin Titre after trypsin 
treatment (TCID50/ml) treatment (TCID50/ml) 
---------------------- -------------------- 
Purified 
virus 
Crude virus 
pellet 
LT cell OK cell LT cell OK cell 
monolayers 
----------- 
monolayers 
---------- 
monolayers 
---------- 
monolayers 
- --------- 
1og109.1 1og108.1 1og108.1 1og106.8 
1og107.8 1og106.8 1og106.8 1og105.8 
---------------------------------------------- 
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Table 6.2 Effect of 32kd monospecific serum on the 
infectivity of the trypsin treated virus 
---------------------------------------------------------- 
Preparation LT-cell monolayers 
--------------------------- 
(1) Purified virus 
Virus titre 
(TCID50/ml) 
-------------------------- 
log108.4 
(2) Purified virus + 32kd monospecific serum log107.4 
(3) Trypsin treated virus log107.4 
(4) Trypsin treated virus + 32kd monospecific serum log107.4 
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CHAPTER 7 
Mapping and Sequencing of The Gene Encoding The 32kd Envelope 
Protein of Capripoxvirus (KS-1) 
7.1 Introduction 
It has been shown that 32kd envelope protein of capripoxvirus (KS-1) is strongly 
immunogenic inducing virus neutralising antibodies in animals (chapter 3). The results 
of in vitro lymphocyte proliferation studies clearly showed that this protein is involved 
in inducing cell-mediated immune responses during capripoxvirus infections (chapter 4). 
It has also been shown that immunoblot analysis of the 32kd protein antibody responses 
is important for serological differentiation between capripoxvirus and orf virus infections 
of sheep. The 32kd protein binds to the surface of cultured LT-cells suggesting that it 
is one of the attachment proteins of the virus and that some `virus attachment' sites are 
present on the surface of host cell for this protein. Studies based on trypsin sensitivity 
of the 32kd protein and reactivity with the monospecific serum indicate that the cell 
surface binding domain of this protein is located within the external 10kd fragment. To 
obtain more detailed information on the 32kd protein, the gene encoding this protein was 
identified, its location within the virus genome and nucleotide sequence determined. In 
order to identify the gene location of the 32kd protein within the genome of 
capripoxvirus we used a degenerate oligonuclotide probe based on a short sequence of 
amino acids of the 32kd protein. After identification of the genome segment containing 
the 32kd protein gene, a directed approach described by Henikoff (1984) was used to 
sequence the genome segment. 
7.2 Results 
7.2.1. N-terminal amino acid sequence and the degenerate oligonucleotide probe design 
The N-terminus of the 32kd protein was found to be blocked (personal communication, 
P Barker, Institute of Animal Physiology & Genetic Research, Cambridge Research 
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Station, Babraham, Cambridge), thus an internal amino acid sequence of the 32kd 
protein was used to design the degenerate oligonucleotide probe. Partial digestion of the 
32kd protein was carried out using Staphylococcus aureus V8 protease enzyme. The V8 
partial cleavage products were separated by SDS-PAGE and transferred to a membrane 
for protein microsequencing. Five V8 partial cleavage products of the 32kd protein were 
clearly seen on the membrane (Fig. 7.1). The top most protein band which represented 
the uncleaved 32kd protein disappeared following degradation with larger amounts of 
the enzyme. 
All five V8 cleavage products were subjected for N-terminal protein microsequencing, 
two were resistant to sequencing. An identical N-terminal amino acid sequence was 
obtained with two of the V8 cleavage products. This sequence was NKFIVVIED 
DNTLKD (single letter code for amino acids). The third V8 cleavage product 
generated two N-terminal amino acid sequences. On the strength of amino acid signals 
they were deduced to be LKFDNDIFYKNVDTV and NQSIVVXED 
DKTLKD (X denotes any amino acid). The analysis also indicated that there could 
be some interchange of amino acids between the two sequences. Allowing for such an 
interchange resulted in one of the amino acid sequences being identical to that of 
obtained with the other two V8 cleavage products. 
A synthetic degenerate oligonucleotide probe of 20 nucleotides was prepared based on 
the first 7 amino acids of the three identical N-terminal sequences. The last nucleotide 
of the seventh amino acid was omitted as this greatly reduced the required degeneracy. 
7.2.2 Analysis of the southern blot 
Capripoxvirus (KS-1) DNA restriction fragments obtained with Hindu , PstI, BamHI, 
SaII and EcoRI restriction endonucleases were separated in a agarose gel and then 
transferred to a nylon membrane. The prehybridised southern blot was hybridised with 
the radiolabelled degenerate oligonucleotide probe. The degenerate oligonucleotide probe 
produced strong hybridisation signals with the Pstl F, BamHI B, EcoRI 0 and either 
HindIIl Q1 or Q2 fragments (Fig 7.2). A weak reaction of hybridisation was observed 
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with the Sall C and Sal! D fragments. Restriction maps of capripoxvirus (KS-1) DNA 
constructed with HindIIl, Pstl and SaII (Gershon and Black, 1987; 1989) and BamHI (D 
N Black and PP Bhatt, unpublished data) are known. The alignment of these maps 
showed that the degenerate oligonucleotide probe reacted with the Hindun Q1 fragment 
as the HindIII Q1 fragment overlaps with BamHI B, PstI F and Sall C fragments 
(Fig. 7.3). Although the EcoRI restriction map of capripoxvirus (KS-1) DNA has not yet 
been constructed the hybridisation results with the EcoRI 0 fragment were found to be 
useful in identifying putative position of the 32kd protein coding region within the 
HindIII Q1 fragment of capripoxvirus (KS-1) DNA. The EcoRI 0 fragment (of 
approximately 1.6Kb) was the smallest of the fragments identified by the degenerate 
oligonucleotide probe. A radiolabelled probe prepared from this fragment hybridised with 
the HindIII B2 fragment in addition to the BamHI B, PstI F, SaII C and Hinduu Q1 
fragments (data not shown). This shows that the EcoRI site is present in both HindU! 
Q1 and B2 fragments and that the EcoRI 0 fragment extends across the junction of the 
Hindill B2 and the Hind!!! Q1 fragments. These results clearly suggest that the complete 
gene for the 32kd protein is present either within the EcoRI 0 fragment or HindIIl Qi 
fragment or it may extend towards the HindIIl B2 fragment. 
7.2.3 Cloning of the HindIlI Q1 fragment of capripoxvirus (KS-1) DNA 
The PstI F fragment of capripoxvirus (KS-1) DNA has been cloned in pUC9 plasmid 
and shown to contain the complete HindIII Q1 fragment (Gershon and Black, 
unpublished data). The presence of the HindIII Q1 fragment within the pUC9/PstI F 
recombinant plasmid was confirmed by using a radiolabelled probe, prepared from the 
EcoRI 0 fragment of capripoxvirus (KS-1) DNA in southern blot analysis. The EcoRI 
0 probe reacted with PstI F fragment showing that HindIIl Q1 fragment was present in 
this fragment (Fig. 7.4A). Digestion of the pUC91PstI F plasmid with HindIIl will 
generate, in addition to the HindIII Q1 fragment, four further fragments: a) pUC9, b) 
HindIIl IA, c) HindIII L and, d) part of the HindIIl B2 fragment. These fragments will 
be generated due to the presence of the HindIIl sites in the PstI F fragment and the 
multiple cloning site. Southern blot analysis of a HindIII digest of the pUC9/PstI F 
plasmid using the EcoRl 0 fragment probe revealed hybridisation reactions with the 
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HindIII Ql fragment and part of the HindlII B2 fragment. Hybridisation reactions 
between the EcoRI 0 fragment probe and the Hindul B2 fragment can also be seen in 
the lane containing HindIH digest of capripoxvirus (KS-1) DNA (Fig. 7.4A). These 
observation further support the above results that the EcoRI 0 fragment is present within 
the Hindul Q1 fragment and extends across the HindIII Q1 and Hindu B2 junction. 
The HindIIl Qi and the pUC9 fragments are virtually of identical size and thus it is not 
possible to extract one of them from the gel without the other. However, it was possible 
to selectively clone the HindIII Q1 fragment following digestion of pUC9/PstI F with 
both Pstl and HindIII enzymes. Such a digestion will generate the pUC9 with Pstl ends 
thus it will not be ligatable with the HindIIl cut bluescript KS+ plasmid. The HindIIl Q1 
fragment was cloned in bluescript and the recombinant plasmid DNA obtained from four 
bacterial colonies was examined by southern blot analysis using EcoRI 0 fragment 
probe. It can be seen that three of the four colonies contained recombinant plasmid 
(Fig. 7.4B). In addition, the EcoRI digests of two recombinant plasmid DNA showed 
examples of the Hindlf Ql fragment cloned in both orientations. 
7.2.4 Nucleotide sequence of the HindIIl Q1 fragment and identification of the open 
reading frames within the fragment 
Overlapping mutants generated by unidirectional deletions of the recombinant plasmid 
DNA using the Exonucleaselll/S1 nuclease method of Henikoff (1984) were employed 
to obtain complete nucleotide sequence of the HindIII Q1 fragment. The caesium 
chloride gradient purified recombinant plasmid DNA obtained from the twelve 
overlapping deletion mutants (Fig. 7.5) was sequenced by the Sanger dideoxy-mediated 
chain-termination method (Sanger et al., 1977). The complete nucleotide sequence of the 
HindIII Q1 fragment is shown in Figure 7.6. Computer assisted analysis of the nucleotide 
sequence revealed that the HindII1 Q1 fragment of capripoxvirus (KS-1) DNA contained 
four complete and one incomplete open reading frames. These open reading frames were 
designated Q, 1 to Q15 and as per their transcriptional direction (either left or right) L 
for left and R for right was added. The deduced amino acid sequence is shown with a 
single letter amino acid code along with the nucleotide sequence (Figure 7.6) of each 
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open reading frame. The four complete open reading frames, Q11L, Q12R, Q13L and 
Q14R are capable of coding for 10.2kd, 22.5kd, 30.6kd and 13.5kd polypeptides, 
respectively. The coding sequence for Q13L and Q14R overlaps, Q, 3L starts from 1644 
nucleotide and ends at 2435 nucleotide whereas Q14R starts from 1993 to 2343 
nucleotides. The incomplete open reading frame, Q15L, revealed a 13.4kd C-terminal 
region of a polypeptide. 
7.2.5 Identification of the open reading frame encoding the 32kd envelope protein 
All the five open reading frames were analysed for the presence of the two fifteen amino 
acid long N-terminal amino acid sequences obtained from the V8 protease cleavage 
products of the 32kd protein. One of the open reading frames, Q13L, was found to 
contain both amino acid sequences. The identical N-terminal amino acid sequence 
observed with the three V8 protease cleavage products was present from the 116 to 130 
amino acid residues. The second N-terminal amino acid sequence has been found from 
the 23 to 37 amino acid residues. These results clearly show that the Q13L open reading 
frame encodes the 32kd envelope protein. This open reading frame can code for a 
30.6kd polypeptide which is very close to the 32kd protein molecular weight as detected 
by SDS-PAGE. The two glycosylation sites present at the amino acid positions 75 to 77 
(N F T) and 229 to 231 (N D S) may account for the higher molecular weight of 32kd 
protein. 
7.2.6 Comparison of capripoxvirus (KS-1) open reading frames with vaccinia virus open 
reading frames 
The computer assisted analysis of the nucleotide sequence of the HindIIl Q1 fragment 
of capripoxvirus (KS-1) DNA using FASTA programme revealed a high consensus at 
the nucleotide level between the HindIIl Q1 fragment and the vaccinia virus DNA 
HindIIl H fragment. The size of the HindIIl H fragment of vaccinia virus DNA is 
approximately 8.6kb and contains seven open reading frames (Goebel et al., 1990). The 
capripoxvirus (KS-1) DNA HindIII Q1 fragment contains five open reading frames, four 
of which are complete open reading frame and one is incomplete. A comparison of the 
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open reading frames of the capripoxvirus (KS-1) DNA Hind fl Q1 fragment with the 
corresponding open reading frames of vaccinia virus DNA Hindu H fragment is 
presented in Table 7.1. The results of analysis clearly show that there is a very high 
similarity between the open reading frames of the two fragments. The Q, 1L, Q12R, Q13L 
and Q15L open reading frames of capripoxvirus (KS-1) displayed identical orientations 
to those of vaccinia virus H1L, H2R, H3L and H4L open reading frames, respectively 
(Fig. 7.7). However, an equivalent to the Q14R open reading frame of capripoxvirus (KS- 
1) was not present in the vaccinia virus DNA HindIll H fragment. The SWISS-PORT 
protein library scores of the predicted products of the corresponding open reading frames 
of the two fragments, were high, suggesting a high level of identity at the amino acid 
sequence level between the open reading frames. 
A direct comparison of predicted amino acid sequence of the Q11L open reading frame 
of capripoxvirus (KS-1) with that of vaccinia virus H1L open reading frames is shown 
in Figure 7.8. The results of this comparison are discussed below. The Q13L open reading 
frame was compared with the H3L and D8L open reading frame of vaccinia virus 
(Fig. 7.9 and 7.10). The result of this analysis will be discussed in the next chapter. 
7.3 Discussion 
Cross-hybridisation of genome segments of capripoxvirus (KS-1) and vaccinia virus 
clearly shows that a large centrally placed 100 to 115kb section is essentially colinear 
in organisation Gershon et al. (1989). Nucleotide sequence analysis of two centrally 
located segments of capripoxvirus (KS-1) DNA show very similar gene organisation to 
the corresponding cross-hybridising segments of the vaccinia virus DNA (Gershon and 
Black, 1989b; Gershon et al., 1989). It has also been shown that the vaccinia virus DNA 
HindIII H fragment cross-hybridised with the capripoxvirus (KS-1) DNA HindIII Q1 
fragment. In the present study, the nucleotide sequence analysis of the HindIII Q1 
fragment of capripoxvirus (KS-1) DNA reveals that it contains 2795 nucleotides. 
Computer assisted analysis, using a FASTA programme for nucleotide sequence 
comparison, shows a very high level of identity at the nucleotide level between the 
Hindill Q1 fragment and the HindIIl H fragment of vaccinia virus DNA. A 62.7% 
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identity in 2604 base pair overlap was observed between these two fragments. These 
results are in agreement with the cross-hybridisation results obtained by Gershon et 
al. (1989). The HindIII Q1 fragment is located between the Hindul B2 and L fragments. 
The vaccinia virus DNA HinduI H fragment (size 8.6kb) cross-hybridises with the 
HindIIl B2 and L fragments, in addition to the HinduI Q1 fragment, of capripoxvirus 
(KS-1) DNA (Gershon et al., 1989). These results suggest that the sequences on either 
side of the cross-hybridising segment of the Hindu H fragment of vaccinia virus DNA 
react with the HindIII B2 and L fragments of capripoxvirus (KS-1) DNA. 
The HindIII Q1 fragment of capripoxvirus (KS-1) DNA contains five open reading 
frames. The Q11L open reading frame of capripoxvirus (KS-1) shows homology with 
that of vaccinia virus H1L open reading frame. The H1L gene of vaccinia virus encodes 
a late protein (Rosel et al., 1986) which, recently, has been shown to be a protein 
tyrosine phosphatase enzyme (PTPase) (Guan et al., 1991). PTPase has been shown to 
be involved in a bacterial disease caused by Yersinia pestis, the causative agent in the 
plague or black death. The Yersinia PTPase gene has been shown to be essential for 
bacterial pathogenesis (Bliska et al., 1991). Guan et al. (1991) identified the exitance of 
H1L gene protein in vaccinia virus by searching the National Biomedical Research 
Foundation data bank using the highly conserved amino acid sequence surrounding the 
active site of PTPase. The in vitro expressed H1L gene product exhibits enzymatic 
activities identical to that of PTPase. The enzymatic activity of vaccinia virus PTPase 
was shown to be dependent on the cysteine residue at amino acid 110 present within the 
signature sequence `HCXAGXXR' at the active site. This property of the vaccinia H1L 
protein was identical to that of Yersinia PTPase. On the basis of these observations a 
role of PTPase has been suggested in vaccinia virus pathogenesis (Guan et al., 1991). 
Interestingly, the deduced amino acid sequence of Q11L gene of capripoxvirus (KS-1) 
shows 61.6% identity and 82.2% similarity at the amino acid level with that of H1L 
gene product of vaccinia virus (Fig. 7.8). The Q, 1L protein is almost half (10.2kd) the 
size of vaccinia virus H1L protein (19.7kd), however, the signature sequence and the 
cystine residue are completely conserved. Whether the Q, 1L gene in capripoxvirus (KS- 
1) expresses a protein with functions similar to that of vaccinia virus H1L protein 
remains to be determined. Cloning and in vitro expression of the Q1L gene will greatly 
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facilitate the understanding of biological functions of this gene in the infectious cycle 
of capripoxvirus. 
The Q12R and Q15L open reading frames show a high order of similarity with that of 
vaccinia virus H2R and H4L open reading frames, respectively. These open reading 
frames either of capripoxvirus (KS-1) or vaccinia virus encode proteins whose functions 
are not known. However, the presence of these open reading frames with such a high 
level of conservation suggest their specific biological importance in both of the viruses. 
Discussion regarding the Q13L open reading frame will be dealt in the next chapter. 
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Table 7.1 Comparison of open reading frames of the Hindill Q1 
fragment of capripoxvirus (KS-1) DNA with the Hindlil H 
fragment of vaccinia virus DNA 
---------------------------------------------------------- 
Capripox- Coding Vaccinia Coding SWISS-PORT Amino 
virus capacity virus capacity library acid 
scores identity 
(%) 
Q11L 10.2kd H1L 19.7kd 297 61.6 
Q12R 22.5kd H2R 21.7kd 780 65.4 
Q13L 30.6kd H3L 37.5kd 556 34.1 
Q14R* 13.5kd Absent in vaccinia virus 
Q15L** 13.6kd H4L 94kd 463 71 
- ---------------- 
* overlapping open 
---------------------- 
reading frame 
-------- ---------- 
**Incomplete open reading fr ame. SWISS-PORT lib rary scores 
and % amino acid identity are based on 108 amino acid 
overlap. 
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Figure 7.1 Partial digestion of the 32kd protein by V8 protease. The 32kd protein was 
digested with different amounts of V8 protease, the cleavage products separated by 16% 
SDS-PAGE, transferred to the ProBlott membrane and stained with coomassie blue. M 
= Molecular weight markers in kilodalton (kd). 
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Figure 7.2 Autoradiograph showing reactions of the [32P] labelled degenerate 
oligonucleotide probe with the restriction fragments of capripoxvirus (KS-1) DNA. Lanes 
H, B, P, S and E represent HinduI, BamHI, Pst!, Sall and EcoRI digests of 
capripoxvirus (KS-1) DNA, respectively. 
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Figure 7.3 Partial HindIII restriction map of capripoxvirus (KS-1) DNA. The BamHI, 
Pstl and Sall sites are also shown. The degenerate oligonucleotide probe reacted with 
the Sall C, BamHI B, PstI F and HindIIl Q1 fragment of capripoxvirus (KS-1) DNA. 
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Figure 7.4A Southern blot analysis of the pUC9/PstI F recombinant plasmid using a [32P] 
labelled probe prepared from EcoRI 0 fragment of capripoxvirus (KS-1) DNA. Lanes 
1 and 2 contain Pstl and Hindul digests of the recombinant plasmid DNA, respectively. 
Lanes 3 and 4 contain HindIH and EcoRI digests of capripoxvirus (KS-1) DNA, 
respectively. 
Figure 7.4B Southern blot analysis of the recombinant Bluescript (KS+) plasmid 
containing Hindul Q1 fragment using a [32P] labelled probe prepared from EcoRJ 0 
fragment of capripoxvirus (KS-1) DNA. Lane 1 contains HindIIl digest of capripoxvirus 
(KS-1) DNA. Lane 2-5 contain Hindu digests from four different recombinant 
Bluescript plasmids. Lane 6 and 7 contain EcoR1 digests from two recombinant 
Bluescript plasmids. 
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Figure 7.5 Analysis of overlapping deletion mutants used for DNA sequencing. The 
deletion mutants generated by the ExonucleasellI/ SI nuclease method of Henikoff 
(1984) were analysed by digesting with KpnI and Sacl together to identify the 
overlapping mutants. Twelve selected mutants (lane 2-13) are shown in the figure. A 
gradual deletion between 200-300bp can be observed in these mutants. M represents 
kilobase (kb) marker. Lane 1 contains recombinant Bluescript plasmid digested with 
KpnI and lane 14 contains uncut plasmid DNA. 
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Figure 7.6 Complete nucleotide sequence of the HindIH Ql fragment of capripoxvirus 
(KS-1) DNA. Open reading frames and their direction of transcription are shown. The 
sequence shows C-terminal region of the Q15L open reading frame. Q14R completely 
overlaps on the Q13L open reading frame and not shown in this figure. < or > indicates 
direction of transcription of the open reading frames and * stop codon. 
1 TTTATTAAATACATACGGTGAAGGATTTGATTATTTGTATCAACCATGTG 
51 ACTTATTGGCTAGCTTAATTTGTATGAGTTACGAACCCGAATCAGTTAAT 
101 AAGTTTAAGTTTGGTGTTACAAGTTCCTTAAAAAGGCTACGTTTGGAGAT 
151 AACAAAGCTCTATTAAATGCTGCATTACATAAAAAGACTGAACCTGTTAA 
201 TGATAACAGCAGTTGTCATTTCTTTAGCAAGGTTCCAAAAATAGGAACAG 
251 GGTACTACCGTTATTTTGTTAACCTAGAATTACTAACTAGATTGGAAAAG 
301 AAACTTTCTGTTACAATATCTGATAGAAAGGTTGAAGAATTAATCGAAAA 
351 TCCGACGAGTTTTAACTTTTTATTCATTAATAATATACTTATCAATTAGT 
401 TGTTTCTAAAGAGGATTTCTATAAATGCGCCTCTTTTTTCTCTCATAGAG 
NNRFLIEIFAGRKERMS 
451 TGGTATATATATAAAAAATATATAAACGCAGGTATATCTTTACTTCTCTT 
HYIYLFYIFAPIDKSRK 
501 TGACATTAAATATGCCATTATCATCGCACCACTTCTATTAACGCCGGCAA 
SMLYAMIMAGSRNVGA 
551 CACAATGTACTAACACAGGATAATGTTCTTCATCACATTTTGATAAAAAA 
VCHVLVPYHEEDCKSLF 
601 TTTGTAACATAATCAAAATGATCATTTAAATTTGTTTTTGCGTCATCAAT 
NTVYDFHDNLNTKADDI 
651 AAGAGGCATATGAATAATATTTATACGTGAATCATTAAAACAATATTTTT 
LPM< Q11L 
701 CTGTAGTAAGATTTAAAATATATTTAAAATTTACATTTGAAGATATTGCA 
751 TTAATTGCATCATCATAATTTCCAAATATACATAATCCGTTACTCTCATC 
801 ATCTTTGTCGGTGCCTTCGCTTTGGGTAGAGAACCTGTAGACTTTAGTAA 
851 AACGTTTTCGTAAAGACTTTTTTTAATCCATTTATAATGGCTACAAATGG 
Q12R >MD 
901 ATAAAACAACATTAAATGTTAATGGTGTTGAATTAGAATACGCTAGAGAA 
KTTLNVNGVELEYARE 
951 AAAGAAAATAAAACAATACAAACGGCTAAAACCTCTACTTTATGTTTCTT 
KENKTIQTAKTSTLCFF 
1001 TATGTTAATTTTAGGTATTAGTATACTATTACTTTGGTTTCAAGTATCTG 
MLILGISILLLWFQVSD 
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1051 ATAATTCTATTTTCTCAGAATTAATGAAGTATATACGGATAAAAAAATCT 
NSIFSELMKYIRIKKS 
1101 ATAAGAGGGTGGAGACCTTTAGTTGAAACCAAAACTAACTTAGAAAGTGA 
IRGWRPLVETKTNLESD 
1151 TAGAGGAAAAATGTTATCAATGGGAAGAGATGAGTATTTTTCTTTTAATT 
RGKMLSMGRDEYFSFNC 
1201 GTGTAGATTTTGGTTCTTACTTTGTTCCTATTAGATTAGATAGAAAAACG 
VDFGSYFVPIRLDRKT 
1251 TTTTTACCACAAGCTATTAGAAGGGGAAAAGGTGATGGATGGATGGTACA 
FLP0AIRRGKGDGWMV0 
1301 AAAAGCAGATAAAATAGATGTATCCGCACAACAATTTTGTCAATATTTAA 
KADKIDVSAQQFCQYLI 
1351 TTAAACATAAATCAGAAAACATAATAACGTGCGGAACCCATATGATTAAC 
KHKSENIITCGTHMIN 
1401 GAAATAGGATATAGTGGCTATTTTACAAACTCTCATTGGTGTTCGGATTT 
EIGYSGYFTNSHWCSDF 
1451 TCATAATCTTTTAAACTAAATTATATACGTAAATAACATACCTGCTAAAA 
HNLLN 
1501 ACCATAGTAATTTAGAATTCAAATCAAAAATTATCATTATTATAATAAAT 
1551 AAAATAATAAGTGCTCCTATTATACTAATATCAAATATACCAAAAAATGA 
1601 AACCAATGGATGGGATACATAGTAAGAAAAATCAGGAAATCTATGAGCCA 
*SG 
1651 TCCATTTTTCCAACTCTATTCCATATACCGTTTTTCATTTCGTTAGCTCT 
DMKGVRNWIGNKMENAR 
1701 TTTTTTTGACAAATACTTAGTATTGTGAAGTATATACTTAGATGAGTCAT 
KKSLYKTNHLIYKSSD 
1751 TTAAAACTTGTCTATTGAGTTTTAATTCTTTTTCCAACTTATACATTTCA 
NLVQRNLKLEKELKYME 
1801 AAACTTAAACTGGTAGAAATACCTTTATTTTTTATAATTTCGTTTATTAT 
FSLSTSIGKNKIIENII 
1851 TTTTATGGCAGACGATAATCTAATTACATATGCGGATAAGGTAAAATCAT 
KIASSLRIVYASLTFD 
1901 ATCCCCCTGTGTACGAATACATAAAATTATTATTTTCTTGATTGAACAAT 
YGGTYSYMFNNNEQNFL 
1951 ATTCTAGAATTACTATTATGAAAAGTTTCACGTAATTGGAAAATGTCTAT 
IRSNSNHFTERLQFIDI 
2001 ATTTTTTTCTTGCATTTCAATTATAATGTTATGTATTGTTATTAAATCTT 
NKEQMEIIINHITILD 
2051 TTAATGTGTTATCATCTTCTATAACAACAATAAACTTATTCTCAGAATTT 
KLTNDDEIVVIFKNESN 
2101 TTTATATCCGCATCGGCATACGATTTCCATAAACTAAAGTGTTTCGCAAT 
KIDADAYSKWLSFHKAI 
151 
2151 AGAACTTTTTGCCTCTTTTGTACAAAGAGCATTACATAATCCAGAAAAAT 
SSKAEKTCLANCLGSF 
2201 ATTCTGTAAAATTTTCAACACCTCCTGATTTTTCTACCTTTTCCCATATA 
YETFNEVGGSKEVKEWI 
2251 AGGAACTTATATGATAAACTGATATCTTTTTTATCTTTAAAAAAAAAATT 
LFKYSLSIDKKDKFFFN 
2301 TACATCTGAATTTTTAAAATCTTTTACTGTGTCAACTTTTTTATAAAATA 
VDSNKFDKVTDVKKYF 
2351 TATCATTGTCACTTTTTAATTCTGGAACTACATCTGAAATTTCGCGACCA 
IDNDSKLEPVVDSIERG 
2401 ACGATTGGTATAACATATAATGGGATATCTGCCATTTTTGATAATTAGTT 
VIPIVYLPIDA M< Q13L 
2451 ATCTAAAGCACTATTTAGTTATTAAAATTAAAGAAGTATAGCTCTCTAAT 
*NNFNFFYLERI 
2501 TTTAGTTATGTTTTCATCTATCCAAATAGAAACATCATTTACGTATCTTG 
KTINEDIWISVDNVYR 
2551 ATAAAAATCTATAAAATGTATACTCTAATTTATCTCTATTAAGCGAATCG 
SLFRYFTYELKDRNLSD 
2601 CTAAAATATACAAAAACATCACTTTCTGGAAGCAAGTGGTAACGGAATAA 
SFYVFVDSEPLLHYRFL 
2651 GTTGTAACAATTTACTTTACTCTGTACATGATATTTATCTACAAGTTCGT 
NYCNVKSQVHYKDVLE 
2701 CAT CAAAAGGAAACGGATCTCCGAATCGAAATACGTATAATGATGGGATA 
DDFPFPDGFRFVYLSPI 
2751 GAATAGTAATATTTTAAAACATTATTTATAAATAAGCTTATCGAT 
SYYYKLVNNIFLSI S< Q15L 
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Figure 7.7 Comparison of orientation of open reading 
frames of the Hindill Q1 and HindIIl H fragments of DNA 
of capripoxvirus (KS-1) and vaccinia virus 
H2R 
-º 
Vaccinia s- No I virus H1L H3L H4L 
Capripoxvirus 
Q'iL QUQ , SL 
Q, 2R Q 14R 
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Figure 7.8 Comparison of the amino acid sequences of Q11L of capripoxvirus 
(KS-1) (CPV) with vaccinia virus (VV) H1L. There is a 61.6% identity and 
80.2% similarity between the open reading frames. 
CPV 1 ........................ MPLIDDAKTNLNDHFDYVTNFLSKCD 26 
: 11: 11.. 1::... 11 11.111111 
VV 51 KFKYVLNLTMDKYTLPNSNINIIHIPLVDDTTTDISKYFDDVTAFLSKCD 100 
27 EEHYPVLVHCVAGVNRSGAMIMAYLMSKRSKDIPAFIYFLYIYHSMREKR 76 
.: IIIIII. IIIIIIIIII: IIIIII . I: .::: IIII: IIIII: I 101 QRNEPVLVHCAAGVNRSGAMILAYLMSK. NKESSPMLYFLYVYHSMRDLR 149 
77 GAFIE ........... ILFRNN* 88 
111: 1 ... .1 150 GAFVENPSFKRQIIEKYVIDKN. 171 
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Figure 7.9 Comparison of the amino acid sequences of capripoxvirus (KS-1) 
(CPV) Q13L and vaccinia virus (VV) H3L. There is a 34.1% identity and 
61.3% similarity between the open reading frames. 
CPV 1 MADI.. PLYVIPIVGREISDVVPELKSDNDIFYKKVDTVKD... FKNSDV 45 
II.. I:. I: I: ": I. I:.. I:. ... I . 1.1.111 .... VV 1 MAAVKTPVIVVPVIDRPPSETFPNV.. HEHINDQKFDDVKDNEVMPEKRN 48 
46 NFFFKDKKDISLSYKFLIWEKVEKSGGVENFTEYFSGLCNALCTKEAKSS 95 
... II.. I .II: I. ..... .: I": III: II.: II"I. I". 49 VVVVKDDPDHYKDYAFIQWTGGNIRND. DKYTHFFSGFCNTMCTEETKRN 97 
96 IAKHFSLWKSYADADIKNSENKFIVVIEDDNTLKDLITIHNIIIEMQEKN 145 
98 IARHLALWDSNFFTELENKKVEYVVIVENDNVIEDITFLRPVLKAMHDKK 147 
146 IDIFQLRETFHNSNSRILFNQENNNFMYSYTGGYDFTLSAYVIRLSSAIK 195 
111: 1: 11.. . ". "" " .: 1: ... 111111.. 1111: 11:.. 1:. 
148 IDILQMREIITGNKVKTELVMKDNHTIFTYTGGYDVSLSAYIIRVTTALN 197 
196 IINEIIKNKGISTSLSFEMYKLEKELKLNRQVLNDSSKYILHNTKYLSKK 245 
I:: IIII" I: I.. " II: .: I"I: I: III: I:... II: I:....... 198 IVDEIIKSGGLSSGFYFEIARIENEMKINRQILDNAAKYVEHDPRLVAEH 247 
246 RANEMKNGIWNRVGKMDGS ............................... 264 
I ": 11 .: 
I. I: I. ... 248 RFENMKPNFWSRIGTAAAKRYPGVMYAFTTPLISFFGLFDINVIGLIVIL 297 
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Figure 7.10 Comparison of the amino acid sequences of capripoxvirus (KS- 
1) (CPV) Q13L with vaccinia virus D8L. There is a 16.3% identity and 38.9% 
similarity between the open reading frames. 
CPV 1 MADIPLYVIPIVGREISDVVPELKSDNDIFYKKVDTVKDFKNSDVNFFFK 50 
W1................... MPQQLSPINIETKKAISNARLKPLDIHYNES 31 
51 DKKDISLSYKF.. LIWEKVEKSGGVENFTEYFSGLCNALCTKEAKSSIAK 98 
.... I . I: ... III. : I: I . II.. . 32 KPTTIQNTGKLVRINFKGGYISGGFLPNEYVLSSLHIYW. GKEDDYGSNH 80 
99 HFSLWKSYADADIKNSENKFIVVIEDDNTLKDLITIHNIIIE. MQEKNI. 146 
81 LIDVYKYSGEINLVHWNKKKYSSYEEAKKHDDGLIIISIFLQVLDHKNVY 130 
147 .. DIFQLRETFHNSNSRILF ....... NQENNNFMYSYTGGYDFTLSAYV 
187 
. 
I.. ...... I.. 
II... II... II 
. 
131 FQKIVNQLDSIRSANTSAPFDSVFYLDNLLPSKLDYFTYLGTTINHSADA 180 
188 IRL ......... SSAIKIINEIIKNKGISTSLSFEMYKLEKELKLNRQVL 
228 
... I .... ......... . I. ..... III .. 181 VWIIFPTPINIHSDQLSKFRTLLSSSNHDTKPHYITENYRNPYKLNDDTQ 230 
229 NDSSKYILHNT...... KYLSKKRANEMKNGIWNRVGKMDGS........ 264 
231 VYYSTEIIRAATTSPARENYFNRWLSDLRETCFSYYQKYIEENKTFAIIA 280 
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Chapter 8 
General Discussion 
Capripoxviruses are responsible for causing a most severe disease in sheep, goats and 
cattle. These viruses are currently classified as the causative agents of three separate 
diseases, sheeppox, goatpox and lumpy skin disease (Neethling) of cattle (Matthews, 
1982). Although capripoxviruses show host preference, a very close relationship exits 
between the isolates from all three species. Kitching and Taylor (1985) have shown that 
isolates of capripoxvirus from different parts of the world were indistinguishable on the 
basis of clinical disease, heterologous serum neutralisation and cross-protection studies. 
A single vaccine has been shown to protect sheep, goats and cattle from capripoxvirus 
infection (Kitching et al., 1987; RP Kitching, personal communication). These studies 
indicate that the different isolates of capripoxvirus possess common immunogenic 
components which are responsible for the generation of immunity in all of the three 
species. Proteins which are localised in the envelope of such viruses, including 
poxviruses, have been shown to be involved in the early events of virus-host cell 
interactions. In the case of poxvirus infections, for example, a 14kd envelope protein of 
vaccinia virus is involved in early events of virus-host cell interaction and also plays an 
important role in the generation of immunity against infection (Rodriguez, et al., 1987; 
Gong et al., 1990; Lai et al., 1991). Thus identification and characterisation of envelope 
protein(s) is important for understanding common immunological relationships, the 
ability of capripoxvirus to infect all three species and early events of virus-host cell 
interactions of capripoxviruses. 
In the present study, structural analysis of capripoxvirus (KS-1) revealed that a large 
number of proteins are associated with the virus. Selective separation of virus proteins 
into envelope and core fractions and examination by immunoblot analysis identified 
three proteins (32kd, 27kd and 19kd) localised in the envelope of virus, of which the 
32kd is a major envelope protein of the virus. Hyperimmune sera obtained against 
different isolates of capripoxvirus reacted equally strongly with the 32kd envelope 
protein in immunoblot analysis . During natural capripoxvirus infection of sheep 
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antibodies against this protein are detected earlier than those against the other virus 
proteins. These studies indicate that the 32kd envelope protein is strongly antigenic in 
nature. 
Monospecific polyclonal sera were prepared in rabbits against the 69kd, 32kd and 26kd 
proteins derived from SDS-PAGE gels (Chapter 3). The monospecific serum against the 
32kd protein decreased the virus infectivity whereas monospecific sera to the 69kd and 
26kd proteins did not affect the virus infectivity. Since the monospecific sera were 
prepared using proteins that had been separated by SDS-PAGE the antibodies produced 
will be against linear antigenic epitopes of the protein molecules. These linear antigenic 
epitopes of the 32kd protein appear to be exposed on the surface of the virus envelope. 
Reaction of the 32kd protein antibodies with the epitopes exposed on the surface of virus 
envelope could interfere in early events of virus-host cell interactions such as binding 
or fusion of the virus particle to the cell surface. 
Immunity to poxvirus infections is due to humoral and cell-mediated responses of the 
immune system (Blanden and Gardner, 1976; Buller et al., 1991). The contribution made 
by antibody to immunity against orthopoxvirus infections was investigated by Fenner 
(1949) using mousepoxvirus as a model. It was shown that mice passively immunised 
with mousepoxvirus antiserum survived a lethal challenge, although virus replication at 
the site of inoculation was not affected. Similarly, passive transfer of immune serum 
obtained from an animal recovered from capripoxvirus infection was found to protect 
sheep from challenge with virulent capripoxvirus isolates, here again local virus 
replication occurred at the site of inoculation (Kitching, 1986). Vaccinated sheep or 
animals recovered from capripoxvirus infection show delayed type hypersensitivity 
reaction on challenge without local virus replication (Kitching, 1985; Kitching et al., 
1987). These results indicate that the cell-mediated immune responses are perhaps 
essential for the recovery from primary capripoxvirus infections and the antiviral 
antibodies produced by B lymphocytes appear to be helpful in preventing reinfection. 
Recently, it has been shown that the 14kd envelope protein of vaccinia virus is capable 
of inducing neutralising antibody as well as cell-mediated immune responses. Mice 
inoculated with the isolated 14kd protein are protected from challenge with virulent 
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vaccinia virus (Lai et al., 1991; Demkowicz et al., 1992). In the present study cell- 
mediated immune responses against capripoxvirus proteins were studied using 
lymphocytes obtained from vaccinated sheep. Capripoxvirus (KS-1) envelope proteins 
and solubilised core proteins were used for in vitro lymphocyte proliferation assays. Both 
the envelope and the core proteins induced a proliferation of lymphocytes indicating that 
they contained T-cell epitopes. Exogenous non-infectious antigens have been shown to 
be processed and presented in association with classII MHC molecules (Braciale et al., 
1987). Antigens which are presented in association with the ClassIl MHC molecules 
have been clearly shown to be involved in inducing the helper T-cells of the immune 
system (Zinkernagel and Doherty, 1979; Germain, 1988; Gerlier and Rabourdin-Combe, 
1989). Therefore, the T-cell stimulations observed in the in vitro assays in the present 
study, were most likely due to proliferation of helper T -cells. These observations 
suggested that the envelope and core proteins of the virus contained helper T-cell 
epitopes. It has been shown that the 32kd envelope protein is strongly antigenic in nature 
and possessed epitopes that induced neutralising antibodies (Chapter 3), indicating that 
this protein could be a major component which is involved in the proliferation of helper 
T-cells in vitro proliferation studies. The assumption that the 32kd envelope protein was 
mainly responsible for the stimulation of helper T-cells the isolated 32kd protein was 
tested. The 32kd protein alone strongly stimulated the lymphocytes in the in vitro 
proliferation assays which supports the idea that this protein contained the helper T-cell 
epitopes. The presence of the helper T-cell epitopes and virus neutralisation epitopes in 
the 32kd protein implies that this protein is involved in humoral as well as cell mediated 
immune responses against the capripoxvirus infections and could form the basis for the 
development of a vaccination programme. 
Capripox is one of the major problems in sheep, goats and cattle and is prevalent 
throughout the Middle East, Asia and most African countries (Kitching, 1985). It has 
been eradicated from Europe although sporadic out breaks have been reported from Italy 
and Cyprus (OIE 1983,1985). The disease is not present in Australia, New Zealand or 
North and South America, and reports of capripox (goatpoxvirus) on the western coast 
of North America (Renshaw and Dodd, 1978) have not been confirmed by other 
workers. Orf is enzootic worldwide, frequently affecting sheep and goats and is 
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transmissible to human beings (Robinson and Balassu, 1981). The disease caused by 
capripoxvirus or orf virus in sheep and goats can not be differentiated on the basis of 
clinical signs or by serological testing (Dubey and Swahney, 1979; Subba Rao and 
Malik, 1979; Subba Rao et al., 1984). It is important to have a serological test for the 
differentiation of capripoxvirus and orf virus infections, because virus specific antibodies 
in serum samples indicate exposure to the virus. A differential serological test is of great 
importance for the determination of the epidemiological situation or the herd status of 
these infections. In addition, in countries or areas free from capripoxvirus infection it is 
important to be able to serologically distinguish capripox from orf. A specific serological 
test would also facilitate the exportation of animals between the countries. Recently a 
specific example has been recorded where problems occurred in exportation of 
Australian sheep to the Middle East countries (New Scientist, 1989). The Australian 
sheep being exported to the Middle East countries were reported to be infected with 
capripoxvirus despite the fact that Australia is free from this disease. In the present study 
serological relationships between capripoxvirus and orf virus were studied by screening 
serum samples obtained from orf and capripox infected sheep using agar gel 
immunodiffusion (AGID) test and immunoblot analysis. The analysis of serum samples 
obtained from capripox or orf infected sheep produced positive reactions in the AGID 
test with both capripoxvirus and orf virus soluble antigens indicating that this method 
is unsuitable for differential diagnosis. Other serological assays such as ELISA, 
complement-fixation and counter-immunoelectrophoresis will not be reliable for the 
differentiation of these infections, because they also detect total antibody response, 
including those from the cross-reactive antibodies. Kitching et al. (1986) show that a 
67kd protein, which is a major common precipitating antigen of capripoxviruses, cross- 
reacts with orf positive serum. As it is unlikely that all structural proteins of both the 
viruses would induce cross-reactive antibodies immunoblot analysis of antibodies 
responses against structural proteins of both the viruses may be useful in differential 
diagnosis. Serum samples from capripox or orf infected sheep produce a unique pattern 
of reactions in immunoblot analysis which provides an easy and definitive method for 
the differential diagnosis of these two infections (Chapter 5). In particular the antibody 
responses to the 32kd protein of capripoxvirus are important for the differentiation. The 
32kd protein is strongly antigenic in nature, as discussed above, and antibodies against 
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this protein are detected in all capripox infected sheep, whereas none of the serum 
samples from orf infected sheep produce reactions with the 32kd protein of 
capripoxvirus. Most of the Australian sheep serum samples produced positive reaction 
in the AGID test with both orf virus and capripoxvirus soluble antigens, none of the 
serum samples, however, reacted with the 32kd protein of capripoxvirus, indicating that 
the Australian sheep had not been infected with capripoxvirus but with orf virus. These 
studies clearly show that the 32kd protein specific antibody responses, as determined by 
immunoblot analysis, provide a reliable method for serological differential diagnosis of 
capripoxvirus and orf virus infections. 
The first event in the infectious cycle of a virus is the binding of the virus particle to 
the surface of host cell. The surface of a host cell probably contains `virus attachment' 
sites to which a specific surface protein of the virus can bind. Specific cell surface 
binding proteins have been shown to be present on the envelope of several viruses 
including poxviruses (Maa et al., 1990). In the present work, the 32kd envelope protein 
of capripoxvirus (KS-1) has been shown to bind to the surface of LT-cells. The binding 
of this 32kd envelope protein is completely abolished by competition with purified 
capripoxvirus (KS-1) but not by bovine serum albumin, indicating that the solubilised 
32kd envelope protein and 32kd protein present on the virus envelope bind to the same 
receptor site on the cell. The presence of a large number of `virus attachment' sites on 
the surface of LT-cells and numerous copies of the 32kd protein on the virus envelope 
would stabilise the interaction between the cell membrane and virus particle. Trypsin 
degrades an externally exposed 10kd fragment of this envelope protein decreasing the 
virus infectivity by at least ten fold. These observations indicate that the cell surface 
binding domain is localised within the external 10kd fragment of the 32kd envelope 
protein. In addition, the monospecific serum to the 32kd protein reduced the virus 
infectivity by ten fold, which was similar to the effect of trypsin on virus infectivity, but 
it did not have any effect on the infectivity of the trypsin treated virus. These results 
strongly suggest that the 32kd monospecific serum contains antibodies against the 10kd 
external fragment of the 32kd protein and that these antibodies are capable of interfering 
with the binding of virus particle to the cell surface. On the basis of these results it can 
be concluded that the 32kd envelope protein is a cell surface binding protein of 
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capripoxvirus (KS-1), and that the cell surface binding domain is localised within the 
external 10kd fragment of the 32kd protein. Since capripoxvirus isolates normally infects 
sheep, goats and cattle it is probable that specific `virus attachment' sites on the host cell 
surface for the 32kd protein of capripoxvirus are present only in these three species of 
animals. 
A vaccinia virus cell surface binding protein of 32kd has been identified and shown to 
be localised in the virus envelope (Maa et al., 1990). The similarity of its location in the 
virus and its molecular weight to that of the 32kd capripoxvirus (KS-1) protein discussed 
above could imply that these proteins are possibly homologous and have very similar 
functions. However, several differences were observed between these two binding 
proteins. Trypsin treatment of capripoxvirus (KS-1) degrades the 32kd protein and 
reduces the virus infectivity whereas trypsin treatment of vaccinia virus although also 
degrading the 32kd protein led to an increase of the virus infectivity. Maa et al. (1990) 
propose that the cell surface binding domain of the vaccinia virus 32kd protein is 
localised within the 3kd fragment which remains associated with the virus after trypsin 
treatment. Contrary to this the present work showed that the cell surface binding domain 
of 32kd protein of capripoxvirus (KS-1) is localised in the external 10kd fragment. 
Monospecific serum to the 32kd binding protein neutralised the capripoxvirus (KS-1), 
however, monospecific serum to the vaccinia virus 32kd binding protein does not 
neutralise the virus (Niles and Seto, 1988). Despite these observed differences it is 
apparent that their major function which is the binding of the virus particle to the cell 
is basically identical. 
Vaccinia virus 32kd protein has been shown to bind to the surface of cells of different 
origins and the degree of binding correlates with the ability of virus to replicate in these 
cells (Maa et al., 1990). The 32kd protein binds with human cells (HeLa-G), monkey 
cells (BSC-40) and mouse cells (L929) all of which are permissive for vaccinia 
replication. Whereas binding of the 32kd protein was not observed with polarized 
epithelial Madin-Darby canine kidney (MDCK) cells in which vaccinia virus does not 
replicate. These results indicate that the `virus attachment' sites for the 32kd protein of 
vaccinia virus are present on a variety of cell types. Vaccinia virus can infect sheep, 
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goats and cattle, presumably cellular `virus attachment' sites for the vaccinia virus 32kd 
protein are also present in these animal species. However, the cell receptors for the 32kd 
protein of vaccinia virus and 32kd protein of capripoxvirus in sheep, goats and cattle are 
likely to be different. 
Subsequent to the binding of the virus particle to the cell membrane, entry of the virus 
or virus core is accomplished either by direct fusion of virus envelope proteins with the 
plasma membrane or by a phagocytic mechanism (1.10.2). A 14kd envelope protein has 
been shown to have a specific role in the fusion process of vaccinia virus with the 
plasma membrane (Rodriguez et al., 1987). A fusion protein of capripoxvirus (KS-1) has 
not yet been definitively identified, however, a gene homolog to the vaccinia virus l4kd 
protein gene is present within the capripoxvirus (KS-1) genome (Gershon et al., 1989). 
The fusion protein gene of capripoxvirus (KS-1) is capable of encoding for a l9kd 
protein which shows 32% amino acid identity with that of vaccinia virus 14kd fusion 
protein. A 19kd protein in the virus envelope has been identified in the present study. 
Further studies are required to confirm whether the l9kd protein is a fusion protein of 
capripoxvirus (KS-1). A fusion protein gene has also been identified in orf virus, a 
parapoxvirus (Naase and Nicholson, 1991). The deduced amino acid sequence shows 
31% identity with the vaccinia virus fusion protein and 32% with capripoxvirus (KS-1) 
protein. Despite the fact that vaccinia virus, orf virus and capripoxvirus (KS-1) belong 
to different genera of the family Poxviridae gene conservation appears to be present in 
these viruses. 
The nucleotide sequence analysis of the segment of capripoxvirus (KS-1) DNA, HindHI 
Q1, containing the 32kd protein gene revealed the presence of five open reading frames. 
Four of these open frames, Q, 1L, Q12R, Q13L and Q15L, show identical orientation and 
a high level of identity in predicted amino acid sequence with those of vaccinia virus 
H1L, H2R, H3L and H4L open reading frames, respectively (Table 7.1). These results 
clearly show the high level of conservation in gene organisation between the two viruses. 
This had also previously been observed between regions of capripoxvirus (KS-1) DNA 
and corresponding cross-hybridising vaccinia virus DNA segments (Gershon and Black, 
1989b; Gershon et al., 1989). The Q13L open reading frame encodes the 32kd binding 
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protein of capripoxvirus (KS-1). This is a late protein as evidenced by the time course 
synthesis and Ara-C inhibition studies (Chapter 4). A conserved TAAAT motif which 
has been shown to be present at the 5' end of most late open reading frame sequences 
(Hanggi et at., 1986; Rosel et at., 1986) was not present at the 5' end of the 32kd open 
reading frame. A similar situation has been observed with the major core polypeptide 
V4b gene (Rosel and Moss, 1985) and the haemagglutinin gene (Shida, 1986) of 
vaccinia virus, both of which are late proteins. It has been shown that if the late motif 
TAAAT is present within the 50bp region upstream of the initiation codon (Davison and 
Moss, 1989) with no intervening ATG, then it has a high potential to express the 
following sequences at late times of infection (Goebel et al., 1990). The TAAAT motif 
is present 27 nucleotides upstream from the 5'end of the 32kd open reading frame 
without intervening ATG, indicating that it acts as a late promoter. 
The Q13L open reading frame which encodes the 32kd binding protein of capripoxvirus 
(KS-1) shows 34.1% identity and 61.3% similarity in amino acid sequence with that of 
H3L open reading frame of vaccinia virus, indicating that Q13L is homologous to 
vaccinia virus H3L. However, the product of H3L has not been identified yet. The H3L 
open reading frame of vaccinia virus is capable of encoding for a 37.5kd multiple 
hydrophobic polypeptide. A potential glycosylation site and a transmembrane sequence 
near C-terminus have been predicted. (Goebel et al., 1990). In addition the 14 amino 
acids near the N-terminus are hydrophobic in nature. The predicted amino acid sequence 
(264 residues) of the Q13L of capripoxvirus (KS-1) contains two glycosylation sites and 
a 14 hydrophobic amino acid at the N-terminus (1-14) which is similar to that of H3L. 
In contrast to the H3L the C-terminus of Q13L does not contain a transmembrane 
sequence. The last C-terminal 65 amino acids (199-264) of the Q13L show a high 
probability to be exposed on the surface of the virus envelope and contain several lysine 
residues. Trypsin probably cleaves the polypeptide from the C-terminus at the lysine 
residue present at 202 or 204 position. Trypsin can cleave at several sites since several 
lysine residues are present in the C-terminal region. Several lysine and arginine residues 
are present in the polypeptide sequence from 1-198 residues, however, they appear to 
be inaccessible to the trypsin due to folding of the polypeptide or they are not exposed 
on the surface of the virus. 
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A 37kd glycoprotein has been identified in the vaccinia virus envelope. This protein has 
been shown to be involved in binding of the virus particle to the cell surface (Ichihashi 
and Oie, 1980). In addition, the trypsin cleaves the 37kd protein at the glycosylated end 
and reduces the binding ability of the virus particle to the cell surface. Monospecific 
antibodies to the 37kd protein neutralise the vaccinia virus infectivity but do not produce 
any effect on trypsin treated virus (Ichihashi and Oie, 1980). However, although trypsin 
treatment reduces the binding ability of the virus it increases the virus infectivity. 
Trypsin also affects 54kd, 34kd, 32kd and 14kd vaccinia virus proteins, it is possible that 
one of these changes is the cause of the increase in infectivity of vaccinia virus. The 
37kd protein is resistant to chymotrypsin and NP-40 and only partially solubilised in NP- 
40 and 2-mercaptoethanol, however, it can be extracted almost completely by 8M urea 
which does not solubilise the virus envelope (Ischihashi and Oie, 1980). It appears that 
hydrogen bonds rather than hydrophobic or disulphide bonds are responsible for the 
stability of the 37kd protein in the virus envelope. The 37kd protein is a glycoprotein 
and it shows several properties which are similar to that of 32kd envelope protein of 
capripoxvirus (KS-1). The 32kd protein of capripoxvirus (KS-1) is encoded by the Q13L 
which showed a high level of similarity with respect to the nucleotide sequence as well 
as amino acid sequence with that of the H3L of vaccinia virus. The H3L of vaccinia 
virus is capable of coding for a 37.5kd polypeptide which contains a potential 
glycosylation site. On the basis of these properties it is reasonable to speculate that the 
H3L of vaccinia virus encodes the 37kd protein. However, further studies are needed to 
demonstrate that the 37kd protein is encoded by the H3L of vaccinia virus. Vaccinia 
virus contains two proteins, 32kd and 37kd, both of which are localised on the virus 
envelope and appear to have similar binding character. Vaccinia virus lacking the 32kd 
binding protein replicates with normal kinetics in tissue culture (Niles and Seto, 1988) 
suggesting that some other mechanism can also be involved in binding of the virus 
particle to the cell surface. The 37kd binding protein supplies an interesting alternative 
for this initial step in vaccinia virus replication. 
It has been clearly shown that the genomes of orthopoxviruses and the capripoxviruses 
are well conserved with respect to gene locations and organisations (Gershon et al., 
1989). Thus the genes encoding the 32kd binding proteins of capripoxvirus and vaccinia 
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virus could be expected to be homologos with respect to nucleotide sequence and located 
in similar position in the genomes of these viruses. However, the genes for these two 
binding proteins '_ -- are present in quite different regions of the virus 
genomes. The 32kd binding protein of vaccinia virus is encoded by the D8L open 
reading frame (Niles et al., 1986; Maa et al., 1990) and shows only a 16.2% identity in 
amino acid sequence with that of capripoxvirus (KS-1) Q13L open reading frames, 
suggesting that these two proteins are not related. Whether capripoxvirus (KS-1) contains 
an homolog of the vaccinia virus D8L gene has not been investigated in the present 
study. It will be useful to determine whether a homolog of the vaccinia virus D8L open 
reading frame is present in capripoxvirus (KS-1). It can be speculated that the homolog 
of vaccinia virus D8L may be present in capripoxvirus genome, but that it is in a 
degenerate form and thus it will not produce a functional protein. 
The 32kd protein is capripoxvirus specific thus analysis of antibody responses against 
this protein provides a simple and definitive diagnostic assay which would be useful in 
assessing the epidemiological situation of capripox as well as in differential diagnosis 
from the infections caused by orf virus. The immunological analysis demonstrated that 
the 32kd major envelope protein of capripoxvirus (KS-1) possesses both neutralising and 
helper T-cell epitopes suggesting that this protein is involved in immunity to 
capripoxvirus infections. This protein could possibly be used alone in vaccination 
procedures against capripoxvirus infections in all three species. In addition, the molecular 
characterisation of the 32kd protein provides an insight into the mechanism involved in 
early events of virus-host cell interactions. The cloning and expression of the 32kd gene 
of capripoxvirus (KS-1) would be useful for obtaining large amounts of the 32kd protein 
which will facilitate : a) development of an easy and field-based serological diagnostic 
test, b) vaccination studies using the 32kd protein alone and, c) identification of the 
`cellular attachment' sites for the 32kd protein. 
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